{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T17:20:25Z","timestamp":1783444825341,"version":"3.54.6"},"reference-count":1044,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.ajo.2025.11.024","type":"journal-article","created":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T21:56:51Z","timestamp":1763762211000},"page":"e144-e221","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["TFOS DEWS III \u7ba1\u7406\u4e0e\u6cbb\u7597\u62a5\u544a"],"prefix":"10.1016","volume":"288","author":[{"given":"Lyndon","family":"Jones","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer P.","family":"Craig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Markoulli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Karpecki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esen K.","family":"Akpek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayan","family":"Basu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etty","family":"Bitton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepinder K.","family":"Dhaliwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murat","family":"Dogru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Alvaro P.","family":"Gomes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miranda","family":"Koehler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jodhbir S.","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor L","family":"Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona","family":"Stapleton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Sullivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Tauber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00f2nia","family":"Trav\u00e9-Huarte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James S.","family":"Wolffsohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Baudouin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Downie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Giannaccare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jutta","family":"Horwath-Winter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuguo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shizuka","family":"Koh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Messmer","family":"Elisabeth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernesto","family":"Otero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edoardo","family":"Villani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Watson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung Chul","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajo.2025.11.024_bib0001","article-title":"TFOS DEWS III Diagnostic Methodology","author":"Wolffsohn","year":"2025","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajo.2025.11.024_bib0002","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.jtos.2017.05.006","article-title":"TFOS DEWS II Management and Therapy Report","volume":"15","author":"Jones","year":"2017","journal-title":"Ocul Surf"},{"issue":"8","key":"10.1016\/j.ajo.2025.11.024_bib0003","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1080\/08820538.2023.2204931","article-title":"Real Life Impact of Dry Eye Disease","volume":"38","author":"Cutrupi","year":"2023","journal-title":"Semin Ophthalmol"},{"key":"10.1016\/j.ajo.2025.11.024_bib0004","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.jtos.2023.08.009","article-title":"TFOS Lifestyle Report Executive Summary: A Lifestyle Epidemic - Ocular Surface Disease","volume":"30","author":"Craig","year":"2023","journal-title":"Ocul Surf"},{"issue":"Suppl 1","key":"10.1016\/j.ajo.2025.11.024_bib0005","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.1097\/ICO.0000000000001731","article-title":"What Have We Learned From the Osaka Study?","volume":"37","author":"Uchino","year":"2018","journal-title":"Cornea"},{"issue":"7","key":"10.1016\/j.ajo.2025.11.024_bib0006","article-title":"Nocturnal Lagophthalmos and Sleep Quality in Patients with Dry Eye Disease","volume":"10","author":"Takahashi","year":"2020","journal-title":"Life (Basel)"},{"key":"10.1016\/j.ajo.2025.11.024_bib0007","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.jtos.2021.04.001","article-title":"Relationship between unhealthy sleep status and dry eye symptoms in a Japanese population: The JPHC-NEXT study","volume":"21","author":"Hanyuda","year":"2021","journal-title":"Ocul Surf"},{"key":"10.1016\/j.ajo.2025.11.024_bib0008","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.2147\/NSS.S378751","article-title":"The Association Between Dry Eye and Sleep Disorders: The Evidence and Possible Mechanisms","volume":"14","author":"Li","year":"2022","journal-title":"Nat Sci Sleep"},{"issue":"9","key":"10.1016\/j.ajo.2025.11.024_bib0009","article-title":"Epidemiology and Risk Factors of Dry Eye Disease: Considerations for Clinical Management","volume":"60","author":"Britten-Jones","year":"2024","journal-title":"Medicina (Kaunas, Lithuania)"},{"issue":"14","key":"10.1016\/j.ajo.2025.11.024_bib0010","doi-asserted-by":"crossref","first-page":"DES143","DOI":"10.1167\/iovs.17-23467","article-title":"Sleep Disorders are a Prevalent and Serious Comorbidity in Dry Eye","volume":"59","author":"Ayaki","year":"2018","journal-title":"Invest Ophthalmol Vis Sci."},{"key":"10.1016\/j.ajo.2025.11.024_bib0011","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jtos.2023.04.005","article-title":"TFOS Lifestyle: Impact of cosmetics on the ocular surface","volume":"29","author":"Sullivan","year":"2023","journal-title":"Ocul Surf"},{"key":"10.1016\/j.ajo.2025.11.024_bib0012","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.jtos.2023.04.011","article-title":"TFOS Lifestyle: Impact of elective medications and procedures on the ocular surface","volume":"29","author":"Gomes","year":"2023","journal-title":"Ocul Surf"},{"issue":"8","key":"10.1016\/j.ajo.2025.11.024_bib0013","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0271267","article-title":"Identified risk factors for dry eye syndrome: A systematic review and meta-analysis","volume":"17","author":"Qian","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.ajo.2025.11.024_bib0014","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jtos.2023.04.004","article-title":"TFOS Lifestyle: Impact of the digital environment on the ocular surface","volume":"28","author":"Wolffsohn","year":"2023","journal-title":"Ocul Surf"},{"issue":"6","key":"10.1016\/j.ajo.2025.11.024_bib0015","doi-asserted-by":"crossref","DOI":"10.3390\/nu13061998","article-title":"Review of Topical and Systemic Vitamin Supplementation in Ocular Surface Diseases","volume":"13","author":"Fogagnolo","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.ajo.2025.11.024_bib0016","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.jtos.2023.04.003","article-title":"TFOS Lifestyle: Impact of nutrition on the ocular surface","volume":"29","author":"Markoulli","year":"2023","journal-title":"Ocul Surf"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0017","doi-asserted-by":"crossref","first-page":"127","DOI":"10.37349\/emed.2024.00211","article-title":"Effects of dietary imbalances of micro- and macronutrients on the ocular microbiome and its implications in dry eye disease","volume":"5","author":"Pilkington","year":"2024","journal-title":"Exploration of Medicine"},{"issue":"10","key":"10.1016\/j.ajo.2025.11.024_bib0018","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.4103\/IJO.IJO_2899_22","article-title":"Nutrition and diet for dry eye disease: Insights toward holistic management","volume":"72","author":"Bhandarkar","year":"2024","journal-title":"Indian J Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0019","doi-asserted-by":"crossref","DOI":"10.3390\/jcm14010196","article-title":"From Symptoms to Satisfaction: Optimizing Patient-Centered Care in Dry Eye Disease","volume":"14","author":"Villani","year":"2025","journal-title":"J Clin Med"},{"key":"10.1016\/j.ajo.2025.11.024_bib0020","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jtos.2020.04.005","article-title":"Prevalence and risk factors of dry eye in 79,866 participants of the population-based Lifelines cohort study in the Netherlands","volume":"19","author":"Vehof","year":"2021","journal-title":"Ocul Surf"},{"issue":"4","key":"10.1016\/j.ajo.2025.11.024_bib0021","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1177\/11206721211060963","article-title":"Dry eye disease and psychiatric disorders: A systematic review and meta-analysis","volume":"32","author":"Basilious","year":"2022","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.ajo.2025.11.024_bib0022","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.jtos.2023.04.008","article-title":"TFOS Lifestyle: Impact of lifestyle challenges on the ocular surface","volume":"28","author":"Galor","year":"2023","journal-title":"Ocul Surf"},{"issue":"52","key":"10.1016\/j.ajo.2025.11.024_bib0023","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000041019","article-title":"Association between potential factors and dry eye disease: A systematic review and meta-analysis","volume":"103","author":"Yang","year":"2024","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ajo.2025.11.024_bib0024","article-title":"Mental burden of ocular surface discomfort","author":"Di Zazzo","year":"2024","journal-title":"Eur J Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2025.11.024_bib0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0123299","article-title":"Associations between subjective happiness and dry eye disease: a new perspective from the Osaka study","volume":"10","author":"Kawashima","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ajo.2025.11.024_bib0026","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jtos.2023.04.007","article-title":"TFOS Lifestyle Report: Impact of environmental conditions on the ocular surface","volume":"29","author":"Alves","year":"2023","journal-title":"Ocul Surf"},{"issue":"11","key":"10.1016\/j.ajo.2025.11.024_bib0027","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1097\/OPX.0000000000001136","article-title":"Randomized Trial of Desktop Humidifier for Dry Eye Relief in Computer Users","volume":"94","author":"Wang","year":"2017","journal-title":"Optom Vis Sci"},{"issue":"13","key":"10.1016\/j.ajo.2025.11.024_bib0028","doi-asserted-by":"crossref","DOI":"10.3390\/jcm13133720","article-title":"Safety and Efficacy of Photocatalytic Micro-Mist Desktop Humidifier for Dry Eye Caused by Digital Environment: A Randomized Controlled Trial","volume":"13","author":"Arita","year":"2024","journal-title":"J Clin Med"},{"issue":"5","key":"10.1016\/j.ajo.2025.11.024_bib0029","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1167\/tvst.7.5.18","article-title":"Effect of Ultrasonic Moisture Glasses on Dry Eye Signs and Symptoms","volume":"7","author":"Onomura","year":"2018","journal-title":"Transl Vis Sci Technol"},{"issue":"3","key":"10.1016\/j.ajo.2025.11.024_bib0030","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/00003226-199405000-00001","article-title":"Spectacle side panels and moist inserts for the treatment of dry-eye patients","volume":"13","author":"Tsubota","year":"1994","journal-title":"Cornea"},{"issue":"6","key":"10.1016\/j.ajo.2025.11.024_bib0031","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/ICL.0000000000000431","article-title":"Evaluation of the Effect of Moist Chamber Spectacles in Patients With Dry Eye Exposed to Adverse Environment Conditions","volume":"44","author":"Ogawa","year":"2018","journal-title":"Eye Contact Lens"},{"issue":"5","key":"10.1016\/j.ajo.2025.11.024_bib0032","doi-asserted-by":"crossref","first-page":"490","DOI":"10.3109\/02713683.2014.932389","article-title":"Specialized moisture retention eyewear for evaporative dry eye","volume":"40","author":"Waduthantri","year":"2015","journal-title":"Curr Eye Res"},{"issue":"2","key":"10.1016\/j.ajo.2025.11.024_bib0033","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1097\/OPX.0000000000000778","article-title":"Effect of Moisture Chamber Spectacles on Tear Functions in Dry Eye Disease","volume":"93","author":"Shen","year":"2016","journal-title":"Optom Vis Sci"},{"key":"10.1016\/j.ajo.2025.11.024_bib0034","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2024-080474","article-title":"Effect of laughter exercise versus 0.1% sodium hyaluronic acid on ocular surface discomfort in dry eye disease: noninferiority randomised controlled trial","volume":"386","author":"Li","year":"2024","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.ajo.2025.11.024_bib0035","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.jtos.2017.05.001","article-title":"TFOS DEWS II Diagnostic Methodology report","volume":"15","author":"Wolffsohn","year":"2017","journal-title":"Review. Ocul Surf."},{"issue":"3","key":"10.1016\/j.ajo.2025.11.024_bib0036","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.jtos.2017.05.011","article-title":"TFOS DEWS II pathophysiology report","volume":"15","author":"Bron","year":"2017","journal-title":"Ocul Surf"},{"issue":"3","key":"10.1016\/j.ajo.2025.11.024_bib0037","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1136\/bjophthalmol-2015-307415","article-title":"Revisiting the vicious circle of dry eye disease: a focus on the pathophysiology of meibomian gland dysfunction","volume":"100","author":"Baudouin","year":"2016","journal-title":"The British journal of ophthalmology"},{"key":"10.1016\/j.ajo.2025.11.024_bib0038","article-title":"TFOS DEWS III Digest Report","author":"Stapleton","year":"2025","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajo.2025.11.024_bib0039","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1517\/14656566.2010.518612","article-title":"Pharmacotherapy of dry eye","volume":"12","author":"Dogru","year":"2011","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.ajo.2025.11.024_bib0040","first-page":"1419","article-title":"Artificial tears potpourri: a literature review","volume":"8","author":"Moshirfar","year":"2014","journal-title":"Clin Ophthalmol"},{"issue":"9","key":"10.1016\/j.ajo.2025.11.024_bib0041","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1089\/jop.2017.0052","article-title":"Relevance of Lipid-Based Products in the Management of Dry Eye Disease","volume":"33","author":"Garrigue","year":"2017","journal-title":"J Ocul Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.ajo.2025.11.024_bib0042","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1089\/jop.2020.0011","article-title":"Cationic Emulsion-Based Artificial Tears as a Mimic of Functional Healthy Tear Film for Restoration of Ocular Surface Homeostasis in Dry Eye Disease","volume":"36","author":"Daull","year":"2020","journal-title":"J Ocul Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.ajo.2025.11.024_bib0043","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23052434","article-title":"Artificial Tears: Biological Role of Their Ingredients in the Management of Dry Eye Disease","volume":"23","author":"Labetoulle","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ajo.2025.11.024_bib0044","first-page":"54","article-title":"Artificial Tears: What Matters and Why","author":"Cole","year":"2020","journal-title":"Review of Optometry"},{"issue":"6","key":"10.1016\/j.ajo.2025.11.024_bib0045","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1097\/ICL.0000000000000138","article-title":"A Comparative Study Between an Oil-in-Water Emulsion and Nonlipid Eye Drops Used for Rewetting Contact Lenses","volume":"41","author":"Guthrie","year":"2015","journal-title":"Eye Contact Lens"},{"issue":"4","key":"10.1016\/j.ajo.2025.11.024_bib0046","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.jtos.2020.08.004","article-title":"Prophylactic action of lipid and non-lipid tear supplements in adverse environmental conditions: A randomised crossover trial","volume":"18","author":"Muntz","year":"2020","journal-title":"Ocul Surf"},{"key":"10.1016\/j.ajo.2025.11.024_bib0047","doi-asserted-by":"crossref","DOI":"10.1016\/j.curtheres.2023.100704","article-title":"In Vitro Inhibition of Evaporation with Perfluorohexyloctane, an Eye Drop for Dry Eye Disease","volume":"98","author":"Vittitow","year":"2023","journal-title":"Curr Ther Res Clin Exp"},{"issue":"4","key":"10.1016\/j.ajo.2025.11.024_bib0048","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s40265-024-02016-5","article-title":"Perfluorohexyloctane Ophthalmic Solution: A Review in Dry Eye Disease","volume":"84","author":"Zhuang-Yan","year":"2024","journal-title":"Drugs"},{"key":"10.1016\/j.ajo.2025.11.024_bib0049","doi-asserted-by":"crossref","DOI":"10.1007\/s40123-025-01097-z","article-title":"Early Effects of Perfluorohexyloctane Ophthalmic Solution on Patient-Reported Outcomes in DryEye Disease: A Prospective, Open-Label, Multicenter Study","author":"Bacharach","year":"2025","journal-title":"Ophthalmol Ther"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0050","first-page":"41","article-title":"Efficacy of Perfluorohexyloctane for the Treatment of Patients with Dry Eye Disease: A Meta-Analysis","volume":"68","author":"Taloni","year":"2025","journal-title":"Ophthalmic research"},{"issue":"10","key":"10.1016\/j.ajo.2025.11.024_bib0051","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21103516","article-title":"The Effects of High Molecular Weight Hyaluronic Acid Eye Drop Application in Environmental Dry Eye Stress Model Mice","volume":"21","author":"Kojima","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ajo.2025.11.024_bib0052","first-page":"577","article-title":"Rat P. High molecular weight hyaluronan decreases UVB-induced apoptosis and inflammation in human epithelial corneal cells","volume":"15","author":"Pauloin","year":"2009","journal-title":"Mol Vis"},{"issue":"4","key":"10.1016\/j.ajo.2025.11.024_bib0053","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.preteyeres.2010.03.001","article-title":"Preservatives in eyedrops: the good, the bad and the ugly","volume":"29","author":"Baudouin","year":"2010","journal-title":"Prog Retin Eye Res."},{"key":"10.1016\/j.ajo.2025.11.024_bib0054","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jtos.2024.08.001","article-title":"Preservatives and ocular surface disease: A review","volume":"34","author":"Kahook","year":"2024","journal-title":"Ocul Surf"},{"issue":"5","key":"10.1016\/j.ajo.2025.11.024_bib0055","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/BF02853166","article-title":"Effects of common ophthalmic preservatives on ocular health","volume":"18","author":"Noecker","year":"2001","journal-title":"Adv Ther"},{"issue":"3","key":"10.1016\/j.ajo.2025.11.024_bib0056","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1080\/15569520902995834","article-title":"Ocular preservatives: associated risks and newer options","volume":"28","author":"Kaur","year":"2009","journal-title":"Cutan Ocul Toxicol"},{"key":"10.1016\/j.ajo.2025.11.024_bib0057","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.2147\/OPTH.S211611","article-title":"The use of preservatives in dry eye drops","volume":"13","author":"Walsh","year":"2019","journal-title":"Clin Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajo.2025.11.024_bib0058","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24032758","article-title":"A Critical Appraisal of the Physicochemical Properties and Biological Effects of Artificial Tear Ingredients and Formulations","volume":"24","author":"Weng","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ajo.2025.11.024_bib0059","doi-asserted-by":"crossref","first-page":"783","DOI":"10.2147\/OPTH.S13773","article-title":"Systane lubricant eye drops in the management of ocular dryness","volume":"5","author":"Benelli","year":"2011","journal-title":"Clin Ophthalmol"},{"issue":"23","key":"10.1016\/j.ajo.2025.11.024_bib0060","doi-asserted-by":"crossref","DOI":"10.3390\/cells12232755","article-title":"The Molecular Mechanisms Responsible for Tear Hyperosmolarity-Induced Pathological Changes in the Eyes of Dry Eye Disease Patients","volume":"12","author":"Harrell","year":"2023","journal-title":"Cells"},{"issue":"5","key":"10.1016\/j.ajo.2025.11.024_bib0061","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1097\/ICO.0b013e318165b19e","article-title":"Effects of osmoprotectants on hyperosmolar stress in cultured human corneal epithelial cells","volume":"27","author":"Corrales","year":"2008","journal-title":"Cornea"},{"issue":"9","key":"10.1016\/j.ajo.2025.11.024_bib0062","doi-asserted-by":"crossref","first-page":"6287","DOI":"10.1167\/iovs.13-12081","article-title":"Efficacy of osmoprotectants on prevention and treatment of murine dry eye","volume":"54","author":"Chen","year":"2013","journal-title":"Invest Ophthalmol Vis Sci."},{"key":"10.1016\/j.ajo.2025.11.024_bib0063","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jtos.2024.03.002","article-title":"Ectoine protects corneal epithelial survival and barrier from hyperosmotic stress by promoting anti-inflammatory cytokine IL- 37","volume":"32","author":"Li","year":"2024","journal-title":"Ocul Surf"},{"issue":"13","key":"10.1016\/j.ajo.2025.11.024_bib0064","article-title":"Novel Gel-Forming Ophthalmic Polymer System for Artificial Tear Solution","volume":"44","author":"Asgharian","year":"2003","journal-title":"Investigative Ophthalmology & Visual Science"},{"issue":"4","key":"10.1016\/j.ajo.2025.11.024_bib0065","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1021\/ma00182a046","article-title":"Reversible gel formation induced by ion complexation. 2. Phase diagrams","volume":"21","author":"Pezron","year":"1988","journal-title":"Macromolecules"},{"key":"10.1016\/j.ajo.2025.11.024_bib0066","doi-asserted-by":"crossref","first-page":"3311","DOI":"10.2147\/OPTH.S377960","article-title":"Propylene Glycol and Hydroxypropyl Guar Nanoemulsion - Safe and Effective Lubricant Eye Drops in the Management of Dry Eye Disease","volume":"16","author":"Srinivasan","year":"2022","journal-title":"Clin Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0067","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1021\/la803095q","article-title":"Reversible flocculation with hydroxypropyl guar-borate, a labile anionic polyelectrolyte","volume":"25","author":"Pelton","year":"2009","journal-title":"Langmuir"},{"key":"10.1016\/j.ajo.2025.11.024_bib0068","doi-asserted-by":"crossref","first-page":"695","DOI":"10.2147\/OPTH.S150587","article-title":"Tear osmolarity changes after use of hydroxypropyl-guar-based lubricating eye drops","volume":"12","author":"Ng","year":"2018","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.ajo.2025.11.024_bib0069","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.2147\/OPTH.S294427","article-title":"A Decade of Effective Dry Eye Disease Management with Systane Ultra (Polyethylene Glycol\/Propylene Glycol with Hydroxypropyl Guar) Lubricant Eye Drops","volume":"15","author":"Srinivasan","year":"2021","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.ajo.2025.11.024_bib0070","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.2147\/OPTH.S164888","article-title":"Efficacy of polyethylene glycol propylene glycol-based lubricant eye drops in reducing squamous metaplasia in patients with dry eye disease","volume":"12","author":"Aguilar","year":"2018","journal-title":"Clin Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajo.2025.11.024_bib0071","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1167\/tvst.8.6.2","article-title":"Physicochemical Properties of Hyaluronic Acid-Based Lubricant Eye Drops","volume":"8","author":"Aragona","year":"2019","journal-title":"Transl Vis Sci Technol"},{"issue":"8","key":"10.1016\/j.ajo.2025.11.024_bib0072","doi-asserted-by":"crossref","DOI":"10.3390\/polym12081800","article-title":"Hyaluronic Acid: The Influence of Molecular Weight on Structural, Physical, Physico-Chemical, and Degradable Properties of Biopolymer","volume":"12","author":"Snetkov","year":"2020","journal-title":"Polymers"},{"issue":"8","key":"10.1016\/j.ajo.2025.11.024_bib0073","article-title":"Why Chain Length of Hyaluronan in Eye Drops Matters","volume":"10","author":"Muller-Lierheim","year":"2020","journal-title":"Diagnostics (Basel)"},{"issue":"8","key":"10.1016\/j.ajo.2025.11.024_bib0074","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/aos.15159","article-title":"Hyaluronic acid in the treatment of dry eye disease","volume":"100","author":"Hynnekleiv","year":"2022","journal-title":"Acta Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0075","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/aos.15675","article-title":"A comparison between hyaluronic acid and other single ingredient eye drops for dry eye, a review","volume":"102","author":"Hynnekleiv","year":"2024","journal-title":"Acta Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0076","doi-asserted-by":"crossref","first-page":"9013","DOI":"10.1038\/s41598-017-08534-5","article-title":"Sodium Hyaluronate in the Treatment of Dry Eye Syndrome: A Systematic Review and Meta-Analysis","volume":"7","author":"Ang","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.ajo.2025.11.024_bib0077","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.2147\/OPTH.S256480","article-title":"Safety and Efficacy of a Preservative-Free Artificial Tear Containing Carboxymethylcellulose and Hyaluronic Acid for Dry Eye Disease: A Randomized, Controlled, Multicenter 3-Month Study","volume":"14","author":"Aragona","year":"2020","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.ajo.2025.11.024_bib0078","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.2147\/OPTH.S187963","article-title":"Cross-linked hyaluronic acid gel occlusive device for the treatment of dry eye syndrome","volume":"12","author":"Fezza","year":"2018","journal-title":"Clin Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajo.2025.11.024_bib0079","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1177\/1120672119833278","article-title":"Changes in conjunctival epithelial cells after treatment with 0.2% xanthan gum eye drops in mild-moderate dry eye","volume":"30","author":"Postorino","year":"2020","journal-title":"Eur J Ophthalmol"},{"issue":"7","key":"10.1016\/j.ajo.2025.11.024_bib0080","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1517\/17425247.2012.690733","article-title":"Ocular drug delivery system: a reference to natural polymers","volume":"9","author":"Pahuja","year":"2012","journal-title":"Expert Opin Drug Deliv"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0081","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/s12886-016-0343-9","article-title":"Efficacy of a fixed combination of 0.09 % xanthan gum\/0.1 % chondroitin sulfate preservative free vs polyethylene glycol\/propylene glycol in subjects with dry eyedisease: a multicenter randomized controlled trial","volume":"16","author":"Perez-Balbuena","year":"2016","journal-title":"BMC Ophthalmol"},{"key":"10.1016\/j.ajo.2025.11.024_bib0082","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2022.109168","article-title":"Preclinical study of a new matrix to help the ocular surface in dry eye disease","volume":"222","author":"Abbate","year":"2022","journal-title":"Exp Eye Res"},{"issue":"10","key":"10.1016\/j.ajo.2025.11.024_bib0083","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1007\/s40123-024-01003-z","article-title":"Observational Clinical Investigation Evaluating an Ophthalmic Solution Containing Xanthan Gum and Low Concentration Desonide Phosphate in Dry Eye Disease Treatment","volume":"13","author":"Aragona","year":"2024","journal-title":"Ophthalmol Ther"},{"issue":"8","key":"10.1016\/j.ajo.2025.11.024_bib0084","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15082152","article-title":"Exploring the Antioxidant Potential of Gellan and Guar Gums in Wound Healing","volume":"15","author":"Dodi","year":"2023","journal-title":"Pharmaceutics"},{"issue":"45","key":"10.1016\/j.ajo.2025.11.024_bib0085","doi-asserted-by":"crossref","first-page":"27103","DOI":"10.1039\/D0RA04366D","article-title":"Xanthan gum derivatives: review of synthesis, properties and diverse applications","volume":"10","author":"Patel","year":"2020","journal-title":"RSC Adv."},{"key":"10.1016\/j.ajo.2025.11.024_bib0086","doi-asserted-by":"crossref","first-page":"3883","DOI":"10.2147\/OPTH.S428725","article-title":"Safe and Effective Management of Dry Eye Symptoms with Hydroxypropyl Guar and Hyaluronic Acid Dual-Polymer Lubricating Eye Drops: A Review of Preclinical and Clinical Studies","volume":"17","author":"Srinivasan","year":"2023","journal-title":"Clin Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2025.11.024_bib0087","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1089\/jop.2017.0080","article-title":"Impact of Hyaluronic Acid-Containing Artificial Tear Products on Reepithelialization in an In Vivo Corneal Wound Model","volume":"34","author":"Carlson","year":"2018","journal-title":"J Ocul Pharmacol Ther"},{"issue":"9","key":"10.1016\/j.ajo.2025.11.024_bib0088","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1097\/OPX.0000000000002172","article-title":"Comparison of eye drop retention time using fluorophotometry in three commercially available lubricant eye drops","volume":"101","author":"Jia","year":"2024","journal-title":"Optom Vis Sci"},{"key":"10.1016\/j.ajo.2025.11.024_bib0089","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.2147\/OPTH.S177176","article-title":"Efficacy and safety of dual polymer hydroxypropyl guar- and hyaluronic acid-containing lubricant eyedrops for the management of dry-eye disease: a randomized double-masked clinical study","volume":"12","author":"Labetoulle","year":"2018","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.ajo.2025.11.024_bib0090","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.2147\/OPTH.S259704","article-title":"Protecting the Ocular Surface in Cataract Surgery: The Efficacy of the Perioperative Use of a Hydroxypropyl Guar and Hyaluronic Acid Ophthalmic Solution","volume":"14","author":"Favuzza","year":"2020","journal-title":"Clin Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajo.2025.11.024_bib0091","doi-asserted-by":"crossref","DOI":"10.31436\/imjm.v18i2.613","article-title":"Comparison of Immediate Effects On Usage of Dual Polymer Artificial Tears on Changes in Tear Film Characteristics","volume":"18","author":"Che Arif","year":"2020","journal-title":"IIUM Medical Journal Malaysia"},{"key":"10.1016\/j.ajo.2025.11.024_bib0092","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2147\/OPTO.S398496","article-title":"Quality of Life in Digital Device Users Who are Treated with Systane Hydration PF","volume":"15","author":"Pucker","year":"2023","journal-title":"Clin Optom (Auckl)"},{"key":"10.1016\/j.ajo.2025.11.024_bib0093","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.2147\/OPTH.S248949","article-title":"Improved Tear Film Stability in Patients with Dry Eye After Hyaluronic Acid and Galactoxyloglucan Use","volume":"14","author":"Molina-Solana","year":"2020","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.ajo.2025.11.024_bib0094","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2147\/OPTO.S350185","article-title":"Artificial Tears: A Systematic Review","volume":"15","author":"Semp","year":"2023","journal-title":"Clin Optom (Auckl)"},{"key":"10.1016\/j.ajo.2025.11.024_bib0095","doi-asserted-by":"crossref","DOI":"10.1111\/aos.17455","article-title":"Can the choice of artificial tears harm patients? A narrative review with an overview of the Nordic market","author":"Mikha","year":"2025","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.ajo.2025.11.024_bib0096","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2025.125355","article-title":"Implications of nanotechnology for the treatment of Dry Eye Disease: Recent advances","volume":"672","author":"Baghban","year":"2025","journal-title":"Int J Pharm"},{"issue":"5","key":"10.1016\/j.ajo.2025.11.024_bib0097","first-page":"588","article-title":"The Effect of Optive and Optive Advanced Artificial Tears on the Healthy Tear Film","volume":"43","author":"Markoulli","year":"2018","journal-title":"Curr EyeRes"},{"key":"10.1016\/j.ajo.2025.11.024_bib0098","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jtos.2020.12.006","article-title":"Developing evidence-based guidance for the treatment of dry eye disease with artificial tear supplements: A six-month multicentre, double-masked randomised controlled trial","volume":"20","author":"Craig","year":"2021","journal-title":"Ocul Surf"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0099","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.clae.2017.07.007","article-title":"Can the optimum artificial tear treatment for dry eye disease be predicted from presenting signs and symptoms?","volume":"41","author":"Essa","year":"2018","journal-title":"Cont Lens Anterior Eye"},{"issue":"2","key":"10.1016\/j.ajo.2025.11.024_bib0100","doi-asserted-by":"crossref","first-page":"122","DOI":"10.5301\/ejo.5000883","article-title":"Clinical evaluation of an oil-based lubricant eyedrop in dry eye patients with lipid deficiency","volume":"27","author":"Baudouin","year":"2017","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.ajo.2025.11.024_bib0101","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.2147\/OPTH.S256351","article-title":"A Comparison of Efficacy and Safety of Two Lipid-Based Lubricant Eye Drops for the Management of Evaporative Dry Eye Disease","volume":"14","author":"Jerkins","year":"2020","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.ajo.2025.11.024_bib0102","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.2147\/OPTH.S263362","article-title":"Symptom Relief Following a Single Dose of Propylene Glycol-Hydroxypropyl Guar Nanoemulsion in Patients with Dry Eye Disease: A Phase IV, Multicenter Trial","volume":"14","author":"Silverstein","year":"2020","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.ajo.2025.11.024_bib0103","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.2147\/OPTH.S261318","article-title":"Efficacy and Safety of Phospholipid Nanoemulsion-Based Ocular Lubricant for the Management of Various Subtypes of Dry Eye Disease: A Phase IV, Multicenter Trial","volume":"14","author":"Yeu","year":"2020","journal-title":"Clin Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajo.2025.11.024_bib0104","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s40123-023-00853-3","article-title":"Multi-symptom Relief with Propylene Glycol-Hydroxypropyl-Guar Nanoemulsion Lubricant Eye Drops in Subjects with Dry Eye Disease: A Post-Marketing Prospective Study","volume":"13","author":"Bickle","year":"2024","journal-title":"Ophthalmol Ther"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0105","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1089\/jop.2018.0031","article-title":"Preclinical Evaluation of a New HydroxypropylGuar Phospholipid Nanoemulsion-Based Artificial Tear Formulation in Models of Corneal Epithelium","volume":"35","author":"Rangarajan","year":"2019","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1016\/j.ajo.2025.11.024_bib0106","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.2147\/OPTH.S58464","article-title":"A prospective, multicenter, noninterventional study of Optive Plus ((R)) in the treatment of patients with dry eye: the prolipid study","volume":"8","author":"Kaercher","year":"2014","journal-title":"Clin Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajo.2025.11.024_bib0107","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1159\/000512635","article-title":"Evaluation of Carboxymethylcellulose Sodium plus Glycerin (Optive (R)) in Ocular Discomfort after Anti-Vascular Endothelial Growth Factor Intravitreal Injection Therapy: AProspective Study","volume":"244","author":"Karcenty","year":"2021","journal-title":"Ophthalmologica Journal international d'ophtalmologie International journal of ophthalmology Zeitschrift fur Augenheilkunde"},{"issue":"4","key":"10.1016\/j.ajo.2025.11.024_bib0108","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.ophtha.2003.07.008","article-title":"Sequential changes of lipid tear film after the instillation of a single drop of a new emulsion eye drop in dry eye patients","volume":"111","author":"Di Pascuale","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2025.11.024_bib0109","first-page":"97","article-title":"Short-term efficacy of two lipidic eyedrops in the treatment of evaporative dry eye","volume":"2","author":"Fogagnolo","year":"2016","journal-title":"Ital Rev Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0110","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.clinthera.2010.01.024","article-title":"Comparison of the clinical effects of carbomer-based lipid-containing gel and hydroxypropyl-guar gel artificial tear formulations in patients with dry eye syndrome: a 4-week, prospective, open-label, randomized, parallel-group, noninferiority study","volume":"32","author":"Wang","year":"2010","journal-title":"Clin Ther"},{"issue":"2","key":"10.1016\/j.ajo.2025.11.024_bib0111","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/ICO.0000000000000660","article-title":"Efficacy and Safety of Carbomer-Based Lipid-Containing Artificial Tear Formulations in Patients With Dry Eye Syndrome","volume":"35","author":"Chung","year":"2016","journal-title":"Cornea"},{"issue":"8","key":"10.1016\/j.ajo.2025.11.024_bib0112","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1089\/jop.2017.0019","article-title":"Effectiveness of Combined Tear Film Therapy in Patients with Evaporative Dry Eye with Short Tear Film Breakup Time","volume":"33","author":"Kim","year":"2017","journal-title":"J Ocul Pharmacol Ther"},{"issue":"7","key":"10.1016\/j.ajo.2025.11.024_bib0113","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1097\/ICO.0000000000001523","article-title":"Effects of Lipid- Versus Sodium Hyaluronate-Containing Eye Drops on Optical Quality and Ocular Surface Parameters as a Function of the Meibomian Gland Dropout Rate","volume":"37","author":"Mihaltz","year":"2018","journal-title":"Cornea"},{"issue":"8","key":"10.1016\/j.ajo.2025.11.024_bib0114","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1167\/tvst.9.8.29","article-title":"Short-Term Changes in Tear Lipid Layer Thickness After Instillation of Lipid Containing Eye Drops","volume":"9","author":"Lim","year":"2020","journal-title":"Transl Vis Sci Technol"},{"issue":"6","key":"10.1016\/j.ajo.2025.11.024_bib0115","doi-asserted-by":"crossref","first-page":"546","DOI":"10.5301\/ejo.5000830","article-title":"Efficacy and safety of a cationic emulsion in the treatment of moderate to severe dry eye disease: a randomized controlled study","volume":"26","author":"Robert","year":"2016","journal-title":"Eur J Ophthalmol."},{"key":"10.1016\/j.ajo.2025.11.024_bib0116","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.2147\/OPTH.S258081","article-title":"Efficacy and Safety of VisuEvo ((R)) and Cationorm ((R)) for the Treatment of Evaporative and NonEvaporative Dry Eye Disease: A Multicenter, Double-Blind, Cross-Over, Randomized Clinical Trial","volume":"14","author":"Fogagnolo","year":"2020","journal-title":"Clin Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0117","doi-asserted-by":"crossref","first-page":"5","DOI":"10.51329\/mehdiophthal1415","article-title":"Short-term effect of non-preserved cationic oil-in-water ophthalmic emulsion on tear meniscus parameters of healthy individuals in a prospective, controlled pilot study","volume":"10","author":"Makri","year":"2021","journal-title":"Med Hypothesis Discov Innov Ophthalmol. Spring"},{"key":"10.1016\/j.ajo.2025.11.024_bib0118","doi-asserted-by":"crossref","first-page":"235","DOI":"10.2147\/OPTH.S75297","article-title":"An evaluation of Retaine ophthalmic emulsion in the management of tear film stability and ocular surface staining in patients diagnosed with dry eye","volume":"9","author":"Ousler","year":"2015","journal-title":"Clin Ophthalmol"},{"issue":"7","key":"10.1016\/j.ajo.2025.11.024_bib0119","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1097\/01.opx.0000171818.01353.8c","article-title":"The effect of two novel lubricant eye drops on tear film lipid layer thickness in subjects with dry eye symptoms","volume":"82","author":"Korb","year":"2005","journal-title":"Optom Vis Sci"},{"key":"10.1016\/j.ajo.2025.11.024_bib0120","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.2147\/OPTH.S70623","article-title":"Effects of Systane ((R)) Balance on noninvasive tear film break-up time in patients with lipid-deficient dry eye","volume":"8","author":"Aguilar","year":"2014","journal-title":"Clin Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0121","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.clae.2017.09.013","article-title":"Tear lipid supplement prophylaxis against dry eye in adverse environments","volume":"41","author":"Gokul","year":"2018","journal-title":"Cont Lens Anterior Eye"},{"issue":"4","key":"10.1016\/j.ajo.2025.11.024_bib0122","article-title":"Application of systane complete for the treatment of contact lens discomfort","volume":"44","author":"Pucker","year":"2021","journal-title":"Cont Lens AnteriorEye"},{"issue":"10","key":"10.1016\/j.ajo.2025.11.024_bib0123","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1097\/ICO.0000000000003505","article-title":"The Short-term Effects of Artificial Tears on the Tear Film Assessed by a Novel High-Resolution Tear Film Imager: A Pilot Study","volume":"43","author":"Antman","year":"2024","journal-title":"Cornea"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0124","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ophtha.2016.09.023","article-title":"A Randomized, Double-Masked, Placebo-Controlled Clinical Trial of Two Forms of Omega-3 Supplements for Treating Dry Eye Disease","volume":"124","author":"Deinema","year":"2017","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2025.11.024_bib0125","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.2147\/OPTH.S228261","article-title":"Changes in Tear Lipid Layer Thickness and Symptoms Following the Use of Artificial Tears with and Without Omega-3 Fatty Acids: A Randomized, Double-Masked, Crossover Study","volume":"13","author":"Fogt","year":"2019","journal-title":"Clin Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0126","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jtos.2019.11.004","article-title":"An artificial tear containing flaxseed oil for treating dry eye disease: A randomized controlled trial","volume":"18","author":"Downie","year":"2020","journal-title":"Ocul Surf"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0127","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.clae.2017.09.004","article-title":"Comparison of treatment effect across varying severities of meibomian gland dropout","volume":"41","author":"Turnbull","year":"2018","journal-title":"Cont Lens Anterior Eye"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0128","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/ICO.0b013e31821b71e6","article-title":"Effectiveness of artificial tears in the management of evaporative dry eye","volume":"31","author":"McCann","year":"2012","journal-title":"Cornea"},{"issue":"2","key":"10.1016\/j.ajo.2025.11.024_bib0129","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.clae.2009.12.007","article-title":"Effect of a liposomal spray on the pre-ocular tear film","volume":"33","author":"Craig","year":"2010","journal-title":"Cont Lens Anterior Eye"},{"issue":"2","key":"10.1016\/j.ajo.2025.11.024_bib0130","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1097\/OPX.0000000000000996","article-title":"Lipid Supplements and Clinical Aspects of Tear Film in Habitual Lens Wearers","volume":"94","author":"Rohit","year":"2017","journal-title":"Optom Vis Sci"},{"issue":"8","key":"10.1016\/j.ajo.2025.11.024_bib0131","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1097\/ICL.0000000000000788","article-title":"Effect of Eye Spray Phospholipid Concentration on the Tear Film and Ocular Comfort","volume":"47","author":"Pult","year":"2021","journal-title":"Eye Contact Lens"},{"issue":"5","key":"10.1016\/j.ajo.2025.11.024_bib0132","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1089\/jop.2021.0102","article-title":"A Water-Free Omega-3 Fatty Acid Eye Drop Formulation for the Treatment of Evaporative Dry Eye Disease: A Prospective, Multicenter Noninterventional Study","volume":"38","author":"Jacobi","year":"2022","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1016\/j.ajo.2025.11.024_bib0133","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.jtos.2023.10.001","article-title":"Perfluorohexyloctane in dry eye disease: A systematic review of its efficacy and safety as a novel therapeutic agent","volume":"30","author":"Ballesteros-Sanchez","year":"2023","journal-title":"Ocul Surf"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0134","article-title":"Managing Dry Eye Disease with Novel Medications: Mechanism, Study Validity, Safety, Efficacy, and Practical Application","volume":"12","author":"Wong","year":"2024","journal-title":"Pharmacy (Basel)"},{"issue":"2","key":"10.1016\/j.ajo.2025.11.024_bib0135","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s40123-024-01076-w","article-title":"Differentiating Between Perfluorohexyloctane Ophthalmic Solution and Water-Free Cyclosporine Ophthalmic Solution 0.1% for Dry Eye Disease: A Review of Preclinical and Clinical Characteristics","volume":"14","author":"Periman","year":"2025","journal-title":"Ophthalmol Ther"},{"issue":"2","key":"10.1016\/j.ajo.2025.11.024_bib0136","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jtos.2019.02.010","article-title":"Preclinical studies evaluating the effect of semifluorinated alkanes on ocular surface and tear fluid dynamics","volume":"17","author":"Agarwal","year":"2019","journal-title":"Ocul Surf"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0137","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0279977","article-title":"The influence of a mineral oil cationic nanoemulsion or perfluorohexyloctane on the tear film lipid layer and higher order aberrations","volume":"18","author":"Habbe","year":"2023","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.ajo.2025.11.024_bib0138","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1089\/jop.2019.0092","article-title":"Influence of Perfluorohexyloctane Eye Drops on Tear Film Thickness in Patients with Mild to Moderate Dry Eye Disease: A Randomized Controlled Clinical Trial","volume":"36","author":"Schmidl","year":"2020","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1016\/j.ajo.2025.11.024_bib0139","article-title":"Deciphering the Action of Perfluorohexyloctane Eye Drops to Reduce Ocular Discomfort and Pain","volume":"8","author":"Delicado-Miralles","year":"2021","journal-title":"Front Med (Lausanne)"},{"issue":"9","key":"10.1016\/j.ajo.2025.11.024_bib0140","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1097\/ICO.0000000000002622","article-title":"A Randomized Clinical Study (SEECASE) to Assess Efficacy, Safety, and Tolerability of NOV03 for Treatment of Dry Eye Disease","volume":"40","author":"Tauber","year":"2021","journal-title":"Cornea"},{"issue":"5","key":"10.1016\/j.ajo.2025.11.024_bib0141","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.ophtha.2022.12.021","article-title":"NOV03 for Dry Eye Disease Associated with Meibomian Gland Dysfunction: Results ofthe Randomized Phase 3 GOBI Study","volume":"130","author":"Tauber","year":"2023","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2025.11.024_bib0142","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.ajo.2023.03.008","article-title":"NOV03 for Signs and Symptoms of Dry Eye Disease Associated With Meibomian Gland Dysfunction: The Randomized Phase 3 MOJAVE Study","volume":"252","author":"Sheppard","year":"2023","journal-title":"Am J Ophthalmol"},{"issue":"9","key":"10.1016\/j.ajo.2025.11.024_bib0143","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1097\/ICO.0000000000003418","article-title":"Long-Term Safety and Efficacy of Perfluorohexyloctane Ophthalmic Solution for the Treatment of Patients With Dry Eye Disease: The KALAHARI Study","volume":"43","author":"Protzko","year":"2024","journal-title":"Cornea"},{"issue":"4","key":"10.1016\/j.ajo.2025.11.024_bib0144","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1001\/jamaophthalmol.2023.0270","article-title":"Perfluorohexyloctane Eye Drops for Dry Eye Disease Associated With Meibomian Gland Dysfunction in Chinese Patients: A Randomized Clinical Trial","volume":"141","author":"Tian","year":"2023","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.ajo.2025.11.024_bib0145","article-title":"Perfluorohexyloctane ophthalmic solution for dry eye disease: pooled analysis of two phase 3 clinical trials","volume":"4","author":"Fahmy","year":"2024","journal-title":"Original Research. Front Ophthalmol (Lausanne)"},{"key":"10.1016\/j.ajo.2025.11.024_bib0146","doi-asserted-by":"crossref","DOI":"10.1016\/j.scitotenv.2023.168040","article-title":"Further contribution to the discussion on perfluorohexyloctane eye drops in dry eye disease","volume":"906","author":"Jung","year":"2024","journal-title":"Sci Total Environ"},{"key":"10.1016\/j.ajo.2025.11.024_bib0147","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/978-0-387-39975-1_13","article-title":"Trehalose as a \"chemical chaperone\": fact and fantasy","volume":"594","author":"Crowe","year":"2007","journal-title":"Adv Exp Med Biol"},{"issue":"6","key":"10.1016\/j.ajo.2025.11.024_bib0148","doi-asserted-by":"crossref","first-page":"503","DOI":"10.2174\/1389203724666230606154719","article-title":"Trehalose and its Diverse Biological Potential","volume":"24","author":"Sharma","year":"2023","journal-title":"Curr Protein Pept Sci"},{"issue":"5","key":"10.1016\/j.ajo.2025.11.024_bib0149","doi-asserted-by":"crossref","DOI":"10.3390\/biom10050809","article-title":"Trehalose for Ocular Surface Health","volume":"10","author":"Laihia","year":"2020","journal-title":"Biomolecules"},{"issue":"7","key":"10.1016\/j.ajo.2025.11.024_bib0150","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1089\/jop.2020.0119","article-title":"Commercially Available Eye Drops Containing Trehalose Protect Against Dry Conditions via Autophagy Induction","volume":"37","author":"Hernandez","year":"2021","journal-title":"J Ocul Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.ajo.2025.11.024_bib0151","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11061518","article-title":"Comparison of Trehalose\/Hyaluronic Acid (HA) vs. 0.001% Hydrocortisone\/HA Eyedrops on Signs and Inflammatory Markers in a Desiccating Model of Dry Eye Disease (DED)","volume":"11","author":"Astolfi","year":"2022","journal-title":"J Clin Med"},{"issue":"23","key":"10.1016\/j.ajo.2025.11.024_bib0152","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11236975","article-title":"Clinical Efficacy, Tolerability and Safety of a New Multiple-Action Eyedrop in Subjects with Moderate to Severe Dry Eye","volume":"11","author":"Roszkowska","year":"2022","journal-title":"J Clin Med."},{"issue":"23","key":"10.1016\/j.ajo.2025.11.024_bib0153","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12237301","article-title":"Trehalose and Dry Eye Disease: A Comprehensive Systematic Review of Randomized Controlled Trials","volume":"12","author":"Ballesteros-Sanchez","year":"2023","journal-title":"J Clin Med."},{"issue":"20","key":"10.1016\/j.ajo.2025.11.024_bib0154","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12206647","article-title":"Tear Film Stabilization and Symptom Improvement in Dry Eye Disease: The Role of Hyaluronic Acid and Trehalose Eyedrops versus Carmellose Sodium","volume":"12","author":"Sanchez-Gonzalez","year":"2023","journal-title":"J Clin Med"},{"issue":"4","key":"10.1016\/j.ajo.2025.11.024_bib0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.clae.2023.101845","article-title":"Efficacy of artificial tears containing trehalose and hyaluronic acid for dry eye disease in women aged 42-54 versus >\/= 55 years","volume":"46","author":"Mateo-Orobia","year":"2023","journal-title":"Cont Lens Anterior Eye."},{"issue":"20","key":"10.1016\/j.ajo.2025.11.024_bib0156","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10204699","article-title":"Hyaluronic Acid\/Trehalose Ophthalmic Solution in Reducing Post-Cataract Surgery Dry Eye Signs and Symptoms: A Prospective, Interventional, Randomized, Open-Label Study","volume":"10","author":"Mencucci","year":"2021","journal-title":"J Clin Med."},{"key":"10.1016\/j.ajo.2025.11.024_bib0157","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/8885032","article-title":"Ectoine in the Treatment of Irritations and Inflammations of the Eye Surface","volume":"2021","author":"Bilstein","year":"2021","journal-title":"Biomed Res Int"},{"issue":"3","key":"10.1016\/j.ajo.2025.11.024_bib0158","doi-asserted-by":"crossref","DOI":"10.1016\/j.clae.2020.04.003","article-title":"Prospective randomized study to evaluate the efficacy and tolerability of Ectoin(R) containing Eye Spray (EES09) and comparison to the liposomal Eye Spray Tears Again(R) (TA) in the treatment of dry eye disease","volume":"44","author":"Nosch","year":"2021","journal-title":"Cont Lens Anterior Eye"},{"issue":"2","key":"10.1016\/j.ajo.2025.11.024_bib0159","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics16020236","article-title":"Ectoine, from a Natural Bacteria Protectant to a New Treatment of Dry Eye Disease","volume":"16","author":"Chen","year":"2024","journal-title":"Pharmaceutics"},{"issue":"6","key":"10.1016\/j.ajo.2025.11.024_bib0160","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1167\/iovs.65.6.39","article-title":"Ectoine Enhances Mucin Production Via Restoring IL-13\/IFN-gamma Balance in a Murine Dry Eye Model","volume":"65","author":"Lin","year":"2024","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1-2","key":"10.1016\/j.ajo.2025.11.024_bib0161","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s11010-013-1908-z","article-title":"Antioxidants and vision health: facts and fiction","volume":"388","author":"Grover","year":"2014","journal-title":"Mol Cell Biochem"},{"issue":"7","key":"10.1016\/j.ajo.2025.11.024_bib0162","doi-asserted-by":"crossref","first-page":"202","DOI":"10.31083\/j.fbl2707202","article-title":"Effects of the Topical Use of the Natural Antioxidant Alpha-Lipoic Acid on the Ocular Surface of Diabetic Patients with Dry Eye Symptoms","volume":"27","author":"Roszkowska","year":"2022","journal-title":"Front Biosci (Landmark Ed)"},{"issue":"5","key":"10.1016\/j.ajo.2025.11.024_bib0163","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics16050631","article-title":"The Potential of Selenium-Based Therapies for Ocular Oxidative Stress","volume":"16","author":"Al-Bassam","year":"2024","journal-title":"Pharmaceutics"},{"issue":"2","key":"10.1016\/j.ajo.2025.11.024_bib0164","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ajo.2008.08.015","article-title":"A comparison of vitamin a and cyclosporine a 0.05% eye drops for treatment of dry eye syndrome","volume":"147","author":"Kim","year":"2009","journal-title":"Am J Ophthalmol"},{"issue":"12","key":"10.1016\/j.ajo.2025.11.024_bib0165","doi-asserted-by":"crossref","DOI":"10.3390\/cells9122660","article-title":"Retinoic Acid and Its Derivatives in Skin","volume":"9","author":"Szymanski","year":"2020","journal-title":"Cells."},{"issue":"6","key":"10.1016\/j.ajo.2025.11.024_bib0166","doi-asserted-by":"crossref","first-page":"4341","DOI":"10.1167\/iovs.13-11863","article-title":"The influence of 13-cis retinoic acid on human meibomian gland epithelial cells","volume":"54","author":"Ding","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"10.1016\/j.ajo.2025.11.024_bib0167","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1167\/iovs.10-6997c","article-title":"The international workshop on meibomian gland dysfunction: report of the subcommittee on anatomy, physiology, and pathophysiology of the meibomian gland","volume":"52","author":"Knop","year":"2011","journal-title":"Invest Ophthalmol Vis Sci."},{"issue":"2","key":"10.1016\/j.ajo.2025.11.024_bib0168","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s00417-021-05415-6","article-title":"Efficacy of hyaluronic acid 0.3%, cyanocobalamin, electrolytes, and P-Plus in menopause patients with moderate dry eye disease","volume":"260","author":"De-Hita-Cantalejo","year":"2022","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"9","key":"10.1016\/j.ajo.2025.11.024_bib0169","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1089\/jop.2022.0048","article-title":"Performance and Safety of a Sodium Hyaluronate Tear Substitute with Polyethylene Glycol in Dry Eye Disease: AMulticenter, Investigator-Masked, Randomized, Noninferiority Trial","volume":"38","author":"Labetoulle","year":"2022","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1016\/j.ajo.2025.11.024_bib0170","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/bs.vh.2022.10.008","article-title":"Ascorbic acid as antioxidant","volume":"121","author":"Gegotek","year":"2023","journal-title":"Vitam Horm"},{"issue":"4","key":"10.1016\/j.ajo.2025.11.024_bib0171","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1039\/D2NR05178H","article-title":"A synergistic therapeutic nano-eyedrop for dry eye disease based on ascorbic acid-coupled exosomes","volume":"15","author":"Ma","year":"2023","journal-title":"Nanoscale"},{"issue":"5","key":"10.1016\/j.ajo.2025.11.024_bib0172","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.clae.2020.03.001","article-title":"Association between vitamin D and dry eye disease: A systematic review and meta-analysis of observational studies","volume":"43","author":"Askari","year":"2020","journal-title":"Cont Lens Anterior Eye"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0173","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s12886-017-0482-7","article-title":"Clinical safety and efficacy of vitamin D3 analog ointment for treatment of obstructive meibomian gland dysfunction","volume":"17","author":"Arita","year":"2017","journal-title":"BMC Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajo.2025.11.024_bib0174","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1097\/ICO.0000000000001822","article-title":"Vitamin D Enhances the Efficacy of Topical Artificial Tears in Patients With Dry Eye Disease","volume":"38","author":"Hwang","year":"2019","journal-title":"Cornea"},{"issue":"3","key":"10.1016\/j.ajo.2025.11.024_bib0175","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s40123-021-00357-y","article-title":"A Novel Multi-Ingredient Supplement Reduces Inflammation of the Eye and Improves Production and Quality of Tears in Humans","volume":"10","author":"Radkar","year":"2021","journal-title":"Ophthalmol Ther"},{"issue":"5","key":"10.1016\/j.ajo.2025.11.024_bib0176","doi-asserted-by":"crossref","DOI":"10.1016\/j.clae.2024.102169","article-title":"The efficacy of vitamin D supplementation in dry eye disease: A systematic review and meta-analysis","volume":"47","author":"Chen","year":"2024","journal-title":"Cont Lens Anterior Eye"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0177","doi-asserted-by":"crossref","DOI":"10.1016\/j.clae.2021.101450","article-title":"Patient-reported experience of dry eye management: An international multicentre survey","volume":"45","author":"Bilkhu","year":"2022","journal-title":"Cont Lens Anterior Eye"},{"issue":"2","key":"10.1016\/j.ajo.2025.11.024_bib0178","article-title":"Over the counter (OTC) artificial tear drops for dry eye syndrome","volume":"2","author":"Pucker","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0179","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/OPX.0000000000002206","article-title":"Effect of different artificial tears on tear film parameters in dry eye disease","volume":"102","author":"Maity","year":"2025","journal-title":"Optom Vis Sci"},{"key":"10.1016\/j.ajo.2025.11.024_bib0180","first-page":"1","article-title":"Squeezability of eye drop containers used in dry eye disease management","author":"Bitton","year":"2024","journal-title":"Clin Exp Optom"},{"issue":"4","key":"10.1016\/j.ajo.2025.11.024_bib0181","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1177\/24741264231175555","article-title":"Randomized Controlled Study of Cooled vs Room-Temperature Artificial Tears for Reducing Ocular Surface Irritation After Intravitreal Injection","volume":"7","author":"Mani","year":"2023","journal-title":"J Vitreoretin Dis"},{"issue":"5","key":"10.1016\/j.ajo.2025.11.024_bib0182","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/cxo.12664","article-title":"Does the temperature of an artificial tear affect its comfort?","volume":"101","author":"Bitton","year":"2018","journal-title":"Clin Exp Optom"},{"key":"10.1016\/j.ajo.2025.11.024_bib0183","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jtos.2023.04.010","article-title":"TFOS Lifestyle: Impact of contact lenses on the ocular surface","volume":"29","author":"Jones","year":"2023","journal-title":"Ocul Surf"},{"issue":"11","key":"10.1016\/j.ajo.2025.11.024_bib0184","doi-asserted-by":"crossref","DOI":"10.1167\/iovs.13-13166","article-title":"The TFOS International Workshop on Contact Lens Discomfort: report of the management and therapy subcommittee","volume":"54","author":"Papas","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"9","key":"10.1016\/j.ajo.2025.11.024_bib0185","article-title":"Silicone hydrogel versus hydrogel soft contact lenses for differences in patient-reported eye comfort and safety","volume":"9","author":"Haworth","year":"2023","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.ajo.2025.11.024_bib0186","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.4103\/IJO.IJO_2778_22","article-title":"Contact lenses in dry eye disease and associated ocular surface disorders","volume":"71","author":"Chaudhary","year":"2023","journal-title":"Indian J Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0187","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12886-018-1023-8","article-title":"Efficacy of an ocular bandage contact lens for the treatment of dry eye after phacoemulsification","volume":"19","author":"Chen","year":"2019","journal-title":"BMC Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0188","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/s12886-024-03385-x","article-title":"The efficacy of bandage contact lens in relieving the aggravation of dry eye disease after complicated cataract or\/and IOL surgery","volume":"24","author":"Chen","year":"2024","journal-title":"BMC Ophthalmol"},{"issue":"9","key":"10.1016\/j.ajo.2025.11.024_bib0189","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1097\/ICO.0000000000000515","article-title":"Comparative Evaluation of Silicone Hydrogel Contact Lenses and Autologous Serum for Management of Sjogren Syndrome-Associated Dry Eye","volume":"34","author":"Li","year":"2015","journal-title":"Cornea"},{"key":"10.1016\/j.ajo.2025.11.024_bib0190","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.2147\/OPTH.S458715","article-title":"Bilateral Sutureless Application of Human Dehydrated Amniotic Membrane with a Specialised Bandage Contact Lens for Moderate-to-Severe Dry Eye Disease: A Prospective Study with 1-Month FollowUp","volume":"18","author":"Trave-Huarte","year":"2024","journal-title":"Clin Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2025.11.024_bib0191","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.4103\/IJO.IJO_17_23","article-title":"Contact lenses for the treatment of ocular surface diseases","volume":"71","author":"Sharma","year":"2023","journal-title":"Indian J Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajo.2025.11.024_bib0192","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.clae.2021.02.007","article-title":"CLEAR - Contact lens technologies of the future","volume":"44","author":"Jones","year":"2021","journal-title":"Cont Lens Anterior Eye"},{"issue":"3","key":"10.1016\/j.ajo.2025.11.024_bib0193","first-page":"149","article-title":"Therapeutic contact lens-related bilateral fungal keratitis","volume":"28","author":"Hoflin-Lima","year":"2002","journal-title":"The CLAO journal : official publication of the Contact Lens Association of Ophthalmologists, Inc"},{"issue":"2","key":"10.1016\/j.ajo.2025.11.024_bib0194","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/s40135-018-0177-0","article-title":"Microbial Keratitis Secondary to Therapeutic Contact Lens Wear","volume":"6","author":"Bregman","year":"2018","journal-title":"Current Ophthalmology Reports"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0195","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1186\/s12886-024-03632-1","article-title":"Analysis of association of bandage contact lens with serious vision-threatening diseases and their management","volume":"24","author":"Siegel","year":"2024","journal-title":"BMC Ophthalmol"},{"issue":"Suppl 1","key":"10.1016\/j.ajo.2025.11.024_bib0196","first-page":"S48","article-title":"Is the dry eye contact lens wearer at risk? Yes","volume":"9","author":"Lemp","year":"1990","journal-title":"Cornea."},{"issue":"13","key":"10.1016\/j.ajo.2025.11.024_bib0197","doi-asserted-by":"crossref","DOI":"10.3390\/jcm13133838","article-title":"Scleral Lenses for Managing Dry Eye Disease in the Absence of Corneal Irregularities: What Is the Current Evidence?","volume":"13","author":"Qiu","year":"2024","journal-title":"J Clin Med."},{"key":"10.1016\/j.ajo.2025.11.024_bib0198","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/OPTO.S337920","article-title":"OSDI Outcomes Based on Patient Demographic and Wear Patterns in Prosthetic Replacement of the Ocular Surface Ecosystem","volume":"14","author":"Asghari","year":"2022","journal-title":"Clin Optom (Auckl)"},{"issue":"2","key":"10.1016\/j.ajo.2025.11.024_bib0199","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.clae.2021.02.002","article-title":"CLEAR - Medical use of contact lenses","volume":"44","author":"Jacobs","year":"2021","journal-title":"Cont Lens Anterior Eye"},{"issue":"2","key":"10.1016\/j.ajo.2025.11.024_bib0200","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.clae.2021.02.001","article-title":"CLEAR - Scleral lenses","volume":"44","author":"Barnett","year":"2021","journal-title":"Cont Lens Anterior Eye"},{"issue":"4","key":"10.1016\/j.ajo.2025.11.024_bib0201","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/ICU.0000000000000171","article-title":"Scleral lens use in dry eye syndrome","volume":"26","author":"Bavinger","year":"2015","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.ajo.2025.11.024_bib0202","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.jtos.2021.09.003","article-title":"Combined therapy of ocular surface disease with plasma rich in growth factors and scleral contact lenses","volume":"23","author":"Wang","year":"2022","journal-title":"Ocul Surf"},{"key":"10.1016\/j.ajo.2025.11.024_bib0203","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ajo.2015.11.034","article-title":"The Use of the Esclera Scleral Contact Lens in the Treatment of Moderate to Severe Dry Eye Disease","volume":"163","author":"La Porta Weber","year":"2016","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2025.11.024_bib0204","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.4103\/IJO.IJO_2820_22","article-title":"Dry eye disease and risk factors for corneal complications in chronic ocular graft-versus-host disease","volume":"71","author":"Kate","year":"2023","journal-title":"Indian J Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0205","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1038\/s41598-021-82010-z","article-title":"Large diameter scleral lens benefits for Asians with intractable ocular surface diseases: a prospective, single-arm clinical trial","volume":"11","author":"Moon","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.ajo.2025.11.024_bib0206","doi-asserted-by":"crossref","first-page":"4829","DOI":"10.2147\/OPTH.S337824","article-title":"Scleral Lens and Prosthetic Replacement of the Ocular Surface Ecosystem Utilization in Ocular Graft-versus-Host Disease: A Survey Study","volume":"15","author":"Bligdon","year":"2021","journal-title":"Clin Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2025.11.024_bib0207","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.clae.2018.10.011","article-title":"Long-term effect of corneoscleral contact lenses on refractory ocular surface diseases","volume":"42","author":"Lee","year":"2019","journal-title":"Cont Lens Anterior Eye"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0208","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jtos.2018.11.008","article-title":"Long-term outcome of using Prosthetic Replacement of Ocular Surface Ecosystem (PROSE) as a drug delivery system for bevacizumab in the treatment of corneal neovascularization","volume":"17","author":"Yin","year":"2019","journal-title":"Ocul Surf"},{"key":"10.1016\/j.ajo.2025.11.024_bib0209","doi-asserted-by":"crossref","first-page":"3203","DOI":"10.2147\/OPTH.S487369","article-title":"Utilizing PROSE as a Drug Delivery Device for Preservative-Free Cyclosporine 0.05% for the Treatment of Dry Eye Disease: A Pilot Study","volume":"18","author":"Nakhla","year":"2024","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.ajo.2025.11.024_bib0210","doi-asserted-by":"crossref","first-page":"6","DOI":"10.12688\/f1000research.74638.1","article-title":"A multi-parameter grading system for optimal fitting of scleral contact lenses","volume":"11","author":"Kumar","year":"2022","journal-title":"F1000Res"},{"issue":"4","key":"10.1016\/j.ajo.2025.11.024_bib0211","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1111\/opo.13293","article-title":"Lens and solution properties in patients with and without midday fogging","volume":"44","author":"Fogt","year":"2024","journal-title":"Ophthalmic Physiol Opt"},{"key":"10.1016\/j.ajo.2025.11.024_bib0212","doi-asserted-by":"crossref","first-page":"209","DOI":"10.2147\/OPTO.S284634","article-title":"Midday Fogging of Scleral Contact Lenses: Current Perspectives","volume":"13","author":"Fogt","year":"2021","journal-title":"Clin Optom (Auckl)"},{"issue":"12","key":"10.1016\/j.ajo.2025.11.024_bib0213","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1097\/ICO.0000000000003228","article-title":"Safety and Efficacy of Contact Lenses in Eyes After Simple Limbal Epithelial Transplantation","volume":"42","author":"Chaudhary","year":"2023","journal-title":"Cornea"},{"issue":"6","key":"10.1016\/j.ajo.2025.11.024_bib0214","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1111\/j.1444-0938.2011.00618.x","article-title":"Limbal stem cell disease: management with scleral lenses","volume":"94","author":"Schornack","year":"2011","journal-title":"Clin Exp Optom"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0215","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1186\/s12886-023-03241-4","article-title":"Moisture chamber goggles for the treatment of postoperative dry eye in patients receiving SMILE and FS-LASIK surgery","volume":"23","author":"Huang","year":"2023","journal-title":"BMC Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajo.2025.11.024_bib0216","article-title":"Punctal occlusion for dry eye syndrome","volume":"6","author":"Ervin","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.ajo.2025.11.024_bib0217","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.jtos.2017.04.002","article-title":"Effects of punctal occlusion on global tear proteins in patients with dry eye","volume":"15","author":"Tong","year":"2017","journal-title":"Ocul Surf"},{"key":"10.1016\/j.ajo.2025.11.024_bib0218","article-title":"Treatment of Dry Eye With Intracanalicular Injection of Hydroxybutyl Chitosan: A Prospective Randomized Clinical Trial","volume":"8","author":"Lin","year":"2021","journal-title":"Front Med (Lausanne)"},{"issue":"9","key":"10.1016\/j.ajo.2025.11.024_bib0219","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11092326","article-title":"Microbiologic Analysis of Removed Silicone Punctal Plugs in Dry Eye Patients","volume":"11","author":"Jung","year":"2022","journal-title":"J Clin Med"},{"issue":"3","key":"10.1016\/j.ajo.2025.11.024_bib0220","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/ceo.14377","article-title":"Antimicrobial resistance in ocular infection: A review","volume":"52","author":"Cabrera-Aguas","year":"2024","journal-title":"Clin Exp Ophthalmol"},{"issue":"9","key":"10.1016\/j.ajo.2025.11.024_bib0221","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1111\/ceo.13988","article-title":"Organisms causing microbial keratitis and antibiotic resistance patterns in Australia","volume":"49","author":"Chandra","year":"2021","journal-title":"Clin Exp Ophthalmol"},{"issue":"10","key":"10.1016\/j.ajo.2025.11.024_bib0222","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1097\/j.jcrs.0000000000001505","article-title":"Effectiveness and safety of a novel crosslinked hyaluronate canalicular gel occlusive device for dry eye","volume":"50","author":"Packer","year":"2024","journal-title":"J Cataract Refract Surg"},{"issue":"11","key":"10.1016\/j.ajo.2025.11.024_bib0223","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1007\/s00417-017-3755-1","article-title":"A new strategy to sustained release of ocular drugs by one-step drug-loaded microcapsule manufacturing in hydrogel punctal plugs","volume":"255","author":"Xie","year":"2017","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.ajo.2025.11.024_bib0224","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.122933","article-title":"In situ formation of injectable organogels for punctal occlusion and sustained release of therapeutics: design, preparation, in vitro and in vivo evaluation","volume":"638","author":"Cao","year":"2023","journal-title":"Int J Pharm"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0225","doi-asserted-by":"crossref","first-page":"297","DOI":"10.4103\/ijo.IJO_997_22","article-title":"Designing and making an open source, 3D-printed, punctal plug with drug delivery system","volume":"71","author":"Khanna","year":"2023","journal-title":"Indian J Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2025.11.024_bib0226","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1167\/iovs.10-6997b","article-title":"The international workshop on meibomian gland dysfunction: report of the definition and classification subcommittee","volume":"52","author":"Nelson","year":"2011","journal-title":"Invest Ophthalmol Vis Sci."},{"issue":"4","key":"10.1016\/j.ajo.2025.11.024_bib0227","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1167\/iovs.10-6997a","article-title":"The international workshop on meibomian gland dysfunction: executive summary","volume":"52","author":"Nichols","year":"2011","journal-title":"Invest Ophthalmol Vis Sci."},{"issue":"4","key":"10.1016\/j.ajo.2025.11.024_bib0228","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1167\/iovs.10-6997e","article-title":"The international workshop on meibomian gland dysfunction: report of the subcommittee on the epidemiology of, and associated risk factors for, MGD","volume":"52","author":"Schaumberg","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"10.1016\/j.ajo.2025.11.024_bib0229","first-page":"2006","article-title":"The international workshop on meibomian gland dysfunction: report of the diagnosis subcommittee","volume":"52","author":"Tomlinson","year":"2011","journal-title":"InvestOphthalmol Vis Sci."},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0230","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/ICL.0000000000000680","article-title":"A Review on Evidence-Based Treatments for Meibomian Gland Dysfunction","volume":"46","author":"Lam","year":"2020","journal-title":"Eye Contact Lens"},{"issue":"5","key":"10.1016\/j.ajo.2025.11.024_bib0231","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.jcjo.2020.05.015","article-title":"Is there enough evidence for the routine recommendation of eyelid wipes? A systematic review of the role of eyelid wipes in the management of blepharitis","volume":"55","author":"Gostimir","year":"2020","journal-title":"Can J Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajo.2025.11.024_bib0232","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.optom.2018.07.002","article-title":"An Eyelid Warming Device for the Management of Meibomian Gland Dysfunction","volume":"12","author":"Ngo","year":"2019","journal-title":"J Optom"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0233","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.clae.2017.09.006","article-title":"The effects of a hydrating mask compared to traditional warm compresses on tear film properties in meibomian gland dysfunction","volume":"41","author":"Tan","year":"2018","journal-title":"Cont Lens Anterior Eye"},{"issue":"2","key":"10.1016\/j.ajo.2025.11.024_bib0234","doi-asserted-by":"crossref","DOI":"10.1016\/j.clae.2022.101775","article-title":"Hot towels: The bedrock of Meibomian gland dysfunction treatment - A review","volume":"46","author":"Schjerven Magno","year":"2023","journal-title":"Cont Lens Anterior Eye"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0235","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jfo.2021.08.009","article-title":"Evaluation of the MGDRx eyebag treatment in young and older subjects with dry eye symptoms","volume":"45","author":"Garcia-Marques","year":"2022","journal-title":"J Fr Ophtalmol"},{"key":"10.1016\/j.ajo.2025.11.024_bib0236","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2147\/OPTO.S350186","article-title":"Eyelid Warming Devices: Safety, Efficacy, and Place in Therapy","volume":"14","author":"Bzovey","year":"2022","journal-title":"Clin Optom (Auckl)"},{"issue":"5","key":"10.1016\/j.ajo.2025.11.024_bib0237","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1080\/02713683.2019.1686153","article-title":"The Efficacy of Warm Compresses in the Treatment of Meibomian Gland Dysfunction and Demodex Folliculorum Blepharitis","volume":"45","author":"Murphy","year":"2020","journal-title":"Curr Eye Res"},{"issue":"6","key":"10.1016\/j.ajo.2025.11.024_bib0238","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1007\/s10792-020-01300-z","article-title":"Efficacy of wheat hot pack (dry heat) and pottery hot pack (moist heat) on eyelid temperature and tissue blood flow in healthy eyes: a randomized control trial","volume":"40","author":"Leeungurasatien","year":"2020","journal-title":"Int Ophthalmol"},{"issue":"9","key":"10.1016\/j.ajo.2025.11.024_bib0239","doi-asserted-by":"crossref","first-page":"e327","DOI":"10.1097\/OPX.0000000000000675","article-title":"All Warm Compresses Are Not Equally Efficacious","volume":"92","author":"Murakami","year":"2015","journal-title":"Optom Vis Sci."},{"issue":"8","key":"10.1016\/j.ajo.2025.11.024_bib0240","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1097\/j.jcrs.0000000000001414","article-title":"Eyelid margin disease (blepharitis and meibomian gland dysfunction): clinical review of evidence-based and emerging treatments","volume":"50","author":"Rocha","year":"2024","journal-title":"J Cataract Refract Surg"},{"issue":"9","key":"10.1016\/j.ajo.2025.11.024_bib0241","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1007\/s40123-024-00988-x","article-title":"Evidence-Based Strategies for Warm Compress Therapy in Meibomian Gland Dysfunction","volume":"13","author":"Lee","year":"2024","journal-title":"Ophthalmol Ther"},{"issue":"4","key":"10.1016\/j.ajo.2025.11.024_bib0242","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.clae.2016.04.002","article-title":"In-vivo heat retention comparison of eyelid warming masks","volume":"39","author":"Bitton","year":"2016","journal-title":"Cont Lens Anterior Eye"},{"issue":"3","key":"10.1016\/j.ajo.2025.11.024_bib0243","doi-asserted-by":"crossref","DOI":"10.1016\/j.clae.2020.06.002","article-title":"Efficacy of a novel water propelled, heating eye mask massager on tear film and ocular adnexa","volume":"44","author":"Trave-Huarte","year":"2021","journal-title":"Cont Lens Anterior Eye"},{"issue":"6","key":"10.1016\/j.ajo.2025.11.024_bib0244","doi-asserted-by":"crossref","first-page":"3805","DOI":"10.1167\/iovs.10-6514","article-title":"Human meibum lipid conformation and thermodynamic changes with meibomian-gland dysfunction","volume":"52","author":"Borchman","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"10.1016\/j.ajo.2025.11.024_bib0245","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.jtos.2019.02.005","article-title":"The optimum temperature for the heat therapy for meibomian gland dysfunction","volume":"17","author":"Borchman","year":"2019","journal-title":"Ocul Surf."},{"issue":"4","key":"10.1016\/j.ajo.2025.11.024_bib0246","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jtos.2015.04.005","article-title":"Effects of Eyelid Warming Devices on Tear Film Parameters in Normal Subjects and Patients with Meibomian Gland Dysfunction","volume":"13","author":"Arita","year":"2015","journal-title":"Ocul Surf."},{"issue":"2","key":"10.1016\/j.ajo.2025.11.024_bib0247","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/OPX.0000000000000134","article-title":"Effect of a commercially available warm compress on eyelid temperature and tear film in healthy eyes","volume":"91","author":"Bilkhu","year":"2014","journal-title":"Optom Vis Sci."},{"issue":"4","key":"10.1016\/j.ajo.2025.11.024_bib0248","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1167\/iovs.10-6997g","article-title":"The international workshop on meibomian gland dysfunction: report of the subcommittee on management and treatment of meibomian gland dysfunction","volume":"52","author":"Geerling","year":"2011","journal-title":"Invest Ophthalmol Vis Sci."},{"issue":"10","key":"10.1016\/j.ajo.2025.11.024_bib0249","doi-asserted-by":"crossref","DOI":"10.3390\/medicina60101603","article-title":"Effect of Heating and Massaging of Meibomian Glands on Their Imaging","volume":"60","author":"Pettayil","year":"2024","journal-title":"Medicina"},{"issue":"6","key":"10.1016\/j.ajo.2025.11.024_bib0250","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.clae.2019.07.008","article-title":"Randomised trial of the clinical utility of an eyelid massage device for the management of meibomian gland dysfunction","volume":"42","author":"Wang","year":"2019","journal-title":"Cont Lens Anterior Eye."},{"issue":"6","key":"10.1016\/j.ajo.2025.11.024_bib0251","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1097\/OPX.0000000000001076","article-title":"Investigating the Short-term Effect of Eyelid Massage on Corneal Topography","volume":"94","author":"Riede-Pult","year":"2017","journal-title":"Optom Vis Sci"},{"issue":"2","key":"10.1016\/j.ajo.2025.11.024_bib0252","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.clae.2019.09.004","article-title":"Therapeutic profile of a latent heat eyelid warming device with temperature setting variation","volume":"43","author":"Wang","year":"2020","journal-title":"Cont Lens Anterior Eye."},{"issue":"7","key":"10.1016\/j.ajo.2025.11.024_bib0253","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1007\/s00417-020-04673-0","article-title":"Infrared thermography: different options of thermal eyelid warming","volume":"258","author":"Kremers","year":"2020","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0254","first-page":"45","article-title":"First-in-human Clinical Trial of a Novel Eyelid warming Device in Meibomian Gland Dysfunction","volume":"26","author":"Arazi","year":"2024","journal-title":"Isr Med Assoc J"},{"issue":"10","key":"10.1016\/j.ajo.2025.11.024_bib0255","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1080\/02713683.2024.2357655","article-title":"Safety and Efficacy of Dry Eye Intelligent Therapeutic Device in the Treatment of Meibomian Gland Dysfunction in Rabbits","volume":"49","author":"Shen","year":"2024","journal-title":"Curr Eye Res"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0256","doi-asserted-by":"crossref","DOI":"10.1038\/srep45848","article-title":"Effects of a warm compress containing menthol on the tear film in healthy subjects and dry eye patients","volume":"7","author":"Arita","year":"2017","journal-title":"Sci Rep."},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0257","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1186\/s12886-024-03642-z","article-title":"Efficacy and safety of the disposable eyelid warming masks in the treatment of dry eye disease due to Meibomian gland dysfunction","volume":"24","author":"Wang","year":"2024","journal-title":"BMC Ophthalmol"},{"key":"10.1016\/j.ajo.2025.11.024_bib0258","first-page":"336","article-title":"The role of omega-3 dietary supplementation in blepharitis and meibomian gland dysfunction (an AOS thesis)","volume":"106","author":"Macsai","year":"2008","journal-title":"Trans Am Ophthalmol Soc"},{"key":"10.1016\/j.ajo.2025.11.024_bib0259","article-title":"A randomized, double-masked study to evaluate the effect of omega-3 fatty acids supplementation in meibomian gland dysfunction","volume":"8","author":"Olenik","year":"2013","journal-title":"Clin Interv Aging"},{"key":"10.1016\/j.ajo.2025.11.024_bib0260","doi-asserted-by":"crossref","first-page":"831","DOI":"10.2147\/OPTH.S62470","article-title":"Benefits of omega-3 fatty acid dietary supplementation on health-related quality of life in patients with meibomian gland dysfunction","volume":"8","author":"Olenik","year":"2014","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.ajo.2025.11.024_bib0261","article-title":"A systematic review of the effect of omega-3 supplements on meibomian gland dysfunction","volume":"12","author":"Al-Namaeh","year":"2020","journal-title":"Ther Adv Ophthalmol"},{"issue":"11","key":"10.1016\/j.ajo.2025.11.024_bib0262","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.18240\/ijo.2021.11.08","article-title":"Effects of dietary high dose DHA omega-3 supplement in dry eye with meibomian gland dysfunction","volume":"14","author":"Jo","year":"2021","journal-title":"International journal of ophthalmology"},{"issue":"2","key":"10.1016\/j.ajo.2025.11.024_bib0263","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1089\/jop.2024.0160","article-title":"A Multicenter, Randomized, Clinical Trial Assessing the Effect of rTG-Omega 3 Supplementation on Meibomian Gland Dysfunction Patients after Cataract Surgery rTG-Omega 3 for Meibomian Gland Dysfunction","volume":"41","author":"Hong","year":"2025","journal-title":"J Ocul Pharmacol Ther"},{"issue":"11","key":"10.1016\/j.ajo.2025.11.024_bib0264","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1167\/tvst.11.11.13","article-title":"Dry Eye Subtypes in the Dry Eye Assessment and Management (DREAM) Study: A Latent Profile Analysis","volume":"11","author":"Yu","year":"2022","journal-title":"Transl Vis Sci Technol."},{"issue":"7","key":"10.1016\/j.ajo.2025.11.024_bib0265","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1001\/jamaophthalmol.2024.1482","article-title":"Re-Esterified Triglyceride omega-3 Fatty Acids in Dry Eye Disease With Meibomian Gland Dysfunction: A Randomized Clinical Trial","volume":"142","author":"Eom","year":"2024","journal-title":"JAMA Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajo.2025.11.024_bib0266","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1089\/jop.2022.0186","article-title":"Effect of Treatment with Topical Azithromycin or Oral Doxycycline on Tear Film Thickness in Patients with Meibomian Gland Dysfunction: A Randomized Controlled Trial","volume":"39","author":"Schlatter","year":"2023","journal-title":"J Ocul Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.ajo.2025.11.024_bib0267","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1007\/s00417-019-04322-1","article-title":"Efficacy of azithromycin 1.5% eyedrops vs oral doxycycline in meibomian gland dysfunction: a randomized trial","volume":"257","author":"Satitpitakul","year":"2019","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"10","key":"10.1016\/j.ajo.2025.11.024_bib0268","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1038\/s41433-020-0876-2","article-title":"Systematic review and meta-analysis of treating meibomian gland dysfunction with azithromycin","volume":"34","author":"Tao","year":"2020","journal-title":"Eye (Lond)."},{"issue":"4","key":"10.1016\/j.ajo.2025.11.024_bib0269","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s13555-018-0259-9","article-title":"Topical Selenium Sulfide for the Treatment of Hyperkeratosis","volume":"8","author":"Cohen","year":"2018","journal-title":"Dermatol Ther (Heidelb)."},{"issue":"S1","key":"10.1016\/j.ajo.2025.11.024_bib0270","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1684\/ejd.2023.4402","article-title":"Selenium Disulfide-based shampoo applied for 4 weeks significantly improves dandruff and seborrheic dermatitis","volume":"33","author":"Turcu","year":"2023","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.ajo.2025.11.024_bib0271","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.jtos.2023.07.002","article-title":"Efficacy and safety of AZR-MD-001 selenium sulfide ophthalmic ointment in adults with meibomian gland dysfunction: A vehicle-controlled, randomized clinical trial","volume":"29","author":"Watson","year":"2023","journal-title":"Ocul Surf"},{"issue":"5","key":"10.1016\/j.ajo.2025.11.024_bib0272","first-page":"489","article-title":"Increased sebum secretion following selenium sulfide shampoos","volume":"48","author":"Goldschmidt","year":"1968","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.ajo.2025.11.024_bib0273","first-page":"117","article-title":"Sebum flow dynamics and antidandruff shampoos","volume":"48","year":"1997","journal-title":"J Soc Cosmet Chem"},{"issue":"3","key":"10.1016\/j.ajo.2025.11.024_bib0274","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1007\/s40123-023-00669-1","article-title":"Dry Eye Disease Associated with Meibomian Gland Dysfunction: Focus on Tear Film Characteristics and the Therapeutic Landscape","volume":"12","author":"Sheppard","year":"2023","journal-title":"Ophthalmol Ther"},{"key":"10.1016\/j.ajo.2025.11.024_bib0275","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jtos.2024.11.008","article-title":"Efficacy and safety of AZR-MD-001 selenium sulfide ophthalmic ointment in adults with meibomian gland dysfunction over six months of treatment: A Phase 2, vehicle-controlled, randomized extension trial","volume":"35","author":"Downie","year":"2025","journal-title":"Ocul Surf"},{"key":"10.1016\/j.ajo.2025.11.024_bib0276","unstructured":"Jones L, Schallhorn J, Stapleton F, Alster Y, Bosworth C. AZR-MD-001 Opens Meibomian Glands, Improves Meibum and Tear Quality Resulting in Increased Wear Time and Desired Lens Use in Patients With CLD. Presented at ARVO. 2024;"},{"key":"10.1016\/j.ajo.2025.11.024_bib0277","unstructured":"Stapleton F, Tan J, Hinds M, Alster Y, Bosworth C. AZR-MD-001 Ophthalmic Ointment Opens Meibomian Glands, Improves Meibum Quality, and Tear Film Stability Over 3 Months of Dosing in Patients with Contact Lens Discomfort. Presented at ARVO. 2024;"},{"issue":"4","key":"10.1016\/j.ajo.2025.11.024_bib0278","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1097\/ICU.0000000000000165","article-title":"Treatment for meibomian gland dysfunction and dry eye symptoms with a single-dose vectored thermal pulsation: a review","volume":"26","author":"Blackie","year":"2015","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.ajo.2025.11.024_bib0279","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.2147\/OPTH.S109663","article-title":"The sustained effect (12 months) of a single-dose vectored thermal pulsation procedure for meibomian gland dysfunction and evaporative dry eye","volume":"10","author":"Blackie","year":"2016","journal-title":"Clin Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajo.2025.11.024_bib0280","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/ICL.0000000000000166","article-title":"Long-Term (3 Year) Effects of a Single Thermal Pulsation System Treatment on Meibomian Gland Function and Dry Eye Symptoms","volume":"42","author":"Greiner","year":"2016","journal-title":"Eye Contact Lens"},{"issue":"12","key":"10.1016\/j.ajo.2025.11.024_bib0281","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1016\/j.ophtha.2023.07.009","article-title":"Thermal Pulsation in the Management of Meibomian Gland Dysfunction and Dry Eye: A Report by the American Academy of Ophthalmology","volume":"130","author":"Tao","year":"2023","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.ajo.2025.11.024_bib0282","article-title":"LipiFlow for the treatment of dry eye disease","volume":"2","author":"Pucker","year":"2024","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ajo.2025.11.024_bib0283","doi-asserted-by":"crossref","first-page":"405","DOI":"10.2147\/OPTH.S234008","article-title":"Comparison of the iLUX and the LipiFlow for the Treatment of Meibomian Gland Dysfunction and Symptoms: A Randomized Clinical Trial","volume":"14","author":"Tauber","year":"2020","journal-title":"Clin Ophthalmol"},{"issue":"5","key":"10.1016\/j.ajo.2025.11.024_bib0284","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/j.survophthal.2022.02.007","article-title":"In-office thermal systems for the treatment of dry eye disease","volume":"67","author":"Beining","year":"2022","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.ajo.2025.11.024_bib0285","doi-asserted-by":"crossref","first-page":"3631","DOI":"10.2147\/OPTH.S379484","article-title":"Systane iLux Thermal Pulsation System in the Treatment of Meibomian Gland Dysfunction: A Post-Hoc Analysis of a 12-Month, Randomized, Multicenter Study","volume":"16","author":"Wesley","year":"2022","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.ajo.2025.11.024_bib0286","doi-asserted-by":"crossref","first-page":"683","DOI":"10.2147\/OPTH.S160403","article-title":"A novel system, TearCare((R)), for the treatment of the signs and symptoms of dry eye disease","volume":"12","author":"Badawi","year":"2018","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.ajo.2025.11.024_bib0287","doi-asserted-by":"crossref","first-page":"189","DOI":"10.2147\/OPTH.S191588","article-title":"TearCare((R)) system extension study: evaluation of the safety, effectiveness, and durability through 12 months of a second TearCare((R))treatment on subjects with dry eye disease","volume":"13","author":"Badawi","year":"2019","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.ajo.2025.11.024_bib0288","doi-asserted-by":"crossref","first-page":"4551","DOI":"10.2147\/OPTH.S285953","article-title":"A Prospective, PostMarket, Multicenter Trial (CHEETAH) Suggested TearCare((R)) System as a Safe and Effective Blink-Assisted Eyelid Device for the Treatment of Dry Eye Disease","volume":"14","author":"Karpecki","year":"2020","journal-title":"Clin Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2025.11.024_bib0289","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1097\/ICO.0000000000002837","article-title":"TearCare for the Treatment of Meibomian Gland Dysfunction in Adult Patients With Dry Eye Disease: A Masked Randomized Controlled Trial","volume":"41","author":"Gupta","year":"2022","journal-title":"Cornea"},{"key":"10.1016\/j.ajo.2025.11.024_bib0290","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.2147\/OPTH.S368319","article-title":"A Comparison of TearCare and Lipiflow Systems in Reducing Dry Eye Disease Symptoms Associated with Meibomian Gland Disease","volume":"16","author":"Holland","year":"2022","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.ajo.2025.11.024_bib0291","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.2147\/OPTH.S442971","article-title":"A Randomized, Controlled Trial Comparing Tearcare((R)) and Cyclosporine Ophthalmic Emulsion for the Treatment of Dry Eye Disease (SAHARA)","volume":"17","author":"Ayres","year":"2023","journal-title":"Clin Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0292","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s40123-021-00431-5","article-title":"Effect of a Novel Thermostatic Device on Meibomian Gland Dysfunction: A Randomized Controlled Trial in Chinese Patients","volume":"11","author":"Li","year":"2022","journal-title":"Ophthalmol Ther"},{"key":"10.1016\/j.ajo.2025.11.024_bib0293","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ajo.2022.06.013","article-title":"Effect of Thermoelectric Warming Therapy for the Treatment of Meibomian Gland Dysfunction","volume":"242","author":"Gomez","year":"2022","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0294","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-72320-3","article-title":"Comparison of manual versus automated thermal lid therapy with expression for meibomian gland dysfunction in patients with dry eye disease","volume":"14","author":"Gomez","year":"2024","journal-title":"Sci Rep"},{"issue":"10","key":"10.1016\/j.ajo.2025.11.024_bib0295","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.jfo.2014.06.004","article-title":"Evaluation of an eyelid warming device (Blephasteam) for the management of ocular surface diseases in France: the ESPOIR study","volume":"37","author":"Doan","year":"2014","journal-title":"J Fr Ophtalmol"},{"issue":"5","key":"10.1016\/j.ajo.2025.11.024_bib0296","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.clae.2013.02.009","article-title":"Evaluation of the ocular tolerance of a novel eyelid-warming device used for meibomian gland dysfunction","volume":"36","author":"Purslow","year":"2013","journal-title":"Cont Lens Anterior Eye."},{"key":"10.1016\/j.ajo.2025.11.024_bib0297","first-page":"2019","article-title":"Evaluation of the efficacy, safety, and acceptability of an eyelid warming device for the treatment of meibomian gland dysfunction","volume":"8","author":"Benitez Del Castillo","year":"2014","journal-title":"Clin Ophthalmol"},{"issue":"1-2","key":"10.1016\/j.ajo.2025.11.024_bib0298","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s40123-014-0025-8","article-title":"A Randomized, Controlled Treatment Trial of Eyelid-Warming Therapies in Meibomian Gland Dysfunction","volume":"3","author":"Sim","year":"2014","journal-title":"Ophthalmol Ther"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0299","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-01899-8","article-title":"TheraPearl Eye Mask and Blephasteam for the treatment of meibomian gland dysfunction: a randomized, comparative clinical trial","volume":"11","author":"Olafsson","year":"2021","journal-title":"Sci Rep"},{"issue":"5","key":"10.1016\/j.ajo.2025.11.024_bib0300","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/aos.15052","article-title":"Chambered warm moist air eyelid warming devices - a review","volume":"100","author":"Magno","year":"2022","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.ajo.2025.11.024_bib0301","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.2147\/OPTH.S139894","article-title":"Intense pulsed light for evaporative dry eye disease","volume":"11","author":"Dell","year":"2017","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.ajo.2025.11.024_bib0302","article-title":"Skin temperature change in patients with meibomian gland dysfunction following intense pulsed light treatment","volume":"9","author":"Yun","year":"2022","journal-title":"Front Med (Lausanne)"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0303","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s10103-024-04060-9","article-title":"Intense pulsed light therapy for ocular surface diseases","volume":"39","author":"Chen","year":"2024","journal-title":"Lasers Med Sci"},{"issue":"4","key":"10.1016\/j.ajo.2025.11.024_bib0304","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1097\/ICU.0000000000001055","article-title":"Intense pulsed light treatment for the management of meibomian gland dysfunction","volume":"35","author":"Gupta","year":"2024","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.ajo.2025.11.024_bib0305","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2147\/OPTO.S217639","article-title":"Intense Pulsed Light Therapy In The Treatment Of Meibomian Gland Dysfunction: Current Perspectives","volume":"11","author":"Giannaccare","year":"2019","journal-title":"Clin Optom (Auckl)"},{"issue":"49","key":"10.1016\/j.ajo.2025.11.024_bib0306","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000028166","article-title":"Factors influencing the clinical outcomes of intense pulsed light for meibomian gland dysfunction","volume":"100","author":"Chen","year":"2021","journal-title":"Medicine (Baltimore)"},{"issue":"6","key":"10.1016\/j.ajo.2025.11.024_bib0307","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0270268","article-title":"Intense pulsed light improves signs and symptoms of dry eye disease due to meibomian gland dysfunction: A randomized controlled study","volume":"17","author":"Toyos","year":"2022","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0308","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1186\/s12886-023-02939-9","article-title":"Intense pulsed-light treatment improves objective optical quality in patients with meibomian gland dysfunction","volume":"23","author":"Whang","year":"2023","journal-title":"BMC Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajo.2025.11.024_bib0309","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.jtos.2020.01.003","article-title":"Randomised doublemasked placebo-controlled trial of the cumulative treatment efficacy profile ofintense pulsed light therapy for meibomian gland dysfunction","volume":"18","author":"Xue","year":"2020","journal-title":"Ocul Surf"},{"issue":"4","key":"10.1016\/j.ajo.2025.11.024_bib0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.clae.2021.101499","article-title":"Tear film interferometry assessment after intense pulsed light in dry eye disease: A randomized, single masked, shamcontrolled study","volume":"45","author":"Song","year":"2022","journal-title":"Cont Lens Anterior Eye"},{"issue":"7","key":"10.1016\/j.ajo.2025.11.024_bib0311","doi-asserted-by":"crossref","first-page":"7857","DOI":"10.21037\/apm-21-1303","article-title":"Efficacy and safety of Intense pulsed light therapy for dry eye caused by meibomian gland dysfunction: a randomised trial","volume":"10","author":"Yan","year":"2021","journal-title":"Ann Palliat Med"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0312","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jtos.2018.11.004","article-title":"Therapeutic efficacy of intense pulsed light in patients with refractory meibomian gland dysfunction","volume":"17","author":"Arita","year":"2019","journal-title":"Ocul Surf"},{"issue":"10","key":"10.1016\/j.ajo.2025.11.024_bib0313","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1089\/pho.2018.4499","article-title":"Long-Term Effects of Intense Pulsed Light Combined with Meibomian Gland Expression in the Treatment of Meibomian Gland Dysfunction","volume":"36","author":"Rong","year":"2018","journal-title":"Photomed Laser Surg"},{"issue":"4","key":"10.1016\/j.ajo.2025.11.024_bib0314","article-title":"Ocular Surface Workup in Patients with Meibomian Gland Dysfunction Treated with Intense Regulated Pulsed Light","volume":"9","author":"Vigo","year":"2019","journal-title":"Diagnostics (Basel)"},{"issue":"16","key":"10.1016\/j.ajo.2025.11.024_bib0315","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11164724","article-title":"Investigation of Prognostic Factors for Intense Pulsed Light Treatment with a Vascular Filter in Patients with Moderate or Severe Meibomian Gland Dysfunction","volume":"11","author":"Lee","year":"2022","journal-title":"J Clin Med."},{"issue":"3","key":"10.1016\/j.ajo.2025.11.024_bib0316","article-title":"Intense pulsed light (IPL) therapy for the treatment of meibomian gland dysfunction","volume":"3","author":"Cote","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"issue":"8","key":"10.1016\/j.ajo.2025.11.024_bib0317","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12083039","article-title":"Intense Pulsed Light Therapy in the Treatment of Dry Eye Diseases: A Systematic Review and MetaAnalysis","volume":"12","author":"Demolin","year":"2023","journal-title":"J Clin Med"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0318","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10103-022-03690-1","article-title":"Intense pulsed light (IPL) therapy for meibomian gland dysfunction (MGD)-related dry eye disease (DED): a systematic review and meta-analysis","volume":"38","author":"Lei","year":"2022","journal-title":"Lasers Med Sci."},{"issue":"Suppl 2","key":"10.1016\/j.ajo.2025.11.024_bib0319","doi-asserted-by":"crossref","first-page":"S183","DOI":"10.4103\/IJO.IJO_671_23","article-title":"Current application of intense pulsed light for the management of dry eye disease: A systematic review and meta-analysis","volume":"72","author":"Pratomo","year":"2024","journal-title":"Indian J Ophthalmol."},{"issue":"4","key":"10.1016\/j.ajo.2025.11.024_bib0320","first-page":"249","article-title":"Preliminary Assessment of Intense Pulsed Light Treatment on the Upper Eyelids for Meibomian Gland Dysfunction","volume":"38","author":"Li","year":"2020","journal-title":"Photobiomodul Photomed Laser Surg"},{"issue":"2","key":"10.1016\/j.ajo.2025.11.024_bib0321","first-page":"70","article-title":"Intense Pulsed Light Treatment for Meibomian Gland Dysfunction in Skin Types III\/IV","volume":"37","author":"Li","year":"2019","journal-title":"Photobiomodul Photomed Laser Surg"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0322","doi-asserted-by":"crossref","first-page":"6700","DOI":"10.1038\/s41598-023-33526-z","article-title":"Comparison of clinical outcomes between intense pulsed light therapy using two different filters in meibomian gland dysfunction: prospective randomized study","volume":"13","author":"Jang","year":"2023","journal-title":"Sci Rep"},{"issue":"7","key":"10.1016\/j.ajo.2025.11.024_bib0323","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1007\/s10792-020-01337-0","article-title":"Comparison of two intense pulsed light patterns for treating patients with meibomian gland dysfunction","volume":"40","author":"Wu","year":"2020","journal-title":"Int Ophthalmol"},{"key":"10.1016\/j.ajo.2025.11.024_bib0324","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.973962","article-title":"Response of tear cytokines following intense pulsed light combined with meibomian gland expression for treating meibomian gland dysfunction-related dry eye","volume":"13","author":"Yu","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"10.1016\/j.ajo.2025.11.024_bib0325","doi-asserted-by":"crossref","first-page":"89","DOI":"10.4274\/tjo.galenos.2020.28924","article-title":"Efficacy of Intense Pulsed Light Treatment for Moderate to Severe Acute Blepharitis or Blepharoconjunctivitis: A Retrospective Case Series","volume":"51","author":"Gedar Totuk","year":"2021","journal-title":"Turk J Ophthalmol"},{"key":"10.1016\/j.ajo.2025.11.024_bib0326","article-title":"Combined Low-Level Light Therapy and Intense Pulsed Light Therapy for the Treatment of Dry Eye in Patients with Sjogren's Syndrome","volume":"2021","author":"Di Marino","year":"2021","journal-title":"J Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0327","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s40662-022-00284-4","article-title":"Intense pulsed light-based treatment for the improvement of symptoms in glaucoma patients treated with hypotensive eye drops","volume":"9","author":"Martinez-de-la-Casa","year":"2022","journal-title":"Eye Vis (Lond)"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0328","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s40123-021-00418-2","article-title":"Management of Post-LASIK Dry Eye with Intense Pulsed Light in Combination with 0.1% Sodium Hyaluronate and Heated Eye Mask","volume":"11","author":"Wu","year":"2022","journal-title":"Ophthalmol Ther."},{"key":"10.1016\/j.ajo.2025.11.024_bib0329","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jtos.2023.10.002","article-title":"Safety and efficacy of intense pulsed light in the treatment of severe chronic ocular graft-versus-host disease","volume":"30","author":"Wang","year":"2023","journal-title":"Ocul Surf"},{"issue":"5","key":"10.1016\/j.ajo.2025.11.024_bib0330","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11051312","article-title":"Efficacy of Intense Pulsed Light Combined Blood Extract Eye Drops for Treatment of Nociceptive Pain in Dry Eye Patients","volume":"11","author":"Wu","year":"2022","journal-title":"J Clin Med"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0331","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1089\/jop.2024.0099","article-title":"Effects of Intense Pulsed Light on Presumed Neuropathic Pain Associated with Meibomian Gland Dysfunction: A Before-After Study","volume":"41","author":"Hoarau","year":"2025","journal-title":"J Ocul Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0332","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s10103-024-04154-4","article-title":"Effects of combined intense pulsed light and cyclosporine 0.05% eyedrops in ocular surface matrix metalloproteinase-9 levels in patients with moderate-to-severe MGD","volume":"39","author":"Jeon","year":"2024","journal-title":"Lasers Med Sci"},{"issue":"6","key":"10.1016\/j.ajo.2025.11.024_bib0333","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.1007\/s40123-023-00784-z","article-title":"The Combined Impact of Intense Pulsed Light Combined and 3% Diquafosol Ophthalmic Solution on Evaporative Dry Eye: A Randomized Control Study","volume":"12","author":"Chen","year":"2023","journal-title":"Ophthalmol Ther"},{"issue":"11","key":"10.1016\/j.ajo.2025.11.024_bib0334","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1097\/DSS.0000000000002009","article-title":"Safety of Combination Laser or Intense Pulsed Light Therapies and Doxycycline for the Treatment of Rosacea","volume":"45","author":"Schilling","year":"2019","journal-title":"Dermatol Surg"},{"issue":"13","key":"10.1016\/j.ajo.2025.11.024_bib0335","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e33852","article-title":"The photothermal effect of intense pulsed light and LipiFlow in eyelid related ocular surface diseases: Meibomian gland dysfunction, Demodex and blepharitis","volume":"10","author":"Li","year":"2024","journal-title":"Heliyon"},{"issue":"11","key":"10.1016\/j.ajo.2025.11.024_bib0336","doi-asserted-by":"crossref","first-page":"3311","DOI":"10.1007\/s10792-022-02330-5","article-title":"Combination treatment with intense pulsed light, thermal pulsation (LipiFlow), and meibomian gland expression for refractory meibomian gland dysfunction","volume":"42","author":"Chung","year":"2022","journal-title":"Int Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajo.2025.11.024_bib0337","first-page":"158","article-title":"Efficiency of Combining Heated Eye Mask with Intense Pulsed Light Therapy as a Treatment Option for Evaporative Dry Eye Disease","volume":"68","author":"Pac","year":"2024","journal-title":"Rom J Ophthalmol"},{"issue":"8","key":"10.1016\/j.ajo.2025.11.024_bib0338","first-page":"435","article-title":"Tear Film Lipid Layer Changes Following Combined Effect of Heated Eye Mask with Intense Pulsed Light Therapy for Evaporative Dry Eye: A Randomized Control Study","volume":"41","author":"Li","year":"2023","journal-title":"Photobiomodul Photomed Laser Surg"},{"issue":"5","key":"10.1016\/j.ajo.2025.11.024_bib0339","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1007\/s40123-024-00919-w","article-title":"Diamond Bur Microblepharoexfoliation Combined with Intense Pulse Light and Meibomian Gland Expression for Evaporative Dry Eye: A Short-term Controlled Clinical Trial","volume":"13","author":"Ballesteros-Sanchez","year":"2024","journal-title":"Ophthalmol Ther"},{"key":"10.1016\/j.ajo.2025.11.024_bib0340","series-title":"StatPearls Internet Treasure Island (FL)","article-title":"Intense Pulsed Light (IPL) Therapy","author":"Gade","year":"2025"},{"issue":"5","key":"10.1016\/j.ajo.2025.11.024_bib0341","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/lsm.23339","article-title":"Adverse Events of Intense Pulsed Light Combined With Meibomian Gland Expression Versus Meibomian Gland Expression in the Treatment of Meibomian Gland Dysfunction","volume":"53","author":"Qiao","year":"2021","journal-title":"Lasers Surg Med"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0342","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-17986-3","article-title":"Efficacy and safety of intense pulsed light direct eyelid application","volume":"12","author":"Martinez-Hergueta","year":"2022","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.ajo.2025.11.024_bib0343","doi-asserted-by":"crossref","DOI":"10.1109\/JSTQE.2016.2561201","article-title":"Proposed Mechanisms of Photobiomodulation or Low-Level Light Therapy","volume":"22","author":"de Freitas","year":"2016","journal-title":"IEEE J Sel Top Quantum Electron"},{"issue":"8","key":"10.1016\/j.ajo.2025.11.024_bib0344","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1002\/iub.359","article-title":"Multiple roles of cytochrome c oxidase in mammalian cells under action of red and IR-A radiation","volume":"62","author":"Karu","year":"2010","journal-title":"IUBMB Life"},{"issue":"5","key":"10.1016\/j.ajo.2025.11.024_bib0345","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1089\/ars.2013.5229","article-title":"Cancer phototherapy via selective photoinactivation of respiratory chain oxidase to trigger a fatal superoxide anion burst","volume":"20","author":"Wu","year":"2014","journal-title":"Antioxid Redox Signal"},{"issue":"57","key":"10.1016\/j.ajo.2025.11.024_bib0346","first-page":"154","article-title":"Therapeutic photobiomodulation: nitric oxide and a novel function of mitochondrial cytochrome c oxidase","volume":"11","author":"Poyton","year":"2011","journal-title":"Discov Med"},{"key":"10.1016\/j.ajo.2025.11.024_bib0347","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.niox.2022.11.005","article-title":"Photobiomodulation and nitric oxide signaling","volume":"130","author":"Kashiwagi","year":"2023","journal-title":"Nitric Oxide"},{"issue":"5","key":"10.1016\/j.ajo.2025.11.024_bib0348","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1111\/j.1751-1097.2008.00394.x","article-title":"Mitochondrial signaling in mammalian cells activated by red and near-IR radiation","volume":"84","author":"Karu","year":"2008","journal-title":"Photochem Photobiol"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0349","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1089\/104454701750066910","article-title":"Biostimulatory windows in low-intensity laser activation: lasers, scanners, and NASA's light-emitting diode array system","volume":"19","author":"Sommer","year":"2001","journal-title":"J Clin Laser Med Surg"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0350","doi-asserted-by":"crossref","first-page":"3575","DOI":"10.1038\/s41598-022-07427-6","article-title":"Effect of low-level light therapy in patients with dry eye: a prospective, randomized, observer-masked trial","volume":"12","author":"Park","year":"2022","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.ajo.2025.11.024_bib0351","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/ICO.0000000000002997","article-title":"Low-Level Light Therapy Versus Intense Pulsed Light for the Treatment of Meibomian Gland Dysfunction: Preliminary Results From a Prospective Randomized Comparative Study","volume":"42","author":"Giannaccare","year":"2023","journal-title":"Cornea"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0352","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s40123-022-00619-3","article-title":"Serial Sessions of a Novel Low-Level Light Therapy Device for Home Treatment of Dry Eye Disease","volume":"12","author":"Giannaccare","year":"2023","journal-title":"Ophthalmol Ther"},{"issue":"8","key":"10.1016\/j.ajo.2025.11.024_bib0353","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1136\/bjo-2023-323920","article-title":"Outcomes of low-level light therapy before and after cataract surgery for the prophylaxis of postoperative dry eye: a prospective randomised double-masked controlled clinical trial","volume":"108","author":"Giannaccare","year":"2024","journal-title":"The British journal of ophthalmology"},{"issue":"7","key":"10.1016\/j.ajo.2025.11.024_bib0354","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1111\/opo.13371","article-title":"Effect of low-level light therapy in individuals with dry eye disease","volume":"44","author":"Antwi","year":"2024","journal-title":"Ophthalmic Physiol Opt"},{"issue":"5","key":"10.1016\/j.ajo.2025.11.024_bib0355","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1080\/08164622.2021.1878866","article-title":"Photobiomodulation (low-level light therapy) and dry eye disease","volume":"104","author":"Markoulli","year":"2021","journal-title":"Clin Exp Optom"},{"issue":"4","key":"10.1016\/j.ajo.2025.11.024_bib0356","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.4103\/IJO.IJO_2834_22","article-title":"A randomized controlled study evaluating outcomes of intense pulsed light and low-level light therapy for treating meibomian gland dysfunction and evaporative dry eye","volume":"71","author":"D'Souza","year":"2023","journal-title":"Indian J Ophthalmol"},{"issue":"10","key":"10.1016\/j.ajo.2025.11.024_bib0357","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/j.jfo.2022.03.015","article-title":"Optimized combined low level light therapy and intense pulsed light therapy for the treatment of dry eye syndrome caused by Meibomian glands dysfunction","volume":"45","author":"El Shami","year":"2022","journal-title":"J Fr Ophtalmol"},{"key":"10.1016\/j.ajo.2025.11.024_bib0358","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.2147\/OPTH.S318885","article-title":"Intense Pulsed Plus Low Level Light Therapy in Meibomian Gland Dysfunction","volume":"15","author":"Marta","year":"2021","journal-title":"Clin Ophthalmol"},{"issue":"9","key":"10.1016\/j.ajo.2025.11.024_bib0359","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1097\/ICO.0000000000002954","article-title":"Clinical and Molecular Outcomes After Combined Intense Pulsed Light Therapy With Low-Level Light Therapy in Recalcitrant Evaporative Dry Eye Disease With Meibomian Gland Dysfunction","volume":"41","author":"D'Souza","year":"2022","journal-title":"Cornea"},{"key":"10.1016\/j.ajo.2025.11.024_bib0360","doi-asserted-by":"crossref","first-page":"993","DOI":"10.2147\/OPTH.S213664","article-title":"Combined low level light therapy and intense pulsed light therapy for the treatment of meibomian gland dysfunction","volume":"13","author":"Stonecipher","year":"2019","journal-title":"Clin Ophthalmol"},{"issue":"5","key":"10.1016\/j.ajo.2025.11.024_bib0361","doi-asserted-by":"crossref","first-page":"127","DOI":"10.15406\/aovs.2020.10.00397","article-title":"Treatment of mild forms of blepharitis using direct plasma discharge","volume":"10","author":"Zemanov\u00e1","year":"2020","journal-title":"Adv Ophthalmol Vis Syst"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0362","article-title":"Plasma Medicine: Applications of Cold Atmospheric Pressure Plasma in Dermatology","volume":"2019","author":"Bernhardt","year":"2019","journal-title":"Oxid Med Cell Longev"},{"issue":"6","key":"10.1016\/j.ajo.2025.11.024_bib0363","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1038\/nprot.2007.205","article-title":"Application of direct current electric fields to cells and tissues in vitro and modulation of wound electric field in vivo","volume":"2","author":"Song","year":"2007","journal-title":"Nat Protoc"},{"issue":"11","key":"10.1016\/j.ajo.2025.11.024_bib0364","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1097\/ICO.0000000000002063","article-title":"High Frequency Electrotherapy for the Treatment of Meibomian Gland Dysfunction","volume":"38","author":"Ferrari","year":"2019","journal-title":"Cornea."},{"key":"10.1016\/j.ajo.2025.11.024_bib0365","article-title":"Quantum molecular resonance electrotherapy (Rexon-Eye) for recalcitrant dry eye in an Asian population","volume":"10","author":"Foo","year":"2023","journal-title":"Front Med (Lausanne)"},{"issue":"5","key":"10.1016\/j.ajo.2025.11.024_bib0366","article-title":"Quantum Molecular Resonance Electrical Stimulation as a Beneficial and Safe Treatment for Multifactorial Dry Eye Disease","volume":"15","author":"Kavroulaki","year":"2023","journal-title":"Cureus"},{"issue":"2","key":"10.1016\/j.ajo.2025.11.024_bib0367","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.optom.2022.06.003","article-title":"Evaluating the efficacy of Quantum Molecular Resonance (QMR) electrotherapy in mixed-type dry eye patients","volume":"16","author":"Trivli","year":"2023","journal-title":"J Optom"},{"issue":"2","key":"10.1016\/j.ajo.2025.11.024_bib0368","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s40123-023-00868-w","article-title":"Efficacy and Safety of Quantum Molecular Resonance Electrotherapy in Patients with Aqueous-Deficient, Evaporative and Mixed-Type Dry Eye: A Randomized Interventional Study","volume":"13","author":"Ballesteros-Sanchez","year":"2024","journal-title":"Ophthalmol Ther"},{"issue":"9","key":"10.1016\/j.ajo.2025.11.024_bib0369","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1097\/ICO.0000000000003443","article-title":"Quantum Molecular Resonance Effects on Patients With Dry Eye Disease: A Randomized Controlled Trial","volume":"43","author":"Shemer","year":"2024","journal-title":"Cornea"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0370","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.22374\/jded.v1i1.2","article-title":"Pellev\u00e9\u2122 vs Lipiflow\u2122 MGD-related dry eye treatment study: the ThermaLid\u2122 procedure","volume":"1","author":"Jaccoma","year":"2018","journal-title":"Journal of Dry Eye Disease"},{"key":"10.1016\/j.ajo.2025.11.024_bib0371","doi-asserted-by":"crossref","first-page":"3089","DOI":"10.2147\/OPTH.S426564","article-title":"Multi-Frequency RF Combined with Intense Pulsed Light Improves Signs and Symptoms of Dry Eye Disease Due to Meibomian Gland Dysfunction","volume":"17","author":"Chelnis","year":"2023","journal-title":"Clin Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajo.2025.11.024_bib0372","first-page":"32","article-title":"Comprehensive Review of Thermomechanical Fractional Injury Device: Applications in Medical and Cosmetic Dermatology","volume":"17","author":"Estupinan","year":"2024","journal-title":"J Clin Aesthet Dermatol"},{"issue":"6","key":"10.1016\/j.ajo.2025.11.024_bib0373","doi-asserted-by":"crossref","DOI":"10.1016\/j.clae.2022.101741","article-title":"The effect of thermo-mechanical device (Tixel) treatment on evaporative dry eye disease - A pilot prospective clinical trial","volume":"45","author":"Safir","year":"2022","journal-title":"Cont Lens Anterior Eye"},{"issue":"2","key":"10.1016\/j.ajo.2025.11.024_bib0374","doi-asserted-by":"crossref","DOI":"10.1016\/j.clae.2022.101811","article-title":"The effect of nonablative thermomechanical skin treatment (Tixel(R)) on dry eye disease: A prospective two centre open-label trial","volume":"46","author":"Shah","year":"2023","journal-title":"Cont Lens Anterior Eye"},{"key":"10.1016\/j.ajo.2025.11.024_bib0375","doi-asserted-by":"crossref","DOI":"10.1097\/j.jcrs.0000000000001602","article-title":"Effectiveness and safety of a thermo-mechanical action device versus thermal pulsation device in the treatment of meibomian gland dysfunction","author":"Sadri","year":"2024","journal-title":"J Cataract Refract Surg"},{"issue":"3","key":"10.1016\/j.ajo.2025.11.024_bib0376","doi-asserted-by":"crossref","DOI":"10.1016\/j.clae.2024.102164","article-title":"Impact of thermo-mechanical skin treatment on refraction and keratometry in patients with dry eye disease and the implications for cataract surgery","volume":"47","author":"Blanco-Vazquez","year":"2024","journal-title":"Cont Lens Anterior Eye"},{"key":"10.1016\/j.ajo.2025.11.024_bib0377","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.2147\/OPTH.S183174","article-title":"Intraductal meibomian gland probing: background, patient selection, procedure, and perspectives","volume":"13","author":"Maskin","year":"2019","journal-title":"Clin Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajo.2025.11.024_bib0378","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1097\/ICO.0000000000000820","article-title":"Effectiveness of Intraductal Meibomian Gland Probing for Obstructive Meibomian Gland Dysfunction","volume":"35","author":"Sik Sarman","year":"2016","journal-title":"Cornea."},{"issue":"7","key":"10.1016\/j.ajo.2025.11.024_bib0379","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1097\/ICO.0000000000001954","article-title":"Expressible Meibomian Glands Have Occult Fixed Obstructions: Findings From Meibomian Gland Probing to Restore Intraductal Integrity","volume":"38","author":"Maskin","year":"2019","journal-title":"Cornea"},{"issue":"12","key":"10.1016\/j.ajo.2025.11.024_bib0380","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1136\/bjophthalmol-2019-315384","article-title":"Meibography guided intraductal meibomian gland probing using real-time infrared video feed","volume":"104","author":"Maskin","year":"2020","journal-title":"The British journal of ophthalmology"},{"key":"10.1016\/j.ajo.2025.11.024_bib0381","doi-asserted-by":"crossref","first-page":"631","DOI":"10.2147\/OPTH.S452549","article-title":"Meibomian Gland Probing Stimulates a Proliferative Epithelial Response Resulting in Duct Regeneration","volume":"18","author":"Maskin","year":"2024","journal-title":"Clin Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2025.11.024_bib0382","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.survophthal.2020.11.005","article-title":"Intraductal meibomian gland probing and its efficacy in the treatment of meibomian gland dysfunction","volume":"66","author":"Magno","year":"2021","journal-title":"Surv Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2025.11.024_bib0383","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.jtos.2020.08.008","article-title":"A randomized, sham-controlled trial of intraductal meibomian gland probing with or without topical antibiotic\/steroid for obstructive meibomian gland dysfunction","volume":"18","author":"Kheirkhah","year":"2020","journal-title":"Ocul Surf"},{"issue":"4","key":"10.1016\/j.ajo.2025.11.024_bib0384","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.survophthal.2021.02.007","article-title":"Comments on: Intraductal Meibomian Gland Probing and its Efficacy in the Treatment of Meibomian Gland Dysfunction","volume":"66","author":"Maskin","year":"2021","journal-title":"Surv Ophthalmol"},{"issue":"8","key":"10.1016\/j.ajo.2025.11.024_bib0385","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1080\/09273948.2018.1522357","article-title":"Effectiveness of Intraductal Meibomian Gland Probing in Addition to the Conventional Treatment in Patients with Obstructive Meibomian Gland Dysfunction","volume":"27","author":"Incekalan","year":"2019","journal-title":"Ocul Immunol Inflamm"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0386","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1186\/s12886-019-1219-6","article-title":"Clinical results of Intraductal Meibomian gland probing combined with intense pulsed light in treating patients with refractory obstructive Meibomian gland dysfunction: a randomized controlled trial","volume":"19","author":"Huang","year":"2019","journal-title":"BMC Ophthalmol"},{"issue":"12","key":"10.1016\/j.ajo.2025.11.024_bib0387","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1097\/ICO.0b013e3182a73843","article-title":"Debridement-scaling: a new procedure that increases Meibomian gland function and reduces dry eye symptoms","volume":"32","author":"Korb","year":"2013","journal-title":"Cornea."},{"issue":"9","key":"10.1016\/j.ajo.2025.11.024_bib0388","doi-asserted-by":"crossref","first-page":"e316","DOI":"10.1097\/OPX.0000000000000668","article-title":"Effect of Lid Debridement Scaling in Sjogren Syndrome Dry Eye","volume":"92","author":"Ngo","year":"2015","journal-title":"Optom Vis Sci."},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0389","doi-asserted-by":"crossref","DOI":"10.2174\/18743641-v17-231005-2023-13","article-title":"MGrx - A Novel Multi-modal Thermal Device for Treating Moderate to Severe Meibomian Gland Dysfunction and Dry Eye","volume":"17","author":"McMurren","year":"2023","journal-title":"The Open Ophthalmology Journal"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0390","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/OPX.0000000000002204","article-title":"Randomized clinical trial: MGrx versus standard debridement and expression for meibomian gland dysfunction","volume":"102","author":"Semp","year":"2025","journal-title":"Optom Vis Sci"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0391","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1186\/s12886-021-01926-2","article-title":"Effects of lid debris debridement combined with meibomian gland expression on the ocular surface MMP-9 levels and clinical outcomes in moderate and severe meibomian gland dysfunction","volume":"21","author":"Moon","year":"2021","journal-title":"BMC Ophthalmol."},{"issue":"7","key":"10.1016\/j.ajo.2025.11.024_bib0392","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s12325-012-0033-9","article-title":"Diquafosol ophthalmic solution for dry eye treatment","volume":"29","author":"Nakamura","year":"2012","journal-title":"Adv Ther"},{"key":"10.1016\/j.ajo.2025.11.024_bib0393","doi-asserted-by":"crossref","first-page":"865","DOI":"10.2147\/OPTH.S69486","article-title":"Clinical utility of 3% diquafosol ophthalmic solution in the treatment of dry eyes","volume":"9","author":"Koh","year":"2015","journal-title":"Clin Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2025.11.024_bib0394","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.4103\/IJO.IJO_268_23","article-title":"Safety and efficacy of topical diquafosol for the treatment of dry eye disease: An updated meta-analysis of randomized controlled trials","volume":"71","author":"Liu","year":"2023","journal-title":"Indian J Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0395","doi-asserted-by":"crossref","first-page":"9091","DOI":"10.1038\/s41598-019-45475-7","article-title":"Tear film lipid layer increase after diquafosol instillation in dry eye patients with meibomian gland dysfunction: a randomized clinical study","volume":"9","author":"Fukuoka","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.ajo.2025.11.024_bib0396","doi-asserted-by":"crossref","first-page":"529","DOI":"10.2147\/OPTH.S129178","article-title":"Influence on ocular surface after cataract surgery and effect of topical diquafosol on postoperative dry eye: a multicenter prospective randomized study","volume":"11","author":"Miyake","year":"2017","journal-title":"Clin Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0397","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-13121-9","article-title":"A Prospective, Randomized Trial of Two Mucin Secretogogues for the Treatment of Dry Eye Syndrome in Office Workers","volume":"7","author":"Shimazaki","year":"2017","journal-title":"Sci Rep."},{"issue":"5","key":"10.1016\/j.ajo.2025.11.024_bib0398","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1007\/s10792-017-0693-1","article-title":"Effect of diquafosol tetrasodium 3% on the conjunctival surface and clinical findings after cataract surgery in patients with dry eye","volume":"38","author":"Cui","year":"2018","journal-title":"Int Ophthalmol"},{"issue":"5","key":"10.1016\/j.ajo.2025.11.024_bib0399","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s12325-018-0685-1","article-title":"Randomized Controlled Study to Investigate the Effect of Topical Diquafosol Tetrasodium on Corneal Sensitivity in Short Tear Break-Up Time Dry Eye","volume":"35","author":"Kaido","year":"2018","journal-title":"Adv Ther"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0400","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-49159-0","article-title":"Effects of Preservative-free 3% Diquafosol in Patients with Pre-existing Dry Eye Disease after Cataract Surgery: A Randomized Clinical Trial","volume":"9","author":"Jun","year":"2019","journal-title":"Sci Rep."},{"issue":"15","key":"10.1016\/j.ajo.2025.11.024_bib0401","doi-asserted-by":"crossref","first-page":"5035","DOI":"10.1167\/iovs.19-27872","article-title":"Changes in Human Tear Proteome Following Topical Treatment of Dry Eye Disease: Cyclosporine A Versus Diquafosol Tetrasodium","volume":"60","author":"Ji","year":"2019","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0402","doi-asserted-by":"crossref","first-page":"9124","DOI":"10.1038\/s41598-021-88589-7","article-title":"A randomised, prospective study of the effects of 3% diquafosol on ocular surface following cataract surgery","volume":"11","author":"Kim","year":"2021","journal-title":"Sci Rep"},{"issue":"10","key":"10.1016\/j.ajo.2025.11.024_bib0403","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.18240\/ijo.2021.10.07","article-title":"Clinical effectiveness of diquafosol ophthalmic solution 3% in Korean patients with dry eye disease: a multicenter prospective observational study","volume":"14","author":"Eom","year":"2021","journal-title":"International journal of ophthalmology"},{"issue":"19","key":"10.1016\/j.ajo.2025.11.024_bib0404","doi-asserted-by":"crossref","first-page":"5757","DOI":"10.3390\/jcm11195757","article-title":"Prevention of Surgery-Induced Dry Eye by Diquafosol Eyedrops after Femtosecond Laser Assisted Cataract Surgery","volume":"11","author":"Yamazaki","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.ajo.2025.11.024_bib0405","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jtos.2023.04.015","article-title":"Proteomic analysis of tears in dry eye disease: A prospective, double-blind multicenter study","volume":"29","author":"Jung","year":"2023","journal-title":"Ocul Surf"},{"key":"10.1016\/j.ajo.2025.11.024_bib0406","article-title":"Combination therapy with 3% diquafosol tetrasodium ophthalmic solution and sodium hyaluronate: an effective therapy for patients with dry eye after femtosecond laser-assisted in situ keratomileusis","volume":"10","author":"Wang","year":"2023","journal-title":"Front Med (Lausanne)"},{"issue":"6","key":"10.1016\/j.ajo.2025.11.024_bib0407","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1007\/s12325-024-02871-4","article-title":"Effects of a Long-Acting Diquafosol Ophthalmic Solution on the Ocular Surface, Tolerability, and Usability in Dry Eye Disease","volume":"41","author":"Kaido","year":"2024","journal-title":"Adv Ther"},{"issue":"9","key":"10.1016\/j.ajo.2025.11.024_bib0408","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0305020","article-title":"Tolerability of Diquas LX on tear film and meibomian glands findings in a real clinical scenario","volume":"19","author":"Arita","year":"2024","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.ajo.2025.11.024_bib0409","first-page":"269","article-title":"Oral pilocarpine for the treatment of dry eye in patients with Sjogren's syndrome","volume":"85","author":"Felberg","year":"2022","journal-title":"Arq Bras Oftalmol"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0410","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3390\/pharmaceutics15010147","article-title":"Management of Sjogren's Dry Eye Disease-Advances in Ocular Drug Delivery Offering a New Hope","volume":"15","author":"Wu","year":"2022","journal-title":"Pharmaceutics"},{"issue":"2","key":"10.1016\/j.ajo.2025.11.024_bib0411","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/APO.0000000000000040","article-title":"Effect of Oral Pilocarpine in Treating Severe Dry Eye in Patients With Sjogren Syndrome","volume":"4","author":"Kawakita","year":"2015","journal-title":"Asia Pac J Ophthalmol (Phila)"},{"issue":"4","key":"10.1016\/j.ajo.2025.11.024_bib0412","first-page":"575","article-title":"Comparison of the discontinuation rates and side-effect profiles of pilocarpine and cevimeline for xerostomia in primary Sjogren's syndrome. Article","volume":"32","author":"Noaiseh","year":"2014","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.ajo.2025.11.024_bib0413","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/6824719","article-title":"Rebamipide, an Amino Acid Analog of 2(1H)-Quinolinone, Inhibits the Formation of Human Osteoclasts","volume":"2016","author":"Nanke","year":"2016","journal-title":"Biomed Res Int"},{"issue":"14","key":"10.1016\/j.ajo.2025.11.024_bib0414","doi-asserted-by":"crossref","first-page":"DES151","DOI":"10.1167\/iovs.17-23623","article-title":"Secreted Mucins on the Ocular Surface","volume":"59","author":"Hori","year":"2018","journal-title":"Invest Ophthalmol Vis Sci."},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0415","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1186\/s12886-023-03004-1","article-title":"Efficacy and safety of 1% and 2% rebamipide clear solution in dry eye disease: a multicenter randomized trial","volume":"23","author":"Eom","year":"2023","journal-title":"BMC Ophthalmol"},{"issue":"8","key":"10.1016\/j.ajo.2025.11.024_bib0416","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/ICL.0000000000001101","article-title":"Clinical Efficacy of 2% Rebamipide in Patients With Video Display Terminal-Associated Dry Eye Disease: A Prospective, Randomized, Double-Blinded Study","volume":"50","author":"Lee","year":"2024","journal-title":"Eye Contact Lens"},{"issue":"22","key":"10.1016\/j.ajo.2025.11.024_bib0417","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12227155","article-title":"The Efficacy and Safety of Rebamipide Ophthalmic Suspension (OPC-12759) in Patients with Dry Eye Disease: A Systematic Review of Randomized Controlled Trials","volume":"12","author":"Ballesteros-Sanchez","year":"2023","journal-title":"J Clin Med."},{"issue":"10","key":"10.1016\/j.ajo.2025.11.024_bib0418","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1089\/jop.2024.0098","article-title":"Effects of Rebamipide for Dry Eye on Optical Quality and Efficacy: A Systematic Review and Meta-Analysis","volume":"40","author":"Yan","year":"2024","journal-title":"J Ocul Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.ajo.2025.11.024_bib0419","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/j.ophtha.2012.12.022","article-title":"A randomized, multicenter phase 3 study comparing 2% rebamipide (OPC-12759) with 0.1% sodium hyaluronate in the treatment of dry eye","volume":"120","author":"Kinoshita","year":"2013","journal-title":"Ophthalmology"},{"issue":"8","key":"10.1016\/j.ajo.2025.11.024_bib0420","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1097\/ICO.0000000000000456","article-title":"Effect of Rebamipide Ophthalmic Suspension on Intraocular Light Scattering for Dry Eye After Corneal Refractive Surgery","volume":"34","author":"Igarashi","year":"2015","journal-title":"Cornea."},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0421","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1089\/jop.2016.0096","article-title":"Randomized Comparison Between Rebamipide Ophthalmic Suspension and Diquafosol Ophthalmic Solution for Dry Eye After Penetrating Keratoplasty","volume":"33","author":"Kobashi","year":"2017","journal-title":"J Ocul Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.ajo.2025.11.024_bib0422","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.4103\/IJO.IJO_2586_22","article-title":"Efficacy and safety of topical 2% rebamipide ophthalmic suspension in dry eye disease at tertiary care centre","volume":"71","author":"Jain","year":"2023","journal-title":"Indian J Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajo.2025.11.024_bib0423","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.jtos.2017.05.002","article-title":"TFOS DEWS II pain and sensation report","volume":"15","author":"Belmonte","year":"2017","journal-title":"Review. Ocul Surf."},{"issue":"2","key":"10.1016\/j.ajo.2025.11.024_bib0425","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/IIO.0000000000000163","article-title":"Intranasal Tear Neurostimulation: An Emerging Concept in the Treatment of Dry Eye","volume":"57","author":"Gumus","year":"2017","journal-title":"Int Ophthalmol Clin. Spring"},{"key":"10.1016\/j.ajo.2025.11.024_bib0426","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jtos.2022.05.001","article-title":"Nicotinic acetylcholine receptor stimulation: A new approach for stimulating tear secretion in dry eye disease","volume":"25","author":"Pflugfelder","year":"2022","journal-title":"Ocul Surf"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0427","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jtos.2018.11.002","article-title":"Neurostimulation in dry eye disease past, present, and future","volume":"17","author":"Dieckmann","year":"2019","journal-title":"Ocul Surf"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0430","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jtos.2019.11.005","article-title":"Conjunctival goblet cells: Ocular surface functions, disorders that affect them, and the potential for their regeneration","volume":"18","author":"Swamynathan","year":"2020","journal-title":"Ocul Surf"},{"key":"10.1016\/j.ajo.2025.11.024_bib0431","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ajo.2017.03.002","article-title":"Randomized Controlled Crossover Trial Comparing the Impact of Sham or Intranasal Tear Neurostimulation on Conjunctival Goblet Cell Degranulation. Article","volume":"177","author":"Gumus","year":"2017","journal-title":"Am J Ophthalmol"},{"issue":"9","key":"10.1016\/j.ajo.2025.11.024_bib0432","article-title":"Effect of TrueTear\u2122 on Dry Eye Symptoms During Exposure to a Controlled Adverse Environment","volume":"59","author":"Senchyna","year":"2018","journal-title":"Investigative Ophthalmology & Visual Science"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0433","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1167\/iovs.18-23984","article-title":"Randomized, Controlled, DoubleMasked, Multicenter, Pilot Study Evaluating Safety and Efficacy of Intranasal Neurostimulation for Dry Eye Disease","volume":"60","author":"Cohn","year":"2019","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"Suppl 3","key":"10.1016\/j.ajo.2025.11.024_bib0434","doi-asserted-by":"crossref","first-page":"S381","DOI":"10.4103\/IJO.IJO_2147_23","article-title":"Efficacy and safety of trigeminal parasympathetic pathway stimulation for dry eye: A systematic review and metaanalysis","volume":"72","author":"Hu","year":"2024","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.ajo.2025.11.024_bib0435","doi-asserted-by":"crossref","first-page":"4291","DOI":"10.2147\/OPTH.S312108","article-title":"Efficacy of an Intranasal Tear Neurostimulator in Sjogren Syndrome Patients","volume":"15","author":"Lilley","year":"2021","journal-title":"Clin Ophthalmol"},{"issue":"12","key":"10.1016\/j.ajo.2025.11.024_bib0436","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1167\/tvst.9.12.23","article-title":"Novel Extranasal Tear Stimulation: Pivotal Study Results","volume":"9","author":"Ji","year":"2020","journal-title":"Transl Vis Sci Technol."},{"issue":"10","key":"10.1016\/j.ajo.2025.11.024_bib0437","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.3390\/medicina58101332","article-title":"Using TENS for Pain Control: Update on the State of the Evidence","volume":"58","author":"Vance","year":"2022","journal-title":"Medicina (Kaunas, Lithuania)"},{"issue":"9","key":"10.1016\/j.ajo.2025.11.024_bib0438","article-title":"Transcutaneous electrical nerve stimulation (TENS) for neuropathic pain in adults","volume":"9","author":"Gibson","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"8","key":"10.1016\/j.ajo.2025.11.024_bib0440","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1111\/ner.12742","article-title":"Noninvasive Electrical Stimulation for the Treatment of Chronic Ocular Pain and Photophobia","volume":"21","author":"Sivanesan","year":"2018","journal-title":"Neuromodulation."},{"issue":"6","key":"10.1016\/j.ajo.2025.11.024_bib0441","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3892\/etm.2020.9305","article-title":"Effectiveness of transcutaneous electrical stimulation combined with artificial tears for the treatment of dry eye: A randomized controlled trial","volume":"20","author":"Cai","year":"2020","journal-title":"Exp Ther Med."},{"issue":"6","key":"10.1016\/j.ajo.2025.11.024_bib0442","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1136\/bjophthalmol-2016-308678","article-title":"Transcutaneous periorbital electrical stimulation in the treatment of dry eye","volume":"101","author":"Pedrotti","year":"2017","journal-title":"The British journal of ophthalmology"},{"issue":"15","key":"10.1016\/j.ajo.2025.11.024_bib0443","doi-asserted-by":"crossref","first-page":"839","DOI":"10.21037\/atm-21-6145","article-title":"Involvement of transient receptor potential channels in ocular diseases: a narrative review","volume":"10","author":"Yang","year":"2022","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.ajo.2025.11.024_bib0444","doi-asserted-by":"crossref","DOI":"10.1016\/j.mehy.2020.109747","article-title":"Improving brain power by applying a cool TRPM8 receptor agonist to the eyelid margin","volume":"142","author":"Wei","year":"2020","journal-title":"Med Hypotheses."},{"issue":"12","key":"10.1016\/j.ajo.2025.11.024_bib0445","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1038\/nm.2264","article-title":"Ocular surface wetness is regulated by TRPM8-dependent cold thermoreceptors of the cornea","volume":"16","author":"Parra","year":"2010","journal-title":"Nat Med"},{"key":"10.1016\/j.ajo.2025.11.024_bib0446","doi-asserted-by":"crossref","first-page":"7150","DOI":"10.1038\/ncomms8150","article-title":"TRPM8 is a neuronal osmosensor that regulates eye blinking in mice","volume":"6","author":"Quallo","year":"2015","journal-title":"Nat Commun."},{"key":"10.1016\/j.ajo.2025.11.024_bib0447","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jtos.2022.08.003","article-title":"A randomized, vehicle-controlled, Phase 2b study of two concentrations of the TRPM8 receptor agonist AR-15512 in the treatment of dry eye disease (COMET-1)","volume":"26","author":"Wirta","year":"2022","journal-title":"Ocul Surf"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0448","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s12886-017-0495-2","article-title":"A novel TRPM8 agonist relieves dry eye discomfort","volume":"17","author":"Yang","year":"2017","journal-title":"BMC Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajo.2025.11.024_bib0449","doi-asserted-by":"crossref","first-page":"250","DOI":"10.3390\/jcm10020250","article-title":"Topical TRPM8 Agonist for Relieving Neuropathic Ocular Pain in Patients with Dry Eye: A Pilot Study","volume":"10","author":"Yoon","year":"2021","journal-title":"J Clin Med"},{"issue":"4","key":"10.1016\/j.ajo.2025.11.024_bib0450","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1007\/s40123-022-00530-x","article-title":"A Single Administration of OC-01 (Varenicline Solution) Nasal Spray Induces Short-Term Alterations in Conjunctival Goblet Cells in Patients with Dry Eye Disease","volume":"11","author":"Dieckmann","year":"2022","journal-title":"Ophthalmol Ther."},{"issue":"10","key":"10.1016\/j.ajo.2025.11.024_bib0451","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1097\/ICO.0000000000002941","article-title":"ONSET-1 Phase 2b Randomized Trial to Evaluate the Safety and Efficacy of OC-01 (Varenicline Solution) Nasal Spray on Signs and Symptoms of Dry Eye Disease","volume":"41","author":"Wirta","year":"2022","journal-title":"Cornea"},{"key":"10.1016\/j.ajo.2025.11.024_bib0452","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jtos.2021.12.007","article-title":"A phase II randomized trial to evaluate the long-term (12-week) efficacy and safety of OC-01 (varenicline solution) nasal spray for dry eye disease: The MYSTIC study","volume":"24","author":"Quiroz-Mercado","year":"2022","journal-title":"Ocul Surf."},{"issue":"11","key":"10.1016\/j.ajo.2025.11.024_bib0453","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1016\/j.clinthera.2022.09.013","article-title":"Bilateral Effect of OC-01 (Varenicline Solution) Nasal Spray for Treatment of Signs and Symptoms in Individuals with Mild, Moderate, and Severe Dry Eye Disease","volume":"44","author":"Katz","year":"2022","journal-title":"Clin Ther"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0454","first-page":"69","article-title":"Matching adjusted indirect comparison of phase 3 clinical trial outcomes of OC-01 (varenicline solution) nasal spray and lifitegrast 5% ophthalmic solution for the treatment of dry eye disease","volume":"29","author":"White","year":"2023","journal-title":"J Manag Care Spec Pharm"},{"issue":"6","key":"10.1016\/j.ajo.2025.11.024_bib0455","doi-asserted-by":"crossref","DOI":"10.57264\/cer-2022-0215","article-title":"Safety, adherence and discontinuation in varenicline solution nasal spray clinical trials for dry eye disease","volume":"12","author":"Hauswirth","year":"2023","journal-title":"Journal of comparative effectiveness research"},{"issue":"4","key":"10.1016\/j.ajo.2025.11.024_bib0456","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.ophtha.2021.11.004","article-title":"Efficacy and Safety of OC-01 (Varenicline Solution) Nasal Spray on Signs and Symptoms of Dry Eye Disease: The ONSET-2 Phase 3 Randomized Trial","volume":"129","author":"Wirta","year":"2022","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0457","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1186\/s12886-023-03069-y","article-title":"The efficacy and safety of varenicline nasal spray for the management of dry eye signs: a systematic review and meta-analysis","volume":"23","author":"Bashrahil","year":"2023","journal-title":"BMC Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0458","doi-asserted-by":"crossref","DOI":"10.1016\/j.clae.2023.102097","article-title":"Efficacy of bilateral OC-01 (varenicline solution) nasal spray in alleviating signs and symptoms of dry eye disease: A systematic review","volume":"47","author":"Ballesteros-Sanchez","year":"2024","journal-title":"Cont Lens Anterior Eye"},{"issue":"9","key":"10.1016\/j.ajo.2025.11.024_bib0459","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/j.clinthera.2022.07.006","article-title":"Efficacy and Safety of Single-dose OC-02 (Simpinicline Solution) Nasal Spray on Signs and Symptoms of Dry Eye Disease: The PEARL Phase II Randomized Trial","volume":"44","author":"Torkildsen","year":"2022","journal-title":"Clin Ther"},{"key":"10.1016\/j.ajo.2025.11.024_bib0460","article-title":"Varenicline solution nasal spray for dry eye disease in Chinese patients: a randomized phase 3 trial","volume":"45","author":"Tian","year":"2024","journal-title":"Lancet Reg Health West Pac"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0461","doi-asserted-by":"crossref","DOI":"10.1136\/bmjophth-2022-001209","article-title":"Hypochlorous acid hygiene solution in patients affected by blepharitis: a prospective randomised study","volume":"8","author":"Mencucci","year":"2023","journal-title":"BMJ Open Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0462","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jtos.2017.10.005","article-title":"Randomized double-masked trial of eyelid cleansing treatments for blepharitis","volume":"16","author":"Sung","year":"2018","journal-title":"Ocul Surf"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0463","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/ICO.0000000000003046","article-title":"Role of Blepharoexfoliation in Demodex Blepharitis: A Randomized Comparative Study","volume":"42","author":"Mohammad-Rabei","year":"2023","journal-title":"Cornea"},{"issue":"3","key":"10.1016\/j.ajo.2025.11.024_bib0464","first-page":"120","article-title":"Efficacy of Portable 445 nm Laser Versus Intense Pulsed Light Treatment for Dry Eye: A Prospective Randomized Pilot Study","volume":"41","author":"Gouws","year":"2023","journal-title":"Photobiomodul Photomed Laser Surg"},{"key":"10.1016\/j.ajo.2025.11.024_bib0465","doi-asserted-by":"crossref","first-page":"497","DOI":"10.2147\/OPTH.S390085","article-title":"Review of Literature on Intraductal Meibomian Gland Probing with Insights from the Inventor and Developer: Fundamental Concepts and Misconceptions","volume":"17","author":"Warren","year":"2023","journal-title":"Clin Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajo.2025.11.024_bib0466","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1080\/02713683.2020.1789663","article-title":"The Effect of Therapeutic Meibomian Glands Expression on Evaporative Dry Eye: A Prospective Randomized Controlled Trial","volume":"46","author":"Kaiserman","year":"2021","journal-title":"Curr Eye Res"},{"issue":"3","key":"10.1016\/j.ajo.2025.11.024_bib0467","doi-asserted-by":"crossref","DOI":"10.1016\/j.clae.2024.102148","article-title":"Efficacy and Safety of Lotilaner Ophthalmic Solution 0.25% for the Treatment of Demodex Blepharitis: A Meta-Analysis of Randomized Controlled Trials","volume":"47","author":"Muhammad Muneeb Akhtar","year":"2024","journal-title":"Cont Lens Anterior Eye"},{"issue":"10","key":"10.1016\/j.ajo.2025.11.024_bib0468","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.ophtha.2023.05.030","article-title":"Lotilaner Ophthalmic Solution 0.25% for Demodex Blepharitis: Randomized, Vehicle-Controlled, Multicenter, Phase 3 Trial (Saturn-2)","volume":"130","author":"Gaddie","year":"2023","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.ajo.2025.11.024_bib0469","doi-asserted-by":"crossref","DOI":"10.1016\/j.clae.2020.04.011","article-title":"Topical ivermectin metronidazole gel therapy in the treatment of blepharitis caused by Demodex spp.: A randomized clinical trial","volume":"44","author":"Avila","year":"2021","journal-title":"Cont Lens Anterior Eye"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0470","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/ICL.0000000000000729","article-title":"Efficacy of Azithromycin Eyedrops for Individuals With Meibomian Gland Dysfunction-Associated Posterior Blepharitis","volume":"47","author":"Arita","year":"2021","journal-title":"Eye Contact Lens"},{"issue":"10","key":"10.1016\/j.ajo.2025.11.024_bib0471","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.4103\/ijo.IJO_3405_20","article-title":"Efficacy of blink software in improving the blink rate and dry eye symptoms in visual display terminal users - A single-blinded randomized control trial","volume":"69","author":"Ashwini","year":"2021","journal-title":"Indian J Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajo.2025.11.024_bib0472","doi-asserted-by":"crossref","first-page":"72","DOI":"10.3109\/08820538.2010.488578","article-title":"Lagophthalmos","volume":"25","author":"Pereira","year":"2010","journal-title":"Semin Ophthalmol."},{"issue":"2","key":"10.1016\/j.ajo.2025.11.024_bib0473","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/ICL.0000000000000072","article-title":"A novel lid seal evaluation: the Korb-Blackie light test","volume":"41","author":"Blackie","year":"2015","journal-title":"Eye Contact Lens"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0474","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S1542-0124(12)70263-X","article-title":"Nocturnal lagophthalmos: an overview and classification","volume":"4","author":"Latkany","year":"2006","journal-title":"Ocul Surf"},{"issue":"6","key":"10.1016\/j.ajo.2025.11.024_bib0475","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S1350-9462(00)00006-9","article-title":"Towards a closed eye model of the pre-ocular tear layer","volume":"19","author":"Sack","year":"2000","journal-title":"Prog Retin Eye Res"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0476","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/SMJ.0000000000000038","article-title":"Graves orbitopathy: update on diagnosis and therapy","volume":"107","author":"Melcescu","year":"2014","journal-title":"Southern medical journal"},{"issue":"4","key":"10.1016\/j.ajo.2025.11.024_bib0477","first-page":"216","article-title":"Moisture aid during sleep for the treatment of dry eye: wet gauze eye mask","volume":"208","author":"Kurihashi","year":"1994","journal-title":"Ophthalmologica Journal international d'ophtalmologie International journal of ophthalmology Zeitschrift fur Augenheilkunde"},{"issue":"6","key":"10.1016\/j.ajo.2025.11.024_bib0478","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.clae.2012.07.009","article-title":"Scleral contact lens management of bilateral exposure and neurotrophic keratopathy","volume":"35","author":"Grey","year":"2012","journal-title":"Cont Lens Anterior Eye"},{"issue":"2","key":"10.1016\/j.ajo.2025.11.024_bib0479","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1097\/IOP.0b013e3182674069","article-title":"PROSE treatment for lagophthalmos and exposure keratopathy","volume":"29","author":"Gire","year":"2013","journal-title":"Ophthalmic Plast Reconstr Surg"},{"issue":"3","key":"10.1016\/j.ajo.2025.11.024_bib0480","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/ICO.0b013e31825fed01","article-title":"Scleral contact lenses as an alternative to tarsorrhaphy for the long-term management of combined exposure and neurotrophic keratopathy","volume":"32","author":"Weyns","year":"2013","journal-title":"Cornea"},{"issue":"4","key":"10.1016\/j.ajo.2025.11.024_bib0481","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/ICL.0000000000000265","article-title":"Prosthetic Replacement of the Ocular Surface Ecosystem Scleral Lens Therapy for Exposure Keratopathy","volume":"43","author":"Chahal","year":"2017","journal-title":"Eye Contact Lens"},{"issue":"3","key":"10.1016\/j.ajo.2025.11.024_bib0482","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/IOP.0000000000000934","article-title":"Utility of PROSE Device in the Management of Complex Oculoplastic Pathology","volume":"34","author":"Scofield-Kaplan","year":"2018","journal-title":"Ophthalmic Plast Reconstr Surg"},{"issue":"7","key":"10.1016\/j.ajo.2025.11.024_bib0483","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2021-248384","article-title":"Scleral contact lenses for optimal visual recovery in a case of severe acid burn with total lagophthalmos","volume":"15","author":"Chaudhary","year":"2022","journal-title":"BMJ Case Rep"},{"issue":"4","key":"10.1016\/j.ajo.2025.11.024_bib0484","doi-asserted-by":"crossref","DOI":"10.1016\/j.clae.2023.101871","article-title":"Case report: Utilization of a scleral lens to mitigate exposure keratopathy and associated mental health decline","volume":"46","author":"Whang","year":"2023","journal-title":"Cont Lens Anterior Eye"},{"issue":"4","key":"10.1016\/j.ajo.2025.11.024_bib0485","doi-asserted-by":"crossref","first-page":"548","DOI":"10.4103\/tjo.TJO-D-23-00043","article-title":"Nonsurgical management of upper eyelid retraction in thyroid eye disease","volume":"14","author":"Young","year":"2024","journal-title":"Taiwan J Ophthalmol"},{"issue":"5","key":"10.1016\/j.ajo.2025.11.024_bib0486","doi-asserted-by":"crossref","first-page":"599","DOI":"10.29271\/jcpsp.2021.05.599","article-title":"Conservative Management of Thyroid Eye Disease","volume":"31","author":"Khan","year":"2021","journal-title":"Journal of the College of Physicians and Surgeons\u2013Pakistan : JCPSP."},{"issue":"2","key":"10.1016\/j.ajo.2025.11.024_bib0487","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3109\/01676830.2013.764440","article-title":"Ocular surface changes in thyroid eye disease","volume":"32","author":"Ismailova","year":"2013","journal-title":"Orbit."},{"issue":"13","key":"10.1016\/j.ajo.2025.11.024_bib0488","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11133604","article-title":"Changes in Dry Eye Status after Steroid Pulse and Orbital Radiation Therapies in Active Thyroid Eye Disease","volume":"11","author":"Takahashi","year":"2022","journal-title":"J Clin Med"},{"issue":"18","key":"10.1016\/j.ajo.2025.11.024_bib0489","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1056\/NEJMoa1614949","article-title":"Teprotumumab for Thyroid Associated Ophthalmopathy","volume":"376","author":"Smith","year":"2017","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.ajo.2025.11.024_bib0490","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/ceo.14208","article-title":"Change in lacrimal gland volume and aqueous tear production following treatment with teprotumumab","volume":"51","author":"Ugradar","year":"2023","journal-title":"Clin Exp Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2025.11.024_bib0491","article-title":"Side Effects and Adverse Events After Treatment With Teprotumumab for Thyroid Eye Disease: A Retrospective Observational Case Series","volume":"16","author":"Mukit","year":"2024","journal-title":"Cureus"},{"issue":"5","key":"10.1016\/j.ajo.2025.11.024_bib0492","doi-asserted-by":"crossref","DOI":"10.3390\/jpm12050802","article-title":"Improvement of Ocular Surface Disease by Lateral Tarsoconjunctival Flap in Thyroid-Associated Orbitopathy Patients with Lid Retraction","volume":"12","author":"Hsu","year":"2022","journal-title":"Journal of personalized medicine"},{"issue":"2","key":"10.1016\/j.ajo.2025.11.024_bib0493","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1055\/s-0035-1549292","article-title":"Management of the eye in facial paralysis","volume":"31","author":"Sohrab","year":"2015","journal-title":"Facial plastic surgery : FPS"},{"issue":"7","key":"10.1016\/j.ajo.2025.11.024_bib0494","first-page":"997","article-title":"Bell's palsy: diagnosis and management","volume":"76","author":"Tiemstra","year":"2007","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.ajo.2025.11.024_bib0495","series-title":"Bell Palsy","author":"Hohman","year":"2025"},{"issue":"5","key":"10.1016\/j.ajo.2025.11.024_bib0496","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.bjoms.2020.02.017","article-title":"Lipofilling of the upper eyelid to treat paralytic lagophthalmos","volume":"58","author":"Biglioli","year":"2020","journal-title":"Br J Oral Maxillofac Surg"},{"issue":"6","key":"10.1016\/j.ajo.2025.11.024_bib0497","doi-asserted-by":"crossref","DOI":"10.1016\/j.clae.2022.101702","article-title":"Blinking and upper eyelid morphology","volume":"45","author":"Shew","year":"2022","journal-title":"Cont Lens Anterior Eye"},{"issue":"4","key":"10.1016\/j.ajo.2025.11.024_bib0498","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.jtos.2018.06.001","article-title":"Impact of blinking on ocular surface and tear film parameters","volume":"16","author":"Wang","year":"2018","journal-title":"Ocul Surf"},{"issue":"4","key":"10.1016\/j.ajo.2025.11.024_bib0499","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/00003226-199407000-00012","article-title":"Tear film lipid layer thickness as a function of blinking","volume":"13","author":"Korb","year":"1994","journal-title":"Cornea"},{"issue":"3","key":"10.1016\/j.ajo.2025.11.024_bib0500","doi-asserted-by":"crossref","DOI":"10.1016\/j.clae.2020.04.014","article-title":"Therapeutic benefits of blinking exercises in dry eye disease","volume":"44","author":"Kim","year":"2021","journal-title":"Cont Lens Anterior Eye"},{"issue":"3","key":"10.1016\/j.ajo.2025.11.024_bib0501","doi-asserted-by":"crossref","DOI":"10.1016\/j.clae.2020.04.015","article-title":"Diagnosis and remediation of blink inefficiency","volume":"44","author":"McMonnies","year":"2021","journal-title":"Cont Lens Anterior Eye"},{"issue":"9","key":"10.1016\/j.ajo.2025.11.024_bib0502","doi-asserted-by":"crossref","first-page":"e310","DOI":"10.1097\/OPX.0000000000000654","article-title":"Blink Animation Software to Improve Blinking and Dry Eye Symptoms","volume":"92","author":"Nosch","year":"2015","journal-title":"Optom Vis Sci."},{"issue":"4","key":"10.1016\/j.ajo.2025.11.024_bib0503","doi-asserted-by":"crossref","DOI":"10.3390\/vision8040067","article-title":"Digital Applications for Videoterminal-Associated Dry Eye Disease","volume":"8","author":"Romeo","year":"2024","journal-title":"Vision"},{"issue":"10","key":"10.1016\/j.ajo.2025.11.024_bib0504","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0161-6420(82)34669-2","article-title":"Classification of chronic blepharitis","volume":"89","author":"McCulley","year":"1982","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2025.11.024_bib0505","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2147\/OPTO.S84795","article-title":"Diagnosis and management of blepharitis: an optometrist's perspective","volume":"8","author":"Putnam","year":"2016","journal-title":"Clin Optom (Auckl)"},{"issue":"5","key":"10.1016\/j.ajo.2025.11.024_bib0506","article-title":"Interventions for chronic blepharitis","volume":"2012","author":"Lindsley","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0507","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/00004397-198502510-00010","article-title":"Blepharitis associated with acne rosacea and seborrheic dermatitis","volume":"25","author":"McCulley","year":"1985","journal-title":"Int Ophthalmol Clin. Spring"},{"issue":"5","key":"10.1016\/j.ajo.2025.11.024_bib0508","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1097\/ACI.0b013e32833df9f4","article-title":"Pathogenic role of Demodex mites in blepharitis","volume":"10","author":"Liu","year":"2010","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0509","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s10792-016-0249-9","article-title":"Demodex species in human ocular disease: new clinicopathological aspects","volume":"37","author":"Nicholls","year":"2017","journal-title":"Int Ophthalmol."},{"issue":"4","key":"10.1016\/j.ajo.2025.11.024_bib0510","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/opo.12691","article-title":"Ocular Demodex: a systematic review of the clinical literature","volume":"40","author":"Zhang","year":"2020","journal-title":"Ophthalmic Physiol Opt"},{"key":"10.1016\/j.ajo.2025.11.024_bib0511","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.2147\/OPTH.S215071","article-title":"Influence of bacterial burden on meibomian gland dysfunction and ocular surface disease","volume":"13","author":"Nattis","year":"2019","journal-title":"Clin Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2025.11.024_bib0512","doi-asserted-by":"crossref","first-page":"317","DOI":"10.4103\/0974-9233.142268","article-title":"Blepharitis: always remember demodex","volume":"21","author":"Bhandari","year":"2014","journal-title":"Middle East Afr J Ophthalmol"},{"issue":"8","key":"10.1016\/j.ajo.2025.11.024_bib0513","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/ICL.0000000000001003","article-title":"Demodex Blepharitis: A Comprehensive Review of the Disease, Current Management, and Emerging Therapies","volume":"49","author":"Rhee","year":"2023","journal-title":"Eye Contact Lens"},{"issue":"8","key":"10.1016\/j.ajo.2025.11.024_bib0514","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1097\/ICO.0000000000002542","article-title":"Prevalence of Ocular Demodicosis in an Older Population and Its Association With Symptoms and Signs of Dry Eye","volume":"40","author":"Cheng","year":"2021","journal-title":"Cornea"},{"key":"10.1016\/j.ajo.2025.11.024_bib0515","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.2147\/OPTH.S354692","article-title":"The Prevalence of Demodex Blepharitis in US Eye Care Clinic Patients as Determined by Collarettes: A Pathognomonic Sign","volume":"16","author":"Trattler","year":"2022","journal-title":"Clin Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajo.2025.11.024_bib0516","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1097\/OPX.0000000000000605","article-title":"Increased numbers of Demodex in contact lens wearers","volume":"92","author":"Jalbert","year":"2015","journal-title":"Optom Vis Sci"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0517","article-title":"The varied influence of ocular Demodex infestation on dry eye disease and meibomian gland dysfunction across different age groups","volume":"13","author":"Lee","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.ajo.2025.11.024_bib0518","doi-asserted-by":"crossref","first-page":"667","DOI":"10.2147\/OPTH.S399989","article-title":"Delphi Panel Consensus Regarding Current Clinical Practice Management Options for Demodex blepharitis","volume":"17","author":"Farid","year":"2023","journal-title":"Clin Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajo.2025.11.024_bib0519","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/cxo.13123","article-title":"Demodex and eye disease: a review","volume":"104","author":"Bitton","year":"2021","journal-title":"Clin Exp Optom"},{"issue":"9","key":"10.1016\/j.ajo.2025.11.024_bib0520","doi-asserted-by":"crossref","first-page":"3089","DOI":"10.1167\/iovs.05-0275","article-title":"High prevalence of Demodex in eyelashes with cylindrical dandruff","volume":"46","author":"Gao","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajo.2025.11.024_bib0521","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2147\/OPTO.S142708","article-title":"Demodex blepharitis: clinical perspectives","volume":"10","author":"Fromstein","year":"2018","journal-title":"Clin Optom (Auckl)"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0522","doi-asserted-by":"crossref","DOI":"10.1016\/j.clae.2023.102080","article-title":"A Delphi approach to establishing consensus on best practice for the diagnosis and treatment of Demodex blepharitis","volume":"47","author":"Sharma","year":"2024","journal-title":"Cont Lens Anterior Eye"},{"issue":"19","key":"10.1016\/j.ajo.2025.11.024_bib0523","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000015595","article-title":"The correlation between the microstructure of meibomian glands and ocular Demodex infestation: A retrospective case-control study in a Chinese population","volume":"98","author":"Cheng","year":"2019","journal-title":"Medicine (Baltimore)"},{"issue":"14","key":"10.1016\/j.ajo.2025.11.024_bib0524","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1167\/tvst.10.14.6","article-title":"Changes in Meibum Lipid Composition With Ocular Demodex Infestation","volume":"10","author":"Gao","year":"2021","journal-title":"Transl Vis Sci Technol"},{"issue":"6","key":"10.1016\/j.ajo.2025.11.024_bib0525","doi-asserted-by":"crossref","first-page":"2906","DOI":"10.1167\/iovs.09-4850","article-title":"The relationship between demodex and ocular discomfort","volume":"51","author":"Lee","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajo.2025.11.024_bib0526","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ajo.2019.03.007","article-title":"Demodex Mite Infestation and its Associations with Tear Film and Ocular Surface Parameters in Patients with Ocular Discomfort","volume":"204","author":"Rabensteiner","year":"2019","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0527","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1186\/s12886-022-02610-9","article-title":"The correlation between Demodex infestation and meibomian gland dysfunction at different ages","volume":"22","author":"Sun","year":"2022","journal-title":"BMC Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2025.11.024_bib0528","doi-asserted-by":"crossref","first-page":"589","DOI":"10.18240\/ijo.2021.04.17","article-title":"The association between demodex infestation and ocular surface manifestations in meibomian gland dysfunction","volume":"11","author":"Zhang","year":"2018","journal-title":"International journal of ophthalmology"},{"issue":"10","key":"10.1016\/j.ajo.2025.11.024_bib0529","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1113\/JP275236","article-title":"Ivermectin and its target molecules: shared and unique modulation mechanisms of ion channels and receptors by ivermectin","volume":"596","author":"Chen","year":"2018","journal-title":"J Physiol"},{"issue":"4","key":"10.1016\/j.ajo.2025.11.024_bib0530","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1093\/jac\/dkz524","article-title":"Safety of high-dose ivermectin: a systematic review and meta-analysis","volume":"75","author":"Navarro","year":"2020","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"10.1016\/j.ajo.2025.11.024_bib0531","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1136\/bjo.2010.201194","article-title":"The efficacy of oral ivermectin for the treatment of chronic blepharitis in patients tested positive for Demodex spp","volume":"95","author":"Filho","year":"2011","journal-title":"The British journal of ophthalmology"},{"issue":"6","key":"10.1016\/j.ajo.2025.11.024_bib0532","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/j.ajo.2010.11.024","article-title":"Clinical treatment of ocular Demodex folliculorum by systemic ivermectin","volume":"151","author":"Holzchuh","year":"2011","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2025.11.024_bib0533","article-title":"Treatment of ocular Demodex infestation with topical ivermectin cream","volume":"26","author":"Helm","year":"2022","journal-title":"Am J Ophthalmol Case Rep"},{"issue":"4","key":"10.1016\/j.ajo.2025.11.024_bib0534","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1097\/ICO.0000000000002802","article-title":"Efficacy of Topical Ivermectin 1% in the Treatment of Demodex Blepharitis","volume":"41","author":"Choi","year":"2022","journal-title":"Cornea"},{"issue":"4","key":"10.1016\/j.ajo.2025.11.024_bib0535","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1007\/s00417-023-06281-0","article-title":"Topical ivermectin ointment treatment of Demodex blepharitis: a 6-year retrospective study","volume":"262","author":"Valvecchia","year":"2024","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0536","doi-asserted-by":"crossref","DOI":"10.1016\/j.clae.2023.102099","article-title":"Topical ivermectin 1.0% cream in the treatment of ocular demodicosis","volume":"47","author":"Smith","year":"2024","journal-title":"Cont Lens Anterior Eye"},{"issue":"6","key":"10.1016\/j.ajo.2025.11.024_bib0537","doi-asserted-by":"crossref","DOI":"10.1016\/j.clae.2021.101453","article-title":"Interventions for Demodex blepharitis and their effectiveness: A systematic review and meta analysis","volume":"44","author":"Martinez-Pulgarin","year":"2021","journal-title":"Cont Lens Anterior Eye"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0538","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1186\/s13071-017-2475-z","article-title":"The intravenous and oral pharmacokinetics of lotilaner in dogs","volume":"10","author":"Toutain","year":"2017","journal-title":"Parasit Vectors"},{"issue":"8","key":"10.1016\/j.ajo.2025.11.024_bib0539","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1089\/jop.2021.0011","article-title":"Collarette Elimination and Demodex Mite Eradication with Topical Lotilaner Ophthalmic Solution, 0.25","volume":"37","author":"Gonzalez-Salinas","year":"2021","journal-title":"J Ocul Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.ajo.2025.11.024_bib0540","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/ICO.0000000000003097","article-title":"Lotilaner Ophthalmic Solution, 0.25%, for the Treatment of Demodex Blepharitis: Results of a Prospective, Randomized, Vehicle-Controlled, Double-Masked, Pivotal Trial (Saturn-1)","volume":"42","author":"Yeu","year":"2023","journal-title":"Cornea"},{"issue":"11","key":"10.1016\/j.ajo.2025.11.024_bib0541","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1097\/ICO.0000000000003484","article-title":"Long-Term Outcomes of 6-Week Treatment of Lotilaner Ophthalmic Solution, 0.25%, for Demodex Blepharitis: A Noninterventional Extension Study","volume":"43","author":"Sadri","year":"2024","journal-title":"Cornea"},{"key":"10.1016\/j.ajo.2025.11.024_bib0542","doi-asserted-by":"crossref","DOI":"10.1021\/acs.jafc.0c04475","article-title":"Structural Properties, Bioactivities, and Applications of Polysaccharides from Okra Abelmoschus esculentus (L.) Moench: A Review","author":"Zhu","year":"2020","journal-title":"J Agric Food Chem."},{"issue":"Suppl 2","key":"10.1016\/j.ajo.2025.11.024_bib0543","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.1097\/ICL.0000000000000415","article-title":"Short-Term Comfort Responses Associated With the Use of Eyelid Cleansing Products to Manage Demodex folliculorum","volume":"44","author":"Ngo","year":"2018","journal-title":"Eye Contact Lens."},{"issue":"6","key":"10.1016\/j.ajo.2025.11.024_bib0544","doi-asserted-by":"crossref","DOI":"10.1016\/j.clae.2022.101733","article-title":"Short-term tolerability of commercial eyelid cleansers: A randomised crossover study","volume":"45","author":"Craig","year":"2022","journal-title":"Cont Lens Anterior Eye"},{"issue":"12","key":"10.1016\/j.ajo.2025.11.024_bib0545","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1097\/ICO.0000000000002506","article-title":"Effects of Terpinen-4-ol on Meibomian Gland Epithelial Cells In Vitro","volume":"39","author":"Chen","year":"2020","journal-title":"Cornea"},{"issue":"12","key":"10.1016\/j.ajo.2025.11.024_bib0546","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1167\/tvst.13.12.18","article-title":"The Effect of Terpinen-4-ol on Human Corneal Epithelium","volume":"13","author":"Park","year":"2024","journal-title":"Transl Vis Sci Technol"},{"issue":"4","key":"10.1016\/j.ajo.2025.11.024_bib0547","doi-asserted-by":"crossref","first-page":"338","DOI":"10.3892\/etm.2021.9769","article-title":"Anti-demodectic effects of okra eyelid patch in Demodex blepharitis compared with tea tree oil","volume":"21","author":"Liu","year":"2021","journal-title":"Exp Ther Med"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0548","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1128\/CMR.19.1.50-62.2006","article-title":"Melaleuca alternifolia (Tea Tree) oil: a review of antimicrobial and other medicinal properties","volume":"19","author":"Carson","year":"2006","journal-title":"Clin Microbiol Rev."},{"issue":"4","key":"10.1016\/j.ajo.2025.11.024_bib0549","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1038\/s41433-021-01642-7","article-title":"Randomized double-blind trial of wipes containing terpinen-4-ol and hyaluronate versus baby shampoo in seborrheic blepharitis patients","volume":"36","author":"Arici","year":"2022","journal-title":"Eye (Lond)"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0550","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.clae.2017.10.012","article-title":"The efficacy of tea tree face wash, 1, 2-Octanediol and microblepharoexfoliation in treating Demodex folliculorum blepharitis","volume":"41","author":"Murphy","year":"2018","journal-title":"Cont Lens Anterior Eye."},{"issue":"3","key":"10.1016\/j.ajo.2025.11.024_bib0551","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1080\/02713683.2018.1536217","article-title":"Therapeutic Effect of Intense Pulsed Light on Ocular Demodicosis","volume":"44","author":"Zhang","year":"2019","journal-title":"Curr Eye Res."},{"issue":"12","key":"10.1016\/j.ajo.2025.11.024_bib0552","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.3346\/jkms.2012.27.12.1574","article-title":"Ocular surface discomfort and Demodex: effect of tea tree oil eyelid scrub in Demodex blepharitis","volume":"27","author":"Koo","year":"2012","journal-title":"J Korean Med Sci."},{"issue":"2","key":"10.1016\/j.ajo.2025.11.024_bib0553","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/01.ico.0000244870.62384.79","article-title":"Clinical treatment of ocular demodecosis by lid scrub with tea tree oil","volume":"26","author":"Gao","year":"2007","journal-title":"Cornea."},{"issue":"5","key":"10.1016\/j.ajo.2025.11.024_bib0554","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.ajo.2007.01.054","article-title":"Corneal manifestations of ocular demodex infestation","volume":"143","author":"Kheirkhah","year":"2007","journal-title":"Am J Ophthalmol"},{"issue":"11","key":"10.1016\/j.ajo.2025.11.024_bib0555","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1136\/bjo.2005.072363","article-title":"In vitro and in vivo killing of ocular Demodex by tea tree oil","volume":"89","author":"Gao","year":"2005","journal-title":"The British journal of ophthalmology"},{"issue":"5","key":"10.1016\/j.ajo.2025.11.024_bib0556","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s10792-016-0188-5","article-title":"Demodex treatment in external ocular disease: the outcomes of a Tasmanian case series","volume":"36","author":"Nicholls","year":"2016","journal-title":"Int Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajo.2025.11.024_bib0557","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1080\/02713683.2021.1978099","article-title":"Different Approach to Manage Demodex Blepharitis - Initial and Maintenance Treatment","volume":"47","author":"Jacobi","year":"2022","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.ajo.2025.11.024_bib0558","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.2147\/OPTH.S198585","article-title":"Improvement in ocular symptoms and signs in patients with Demodex anterior blepharitis using a novel terpinen-4-ol (2.5%) and hyaluronic acid (0.2%) cleansing wipe","volume":"13","author":"Messaoud","year":"2019","journal-title":"Clin Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajo.2025.11.024_bib0559","article-title":"Tea tree oil for Demodex blepharitis","volume":"6","author":"Savla","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"issue":"7","key":"10.1016\/j.ajo.2025.11.024_bib0560","first-page":"3622","article-title":"In vitro demodicidal activity using high concentration terpinen-4-ol (T4O) encapsulated in nano-lipidic particle emulsion","volume":"65","author":"Hom","year":"2024","journal-title":"Investigative Ophthalmology & Visual Science"},{"issue":"3","key":"10.1016\/j.ajo.2025.11.024_bib0561","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/OPX.0000000000001354","article-title":"The Effect of Microblepharon Exfoliation on Clinical Correlates of Contact Lens Discomfort","volume":"96","author":"Siddireddy","year":"2019","journal-title":"Optom Vis Sci."},{"issue":"4","key":"10.1016\/j.ajo.2025.11.024_bib0562","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/ICL.0000000000000673","article-title":"Effect of Eyelid Treatments on Bacterial Load and Lipase Activity in Relation to Contact Lens Discomfort","volume":"46","author":"Siddireddy","year":"2020","journal-title":"Eye Contact Lens"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0563","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s12886-019-1052-y","article-title":"Safety and efficacy of wiping lid margins with lid hygiene shampoo using the \"eye brush\", a novel lid hygiene item, in healthy subjects: a pilot study","volume":"19","author":"Tanabe","year":"2019","journal-title":"BMC Ophthalmol."},{"issue":"4","key":"10.1016\/j.ajo.2025.11.024_bib0564","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1097\/ICO.0000000000002243","article-title":"Double-Masked and Unmasked Prospective Study of Terpinen-4-ol Lid Scrubs With Microblepharoexfoliation for the Treatment of Demodex Blepharitis","volume":"39","author":"Epstein","year":"2020","journal-title":"Cornea."},{"issue":"4","key":"10.1016\/j.ajo.2025.11.024_bib0565","doi-asserted-by":"crossref","first-page":"659","DOI":"10.18240\/ijo.2024.04.08","article-title":"Assessment of tear film parameters post-treatment with commercial eyelid cleaning wipes: a pilot study","volume":"17","author":"Aldarwesh","year":"2024","journal-title":"International journal of ophthalmology"},{"issue":"3","key":"10.1016\/j.ajo.2025.11.024_bib0566","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.freeradbiomed.2012.05.008","article-title":"What really happens in the neutrophil phagosome?","volume":"53","author":"Hurst","year":"2012","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.ajo.2025.11.024_bib0567","first-page":"e5","article-title":"Hypochlorous acid as a potential wound care agent: part I. Stabilized hypochlorous acid: a component of the inorganic armamentarium of innate immunity","volume":"6","author":"Wang","year":"2007","journal-title":"J Burns Wounds."},{"key":"10.1016\/j.ajo.2025.11.024_bib0568","doi-asserted-by":"crossref","first-page":"707","DOI":"10.2147\/OPTH.S132851","article-title":"Reduction in bacterial load using hypochlorous acid hygiene solution on ocular skin","volume":"11","author":"Stroman","year":"2017","journal-title":"Clin Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajo.2025.11.024_bib0569","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1177\/24741264211013622","article-title":"Hypochlorous Acid 0.01% vs Povidone-Iodine 5% for Ocular Antisepsis","volume":"6","author":"Hejkal","year":"2022","journal-title":"J Vitreoretin Dis"},{"issue":"Suppl 2","key":"10.1016\/j.ajo.2025.11.024_bib0570","doi-asserted-by":"crossref","first-page":"S187","DOI":"10.1097\/ICL.0000000000000456","article-title":"In Vitro Evaluation of a Hypochlorous Acid Hygiene Solution on Established Biofilms","volume":"44","author":"Romanowski","year":"2018","journal-title":"Eye Contact Lens"},{"issue":"2","key":"10.1016\/j.ajo.2025.11.024_bib0571","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1111\/jocd.13280","article-title":"Topical stabilized hypochlorous acid: The future gold standard for wound care and scar management in dermatologic and plastic surgery procedures","volume":"19","author":"Gold","year":"2020","journal-title":"J Cosmet Dermatol."},{"issue":"4","key":"10.1016\/j.ajo.2025.11.024_bib0572","doi-asserted-by":"crossref","first-page":"223","DOI":"10.4265\/bio.22.223","article-title":"Stability of Weakly Acidic Hypochlorous Acid Solution with Microbicidal Activity","volume":"22","author":"Ishihara","year":"2017","journal-title":"Biocontrol Sci"},{"issue":"3","key":"10.1016\/j.ajo.2025.11.024_bib0573","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12031164","article-title":"Effect of Hypochlorous Acid on Blepharitis through Ultrasonic Atomization: A Randomized Clinical Trial","volume":"12","author":"Zhang","year":"2023","journal-title":"J Clin Med."},{"key":"10.1016\/j.ajo.2025.11.024_bib0574","article-title":"Hypochlorous Acid Can Be the Novel Option for the Meibomian Gland Dysfunction Dry Eye through Ultrasonic Atomization","volume":"2022","author":"Li","year":"2022","journal-title":"Dis Markers"},{"issue":"6","key":"10.1016\/j.ajo.2025.11.024_bib0575","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.clae.2019.09.008","article-title":"Eyelid hygiene products: A scoping review","volume":"42","author":"Bitton","year":"2019","journal-title":"Cont Lens Anterior Eye."},{"key":"10.1016\/j.ajo.2025.11.024_bib0576","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jtos.2021.04.011","article-title":"Clinical practice patterns in the management of dry eye disease: A TFOS international survey","volume":"21","author":"Wolffsohn","year":"2021","journal-title":"Ocul Surf"},{"key":"10.1016\/j.ajo.2025.11.024_bib0577","doi-asserted-by":"crossref","first-page":"255","DOI":"10.2147\/OPTO.S469599","article-title":"Comparison of the Diagnosis and Management of Demodex Blepharitis Between Eye Care Practitioners in India and Australasia - A Survey-Based Comparison","volume":"16","author":"Sharma","year":"2024","journal-title":"Clin Optom (Auckl)"},{"issue":"6","key":"10.1016\/j.ajo.2025.11.024_bib0578","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1097\/ICL.0000000000000221","article-title":"Importance of Lid Hygiene Before Ocular Surgery: Qualitative and Quantitative Analysis of Eyelid and Conjunctiva Microbiota","volume":"42","author":"Peral","year":"2016","journal-title":"Eye Contact Lens"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0579","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-67888-5","article-title":"Clinical efficacy of eyelid hygiene in blepharitis and meibomian gland dysfunction after cataract surgery: a randomized controlled pilot trial","volume":"10","author":"Eom","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.ajo.2025.11.024_bib0580","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ajo.2021.04.009","article-title":"Comparison of the Effect of Tea Tree Oil Shampoo With Regular Eyelid Shampoo in Meibomian Gland Dysfunction Treatment","volume":"229","author":"Zarei-Ghanavati","year":"2021","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajo.2025.11.024_bib0581","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.4103\/ijo.IJO_2885_21","article-title":"Tear film lipid layer thickness measurement from Ocular Surface Analyzer as a marker to monitor treatment of meibomian gland dysfunction in a study comparing physiological detergent-free eyelid wipes with conventional therapy: A randomized trial","volume":"70","author":"Runda","year":"2022","journal-title":"Indian J Ophthalmol"},{"issue":"5","key":"10.1016\/j.ajo.2025.11.024_bib0582","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.4103\/IJO.IJO_2546_22","article-title":"Comparison of the effect of tea tree oil eye gel with standard treatment in patients with anterior blepharitis: An open-label clinical trial","volume":"71","author":"Aghaei","year":"2023","journal-title":"Indian J Ophthalmol"},{"issue":"10","key":"10.1016\/j.ajo.2025.11.024_bib0583","first-page":"549","article-title":"Blue Light-Emitting Diode Irradiation Without a Photosensitizer Alters Oral Microbiome Composition of LigatureInduced Periodontitis in Mice","volume":"41","author":"Toyoshima","year":"2023","journal-title":"Photobiomodul Photomed Laser Surg"},{"issue":"5","key":"10.1016\/j.ajo.2025.11.024_bib0584","doi-asserted-by":"crossref","first-page":"91","DOI":"10.25270\/wnds\/22097","article-title":"Blue light therapy in the management of chronic wounds: a narrative review of its physiological basis and clinical evidence","volume":"35","author":"Zhang","year":"2023","journal-title":"Wounds"},{"key":"10.1016\/j.ajo.2025.11.024_bib0585","doi-asserted-by":"crossref","DOI":"10.1016\/j.jphotobiol.2023.112814","article-title":"Blue light photobiomodulation induced apoptosis by increasing ROS level and regulating SOCS3 and PTEN\/PI3K\/AKT pathway in osteosarcoma cells","volume":"249","author":"Yang","year":"2023","journal-title":"J Photochem Photobiol B."},{"issue":"3","key":"10.1016\/j.ajo.2025.11.024_bib0586","doi-asserted-by":"crossref","first-page":"187","DOI":"10.23736\/S1121-421X.19.02593-5","article-title":"Blue light emitting diodes cripple Helicobacter pylori by targeting its virulence factors","volume":"65","author":"Darmani","year":"2019","journal-title":"Minerva Gastroenterol Dietol."},{"issue":"9","key":"10.1016\/j.ajo.2025.11.024_bib0587","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2023-075084","article-title":"Antimicrobial photodynamic therapy with erythrosine and blue light on dental biofilm bacteria: study protocol for randomised clinical trial","volume":"13","author":"Goncalves","year":"2023","journal-title":"BMJ Open"},{"issue":"9","key":"10.1016\/j.ajo.2025.11.024_bib0588","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1097\/01.ico.0000225716.85382.7b","article-title":"Effect of antibacterial honey on the ocular flora in tear deficiency and meibomian gland disease","volume":"25","author":"Albietz","year":"2006","journal-title":"Cornea."},{"issue":"8","key":"10.1016\/j.ajo.2025.11.024_bib0589","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/j.carres.2009.03.020","article-title":"The origin of methylglyoxal in New Zealand manuka (Leptospermum scoparium) honey","volume":"344","author":"Adams","year":"2009","journal-title":"Carbohydr Res"},{"issue":"3","key":"10.1016\/j.ajo.2025.11.024_bib0590","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1093\/jac\/dku448","article-title":"Manuka honey reduces the motility of Pseudomonas aeruginosa by suppression of flagella-associated genes","volume":"70","author":"Roberts","year":"2015","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0591","doi-asserted-by":"crossref","DOI":"10.1136\/bmjophth-2016-000065","article-title":"Preclinical development of MGO Manuka Honey microemulsion for blepharitis management","volume":"1","author":"Craig","year":"2017","journal-title":"BMJ Open Ophthalmol"},{"issue":"5","key":"10.1016\/j.ajo.2025.11.024_bib0592","doi-asserted-by":"crossref","first-page":"172","DOI":"10.31989\/ffhd.v4i5.13","article-title":"Enhanced antibacterial activity of MGOTM manuka honey complexed with a-cyclodextrin (manuka honey with CycloPowerTM)","volume":"4","author":"Swift","year":"2014","journal-title":"Functional Foods in Health and Disease"},{"issue":"9","key":"10.1016\/j.ajo.2025.11.024_bib0593","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1002\/jps.23077","article-title":"Cyclodextrins as functional excipients: methods to enhance complexation efficiency","volume":"101","author":"Loftsson","year":"2012","journal-title":"J Pharm Sci."},{"issue":"6","key":"10.1016\/j.ajo.2025.11.024_bib0594","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.clae.2018.06.006","article-title":"Comparing the in vitro effects of MGO Manuka honey and tea tree oil on ocular Demodex viability","volume":"41","author":"Frame","year":"2018","journal-title":"Cont Lens Anterior Eye."},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0595","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.jtos.2019.11.009","article-title":"Randomized masked trial of the clinical efficacy of MGO Manuka Honey microemulsion eye cream for the treatment of blepharitis","volume":"18","author":"Craig","year":"2020","journal-title":"Ocul Surf"},{"issue":"5","key":"10.1016\/j.ajo.2025.11.024_bib0596","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1177\/1120672119854985","article-title":"Prevalence and antibiotic susceptibility of bacteria isolated in patients affected with blepharitis in a tertiary eye centre in Spain","volume":"30","author":"de Paula","year":"2020","journal-title":"Eur J Ophthalmol."},{"issue":"6","key":"10.1016\/j.ajo.2025.11.024_bib0597","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s10384-022-00947-8","article-title":"Analysis of treatment protocols using azithromycin eye drops for bacterial blepharitis: second report-bacteriological investigation","volume":"66","author":"Nejima","year":"2022","journal-title":"Jpn J Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajo.2025.11.024_bib0598","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.oftal.2023.04.001","article-title":"In vitro evaluation of multiple antibacterial agents for the treatment of chronic staphylococcal anterior blepharitis","volume":"98","author":"Fernandez-Engroba","year":"2023","journal-title":"Arch Soc Esp Oftalmol (Engl Ed)"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0599","doi-asserted-by":"crossref","DOI":"10.1016\/j.diagmicrobio.2023.116069","article-title":"Antibiotic resistance of bacterial pathogens isolated from the conjunctiva in the Antibiotic Resistance Monitoring in Ocular micRoorganisms (ARMOR) surveillance study (2009-2021)","volume":"108","author":"Asbell","year":"2024","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"12","key":"10.1016\/j.ajo.2025.11.024_bib0600","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1128\/AAC.31.12.1939","article-title":"Spectrum and mode of action of azithromycin (CP-62,993), a new 15-membered-ring macrolide with improved potency against gram-negative organisms","volume":"31","author":"Retsema","year":"1987","journal-title":"Antimicrob Agents Chemother."},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0601","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S0022-3565(24)35272-3","article-title":"Anti-inflammatory activity of macrolide antibiotics","volume":"292","author":"Ianaro","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0602","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1093\/jac\/dkh519","article-title":"Anti-inflammatory effects of macrolides\u2013an underappreciated benefit in the treatment of community-acquired respiratory tract infections and chronic inflammatory pulmonary conditions?","volume":"55","author":"Amsden","year":"2005","journal-title":"J Antimicrob Chemother"},{"issue":"5","key":"10.1016\/j.ajo.2025.11.024_bib0603","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1007\/s10384-024-01079-x","article-title":"Efficacy and safety of topical azithromycin therapy in patients with blepharitis and meibomian gland dysfunction","volume":"68","author":"Shimazaki","year":"2024","journal-title":"Jpn J Ophthalmol"},{"issue":"5","key":"10.1016\/j.ajo.2025.11.024_bib0604","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1111\/opo.13330","article-title":"The topical azithromycin meibomian gland dysfunction survey: The effect of topical azithromycin on signs and symptoms of meibomian gland dysfunction","volume":"44","author":"Jarvis","year":"2024","journal-title":"Ophthalmic Physiol Opt"},{"issue":"4","key":"10.1016\/j.ajo.2025.11.024_bib0605","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1089\/jop.2017.0095","article-title":"Comparison of the Clinical Efficacy of Topical and Systemic Azithromycin Treatment for Posterior Blepharitis","volume":"34","author":"Yildiz","year":"2018","journal-title":"J Ocul Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.ajo.2025.11.024_bib0606","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1080\/09273948.2017.1341988","article-title":"The Use of Topical Corticosteroids for Treatment of Dry Eye Syndrome","volume":"27","author":"Cutolo","year":"2019","journal-title":"Ocul Immunol Inflamm"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0607","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s12325-019-01137-8","article-title":"Topical Low Dose Preservative Free Hydrocortisone Reduces Signs and Symptoms in Patients with Chronic Dry Eye: A Randomized Clinical Trial","volume":"37","author":"Kallab","year":"2020","journal-title":"Adv Ther"},{"issue":"10","key":"10.1016\/j.ajo.2025.11.024_bib0608","article-title":"Topical corticosteroids for dry eye","volume":"10","author":"Liu","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ajo.2025.11.024_bib0609","first-page":"299","article-title":"Development of a non-settling gel formulation of 0.5% loteprednol etabonate for anti-inflammatory use as an ophthalmic drop","volume":"7","author":"Coffey","year":"2013","journal-title":"Clin Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2025.11.024_bib0610","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1080\/14656566.2018.1439920","article-title":"Loteprednol etabonate for inflammatory conditions of the anterior segment of the eye: twenty years of clinical experience with a retrometabolically designed corticosteroid","volume":"19","author":"Comstock","year":"2018","journal-title":"Expert Opin Pharmacother."},{"issue":"2","key":"10.1016\/j.ajo.2025.11.024_bib0611","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0960-0760(91)90120-T","article-title":"Soft drugs\u201310. Blanching activity and receptor binding affinity of a new type of glucocorticoid: loteprednol etabonate","volume":"38","author":"Druzgala","year":"1991","journal-title":"J Steroid Biochem Mol Biol."},{"issue":"10","key":"10.1016\/j.ajo.2025.11.024_bib0612","doi-asserted-by":"crossref","first-page":"933","DOI":"10.3109\/02713689109020329","article-title":"Ocular absorption and distribution of loteprednol etabonate, a soft steroid, in rabbit eyes","volume":"10","author":"Druzgala","year":"1991","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.ajo.2025.11.024_bib0613","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.bcp.2016.12.010","article-title":"Identification of esterase involved in the metabolism of two corticosteroid soft drugs","volume":"127","author":"Samir","year":"2017","journal-title":"Biochem Pharmacol"},{"issue":"2","key":"10.1016\/j.ajo.2025.11.024_bib0614","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.ophtha.2015.10.011","article-title":"Long-term Natural History of Dry Eye Disease from the Patient's Perspective","volume":"123","author":"Lienert","year":"2016","journal-title":"Ophthalmology"},{"issue":"23","key":"10.1016\/j.ajo.2025.11.024_bib0615","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21239271","article-title":"Defining Dry Eye from a Clinical Perspective","volume":"21","author":"Tsubota","year":"2020","journal-title":"Int J Mol Sci."},{"issue":"3","key":"10.1016\/j.ajo.2025.11.024_bib0616","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jtos.2017.05.008","article-title":"TFOS DEWS II Definition and Classification Report","volume":"15","author":"Craig","year":"2017","journal-title":"Ocul Surf"},{"issue":"4","key":"10.1016\/j.ajo.2025.11.024_bib0617","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1080\/02713683.2017.1420197","article-title":"Controlled Adverse Environment Chambers in Dry Eye Research","volume":"43","author":"Calonge","year":"2018","journal-title":"Curr Eye Res."},{"issue":"2","key":"10.1016\/j.ajo.2025.11.024_bib0618","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.jtos.2018.01.002","article-title":"Web-based longitudinal remote assessment of dry eye symptoms","volume":"16","author":"Amparo","year":"2018","journal-title":"Ocul Surf"},{"key":"10.1016\/j.ajo.2025.11.024_bib0619","doi-asserted-by":"crossref","DOI":"10.1100\/2012\/589875","article-title":"The dry eye disease activity log study","volume":"2012","author":"Iyer","year":"2012","journal-title":"ScientificWorldJournal"},{"issue":"10","key":"10.1016\/j.ajo.2025.11.024_bib0620","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1016\/j.ophtha.2018.03.039","article-title":"Effects of Prolonged Reading on Dry Eye","volume":"125","author":"Karakus","year":"2018","journal-title":"Ophthalmology."},{"key":"10.1016\/j.ajo.2025.11.024_bib0621","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jtos.2021.07.001","article-title":"Dry eye disease flares: A rapid evidence assessment","volume":"22","author":"Starr","year":"2021","journal-title":"Ocul Surf"},{"key":"10.1016\/j.ajo.2025.11.024_bib0622","doi-asserted-by":"crossref","first-page":"349","DOI":"10.2147\/OPTH.S323301","article-title":"Practical Guidance for the Use of Loteprednol Etabonate Ophthalmic Suspension 0.25% in the Management of Dry Eye Disease","volume":"16","author":"Venkateswaran","year":"2022","journal-title":"Clin Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajo.2025.11.024_bib0623","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.addr.2008.11.002","article-title":"Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues","volume":"61","author":"Lai","year":"2009","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.ajo.2025.11.024_bib0624","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.reactfunctpolym.2016.01.011","article-title":"Mucoadhesion: A promising approach in drug delivery system","volume":"100","author":"Mansuri","year":"2016","journal-title":"Reactive and Functional Polymers"},{"issue":"5","key":"10.1016\/j.ajo.2025.11.024_bib0625","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.molmed.2020.12.001","article-title":"Avoiding a Sticky Situation: Bypassing the Mucus Barrier for Improved Local Drug Delivery","volume":"27","author":"Zierden","year":"2021","journal-title":"Trends Mol Med"},{"issue":"6","key":"10.1016\/j.ajo.2025.11.024_bib0626","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1089\/jop.2020.0022","article-title":"Mucus-Penetrating Particles and the Role of Ocular Mucus as a Barrier to Micro- and Nanosuspensions","volume":"36","author":"Popov","year":"2020","journal-title":"J Ocul Pharmacol Ther"},{"issue":"1-2","key":"10.1016\/j.ajo.2025.11.024_bib0627","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s40123-014-0021-z","article-title":"Ocular Pharmacokinetics of a Novel Loteprednol Etabonate 0.4% Ophthalmic Formulation","volume":"3","author":"Schopf","year":"2014","journal-title":"Ophthalmol Ther"},{"issue":"5","key":"10.1016\/j.ajo.2025.11.024_bib0628","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1097\/ICO.0000000000002452","article-title":"Safety of KPI-121 Ophthalmic Suspension 0.25% in Patients With Dry Eye Disease: A Pooled Analysis of 4 Multicenter, Randomized, Vehicle-Controlled Studies","volume":"40","author":"Korenfeld","year":"2021","journal-title":"Cornea"},{"issue":"4","key":"10.1016\/j.ajo.2025.11.024_bib0629","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1177\/11206721211048730","article-title":"Is there a role for tapered topical dose steroidal treatment for dry eye disease? A randomized, pilot study","volume":"32","author":"Barabino","year":"2022","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.ajo.2025.11.024_bib0630","article-title":"The role of KPI-121 0.25% in the treatment of dry eye disease: penetrating the mucus barrier to treat periodic flares","volume":"13","author":"Gupta","year":"2021","journal-title":"Ther Adv Ophthalmol"},{"issue":"12","key":"10.1016\/j.ajo.2025.11.024_bib0631","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11123277","article-title":"Dry Eye Para Inflammation Treatment: Evaluation of a Novel Tear Substitute Containing Hyaluronic Acid and Low-Dose Hydrocortisone","volume":"11","author":"Borroni","year":"2023","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0632","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s40123-023-00833-7","article-title":"Effectiveness of a New Active Tear Substitute Containing 0.2% Hyaluronic Acid and 0.001% Hydrocortisone on Signs and Symptoms of Dry Eye Disease by Means of Lowand High-Tech Assessments","volume":"13","author":"Fogagnolo","year":"2024","journal-title":"Ophthalmol Ther"},{"issue":"3","key":"10.1016\/j.ajo.2025.11.024_bib0633","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.survophthal.2009.02.002","article-title":"Topical ophthalmic cyclosporine: pharmacology and clinical uses","volume":"54","author":"Donnenfeld","year":"2009","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.ajo.2025.11.024_bib0634","doi-asserted-by":"crossref","first-page":"4187","DOI":"10.2147\/OPTH.S279051","article-title":"A Review of the Mechanism of Action of Cyclosporine A: The Role of Cyclosporine A in Dry Eye Disease and Recent Formulation Developments","volume":"14","author":"Periman","year":"2020","journal-title":"Clin Ophthalmol"},{"issue":"5","key":"10.1016\/j.ajo.2025.11.024_bib0635","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1097\/ACI.0000000000001017","article-title":"The evolution of cyclosporine treatments for treatment of ocular surface diseases","volume":"24","author":"Flts","year":"2024","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"7","key":"10.1016\/j.ajo.2025.11.024_bib0636","doi-asserted-by":"crossref","first-page":"4717","DOI":"10.1167\/iovs.13-11681","article-title":"Mitochondrial permeability transition pore in inflammatory apoptosis of human conjunctival epithelial cells and T cells: effect of cyclosporin A","volume":"54","author":"Gao","year":"2013","journal-title":"Invest Ophthalmol Vis Sci."},{"issue":"2","key":"10.1016\/j.ajo.2025.11.024_bib0637","doi-asserted-by":"crossref","first-page":"195","DOI":"10.5114\/ceji.2016.60995","article-title":"Immunomodulation on the ocular surface: a review","volume":"41","author":"Ambroziak","year":"2016","journal-title":"Cent Eur J Immunol"},{"issue":"2-3","key":"10.1016\/j.ajo.2025.11.024_bib0638","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0162-3109(00)00192-2","article-title":"Mechanisms of action of cyclosporine","volume":"47","author":"Matsuda","year":"2000","journal-title":"Immunopharmacology"},{"issue":"2","key":"10.1016\/j.ajo.2025.11.024_bib0639","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/S0014-5793(97)00930-7","article-title":"Cyclosporine A is an uncompetitive inhibitor of proteasome activity and prevents NF-kappaB activation","volume":"413","author":"Meyer","year":"1997","journal-title":"FEBS Lett"},{"key":"10.1016\/j.ajo.2025.11.024_bib0640","article-title":"Evidence on the Use of Topical Ciclosporin for Ocular Surface Disease: A Systematic Review and Meta-Analysis","author":"Chidi-Egboka","year":"2025","journal-title":"Clin Exp Ophthalmol."},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0641","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1136\/bjophthalmol-2017-311801","article-title":"Efficacy and safety of 0.1% ciclosporin A cationic emulsion in dry eye disease: a pooled analysis of two double-masked, randomised, vehicle-controlled phase III clinical studies","volume":"103","author":"Leonardi","year":"2019","journal-title":"The British journal of ophthalmology"},{"key":"10.1016\/j.ajo.2025.11.024_bib0642","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.882803","article-title":"Comparison of seven cyclosporine A formulations for dry eye disease: A systematic review and network meta analysis","volume":"13","author":"Gao","year":"2022","journal-title":"Front Pharmacol"},{"issue":"31","key":"10.1016\/j.ajo.2025.11.024_bib0643","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000016710","article-title":"Efficacy and safety of 0.05% cyclosporine ophthalmic emulsion in treatment of Chinese patients with moderate to severe dry eye disease: A 12-week, multicenter, randomized, double-masked, placebocontrolled phase III clinical study","volume":"98","author":"Chen","year":"2019","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0644","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1186\/s12886-024-03771-5","article-title":"Comparison of therapeutic effects of 0.05% Cyclosporine A versus 0.1% Fluorometholone in Chinese patients with mild dry eye unresponsive to artificial tears: a randomized control study","volume":"24","author":"Gao","year":"2024","journal-title":"BMC Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0645","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s12886-024-03294-z","article-title":"Efficacy of topical 0.05% cyclosporine A and 0.1% sodium hyaluronate in post-refractive surgery chronic dry eye patients with ocular pain","volume":"24","author":"Zhao","year":"2024","journal-title":"BMC Ophthalmol"},{"issue":"8","key":"10.1016\/j.ajo.2025.11.024_bib0646","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1097\/ICL.0000000000001103","article-title":"Impact of Topical 0.05% Cyclosporine A Eye Drops on Post-Femtosecond-Assisted Laser In Situ Keratomileusis Ocular Surface Recovery: A Randomized Clinical Trial","volume":"50","author":"Zhao","year":"2024","journal-title":"Eye Contact Lens"},{"issue":"4","key":"10.1016\/j.ajo.2025.11.024_bib0647","doi-asserted-by":"crossref","first-page":"e229","DOI":"10.3928\/1081597X-20240311-03","article-title":"Effects of Topical 0.05% Cyclosporine A on Dry Eye Symptoms and Parameters Following Small Incision Lenticule Extraction","volume":"40","author":"Zhu","year":"2024","journal-title":"J Refract Surg"},{"issue":"4","key":"10.1016\/j.ajo.2025.11.024_bib0648","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1001\/jamaophthalmol.2024.0101","article-title":"Water-Free Cyclosporine Ophthalmic Solution vs Vehicle for Dry Eye Disease: A Randomized Clinical Trial","volume":"142","author":"Peng","year":"2024","journal-title":"JAMA Ophthalmol"},{"issue":"5","key":"10.1016\/j.ajo.2025.11.024_bib0649","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1001\/jamaophthalmol.2023.0709","article-title":"Efficacy and Safety of a Water Free Topical Cyclosporine, 0.1%, Solution for the Treatment of Moderate to Severe Dry Eye Disease: The ESSENCE-2 Randomized Clinical Trial","volume":"141","author":"Akpek","year":"2023","journal-title":"JAMA Ophthalmol"},{"issue":"10","key":"10.1016\/j.ajo.2025.11.024_bib0650","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1097\/ICO.0000000000002633","article-title":"A Water-free 0.1% Cyclosporine A Solution for Treatment of Dry Eye Disease: Results of the Randomized Phase 2B\/3 ESSENCE Study","volume":"40","author":"Sheppard","year":"2021","journal-title":"Cornea"},{"issue":"6","key":"10.1016\/j.ajo.2025.11.024_bib0651","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.ophtha.2019.01.024","article-title":"A Clinical Phase II Study to Assess Efficacy, Safety, and Tolerability of Waterfree Cyclosporine Formulation for Treatment of Dry Eye Disease","volume":"126","author":"Wirta","year":"2019","journal-title":"Ophthalmology"},{"issue":"1-2","key":"10.1016\/j.ajo.2025.11.024_bib0652","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ijpharm.2018.01.019","article-title":"Semifluorinated alkane based systems for enhanced corneal penetration of poorly soluble drugs","volume":"538","author":"Agarwal","year":"2018","journal-title":"Int J Pharm"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0653","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/j.1538-9235.1997.tb04573.x","article-title":"Importance of the lipid layer in human tear film stability and evaporation","volume":"74","author":"Craig","year":"1997","journal-title":"Optom Vis Sci"},{"key":"10.1016\/j.ajo.2025.11.024_bib0654","article-title":"Long-Term Safety and Efficacy of a Water-Free Cyclosporine 0.1% Ophthalmic Solution for Treatment of Dry Eye Disease: ESSENCE-2 OLE","author":"Wirta","year":"2024","journal-title":"Cornea"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0655","article-title":"A randomized multicenter evaluation of the efficacy of 0.15% hyaluronic acid versus 0.05% cyclosporine A in dry eye syndrome","volume":"12","author":"Lee","year":"2022","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.ajo.2025.11.024_bib0656","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1080\/02713683.2021.1966477","article-title":"The Effect of OTX-101 on Tear Production in Patients with Severe Tear-deficient Dry Eye Disease: A Pooled Analysis of Phase 2b\/3 and Phase 3 Studies","volume":"47","author":"Toyos","year":"2022","journal-title":"Curr Eye Res."},{"issue":"7","key":"10.1016\/j.ajo.2025.11.024_bib0657","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1089\/jop.2018.0154","article-title":"Effect of OTX-101, a Novel Nanomicellar Formulation of Cyclosporine A, on Conjunctival Staining in Patients with Keratoconjunctivitis Sicca: A Pooled Analysis of Phase 2b\/3 and 3 Clinical Trials","volume":"35","author":"Smyth-Medina","year":"2019","journal-title":"J Ocul Pharmacol Ther."},{"issue":"9","key":"10.1016\/j.ajo.2025.11.024_bib0658","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1016\/j.ophtha.2019.03.050","article-title":"A Phase 3, Randomized, Double-Masked Study of OTX-101 Ophthalmic Solution 0.09% in the Treatment of Dry Eye Disease","volume":"126","author":"Goldberg","year":"2019","journal-title":"Ophthalmology."},{"key":"10.1016\/j.ajo.2025.11.024_bib0659","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.2147\/OPTH.S175065","article-title":"A Phase II\/III, randomized, double-masked, vehicle-controlled, dose-ranging study of the safety and efficacy of OTX-101 in the treatment of dry eye disease","volume":"12","author":"Tauber","year":"2018","journal-title":"Clin Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0660","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1186\/s12886-024-03620-5","article-title":"Effectiveness of cyclosporine nanoemulsion eye drops in patients with mild-to-moderate dry eyes: objective and subjective evaluation","volume":"24","author":"Moon","year":"2024","journal-title":"BMC Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2025.11.024_bib0661","doi-asserted-by":"crossref","first-page":"343","DOI":"10.3341\/kjo.2018.0116","article-title":"Efficacy of Topical Cyclosporine Nanoemulsion 0.05% Compared with Topical Cyclosporine Emulsion 0.05% and Diquafosol 3% in Dry Eye","volume":"33","author":"Park","year":"2019","journal-title":"Korean J Ophthalmol."},{"issue":"3","key":"10.1016\/j.ajo.2025.11.024_bib0662","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1080\/09273948.2019.1587470","article-title":"Evaluation of the Efficacy and Safety of A Novel 0.05% Cyclosporin A Topical Nanoemulsion in Primary Sjogren's Syndrome Dry Eye","volume":"28","author":"Kang","year":"2020","journal-title":"Ocul Immunol Inflamm"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0663","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1089\/jop.2022.0119","article-title":"A Multicenter, Randomized, Double-Blind Evaluation of the Efficacy of TJO-087 Versus 0.05% Cyclosporine A in Moderate to Severe Dry Eye","volume":"39","author":"Eom","year":"2023","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1016\/j.ajo.2025.11.024_bib0664","article-title":"Comparison of Consecutive Therapeutic Effects of Nanoemulsion and Emulsion Cyclosporin in Dry Eye Patients after Short-Term Treatment with Topical Fluorometholone","volume":"2022","author":"Choi","year":"2022","journal-title":"J Ophthalmol"},{"key":"10.1016\/j.ajo.2025.11.024_bib0665","doi-asserted-by":"crossref","first-page":"265","DOI":"10.2147\/DDDT.S207743","article-title":"An Updated Systematic Review With Meta Analysis Of Randomized Trials On Topical Cyclosporin A For Dry-Eye Disease","volume":"14","author":"Tuan","year":"2020","journal-title":"Drug Des Devel Ther"},{"issue":"2","key":"10.1016\/j.ajo.2025.11.024_bib0666","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1089\/jop.2016.0086","article-title":"A Randomized Multicenter Study Comparing 0.1%, 0.15%, and 0.3% Sodium Hyaluronate with 0.05% Cyclosporine in the Treatment of Dry Eye","volume":"33","author":"Park","year":"2017","journal-title":"J Ocul Pharmacol Ther"},{"issue":"3","key":"10.1016\/j.ajo.2025.11.024_bib0667","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1007\/s10384-022-00906-3","article-title":"Efficacy of a 0.05% cyclosporine a topical nanoemulsion in dry eyes with obstructive meibomian gland dysfunction","volume":"66","author":"Rhim","year":"2022","journal-title":"Jpn J Ophthalmol"},{"issue":"36","key":"10.1016\/j.ajo.2025.11.024_bib0668","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000034923","article-title":"A randomized controlled trial involving college student: Comparing 0.15% hyaluronic acid with 0.05% cyclosporine A and 3% diquafosol sodium in the Treatment of Dry Eye","volume":"102","author":"Xu","year":"2023","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"10.1016\/j.ajo.2025.11.024_bib0669","article-title":"Effectiveness of Topical Cyclosporin-A 0.1% Compared to Combined Topical Cyclosporin-A 0.1% with Topical Sodium Hyaluronate on Interleukin-6 Levels in the Tears of Patients with Dry Eye Disease","volume":"7","author":"Priani","year":"2023","journal-title":"Vision (Basel)"},{"issue":"8","key":"10.1016\/j.ajo.2025.11.024_bib0670","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1080\/09273948.2022.2094812","article-title":"Evaluation of the Efficacy and Safety of Topical 0.05% Cyclosporine Eye Drops (II) in the Treatment of Dry Eye Associated with Primary Sjogren's Syndrome","volume":"31","author":"Gao","year":"2023","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.ajo.2025.11.024_bib0671","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.2147\/OPTH.S419600","article-title":"A Prospective Study of Cyclosporine A 0.1% Combined with Loteprednol 0.2% vs Cyclosporine A 0.05% Alone in the Treatment of Dry Eye","volume":"17","author":"Hovanesian","year":"2023","journal-title":"Clin Ophthalmol"},{"issue":"10","key":"10.1016\/j.ajo.2025.11.024_bib0672","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1089\/jop.2022.0031","article-title":"Effectiveness of Topical Cyclosporin A 0.1%, Diquafosol Tetrasodium 3%, and Their Combination, in Dry Eye Disease","volume":"38","author":"Eom","year":"2022","journal-title":"J Ocul Pharmacol Ther"},{"issue":"28","key":"10.1016\/j.ajo.2025.11.024_bib0673","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3126\/nepjoph.v14i2.38928","article-title":"Safety and efficacy of cyclosporine (0.05% versus 0.09%) in dry eye disease. Is it the strength of cyclosporin that really matters?","volume":"14","author":"Rajpoot","year":"2022","journal-title":"Nepal J Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0674","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1089\/jop.2020.0104","article-title":"A Randomized, Placebo-Controlled Phase II Clinical Trial of 0.01% or 0.02% Cyclosporin A with 3% Trehalose in Patients with Dry Eye Disease","volume":"37","author":"Shin","year":"2021","journal-title":"J Ocul Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.ajo.2025.11.024_bib0675","doi-asserted-by":"crossref","first-page":"678","DOI":"10.5301\/ejo.5001002","article-title":"One-Year Efficacy and Safety of 0.1% Cyclosporine a Cationic Emulsion in the Treatment of Severe Dry Eye Disease","volume":"27","author":"Baudouin","year":"2017","journal-title":"Eur J Ophthalmol."},{"issue":"11","key":"10.1016\/j.ajo.2025.11.024_bib0676","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1016\/j.clinthera.2018.09.012","article-title":"Persistence of Efficacy of 0.1% Cyclosporin A Cationic Emulsion in Subjects with Severe Keratitis Due to Dry Eye Disease: A Nonrandomized, Open-label Extension of the SANSIKA Study","volume":"40","author":"Labetoulle","year":"2018","journal-title":"Clin Ther."},{"issue":"4","key":"10.1016\/j.ajo.2025.11.024_bib0677","first-page":"593","article-title":"Clinical efficacy of combined topical 0.05% cyclosporine A and 0.1% sodium hyaluronate in the dry eyes with meibomian gland dysfunction","volume":"11","author":"Kim","year":"2018","journal-title":"International journal of ophthalmology"},{"issue":"12","key":"10.1016\/j.ajo.2025.11.024_bib0678","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.18240\/ijo.2022.12.05","article-title":"Clinical efficacy of 0.05% cyclosporine nanoemulsion in the treatment of dry eye syndrome associated with meibomian gland dysfunction","volume":"15","author":"Jo","year":"2022","journal-title":"International journal of ophthalmology"},{"key":"10.1016\/j.ajo.2025.11.024_bib0679","article-title":"Lifitegrast: a novel drug for patients with dry eye disease","volume":"11","author":"Haber","year":"2019","journal-title":"Ther Adv Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajo.2025.11.024_bib0680","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.ophtha.2013.09.015","article-title":"Lifitegrast ophthalmic solution 5.0% for treatment of dry eye disease: results of the OPUS-1 phase 3 study","volume":"121","author":"Sheppard","year":"2014","journal-title":"Ophthalmology."},{"issue":"12","key":"10.1016\/j.ajo.2025.11.024_bib0681","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1016\/j.ophtha.2015.08.001","article-title":"Lifitegrast Ophthalmic Solution 5.0% versus Placebo for Treatment of Dry Eye Disease: Results of the Randomized Phase III OPUS-2 Study","volume":"122","author":"Tauber","year":"2015","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0682","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ophtha.2016.09.025","article-title":"Lifitegrast for the Treatment of Dry Eye Disease: Results of a Phase III, Randomized, Double-Masked, Placebo-Controlled Trial (OPUS-3)","volume":"124","author":"Holland","year":"2017","journal-title":"Ophthalmology"},{"issue":"11","key":"10.1016\/j.ajo.2025.11.024_bib0683","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1001\/jamaophthalmol.2021.3943","article-title":"Efficacy of Lifitegrast Ophthalmic Solution, 5.0%, in Patients With Moderate to Severe Dry Eye Disease: A Post Hoc Analysis of 2 Randomized Clinical Trials","volume":"139","author":"Holland","year":"2021","journal-title":"JAMA Ophthalmol"},{"issue":"17","key":"10.1016\/j.ajo.2025.11.024_bib0684","doi-asserted-by":"crossref","first-page":"5014","DOI":"10.3390\/jcm11175014","article-title":"Lifitegrast Ophthalmic Solution 5% Is a Safe and Efficient Eyedrop for Dry Eye Disease: A Systematic Review and Meta-Analysis","volume":"11","author":"Li","year":"2022","journal-title":"J Clin Med"},{"issue":"4","key":"10.1016\/j.ajo.2025.11.024_bib0685","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1177\/1120672118791936","article-title":"Safety and tolerability of lifitegrast ophthalmic solution 5.0%: Pooled analysis of five randomized controlled trials in dry eye disease","volume":"29","author":"Nichols","year":"2019","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.ajo.2025.11.024_bib0686","doi-asserted-by":"crossref","first-page":"909","DOI":"10.2147\/OPTH.S347496","article-title":"Reduction of Artificial Tears and Use of Adjunctive Dry Eye Therapies After Lifitegrast Treatment: Evidence from Clinical and Real-World Studies","volume":"16","author":"Nichols","year":"2022","journal-title":"Clin Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2025.11.024_bib0687","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/ICO.0000000000002235","article-title":"A 6-Week, Prospective, Randomized, Single-Masked Study of Lifitegrast Ophthalmic Solution 5% Versus Thermal Pulsation Procedure for Treatment of Inflammatory Meibomian Gland Dysfunction","volume":"39","author":"Tauber","year":"2020","journal-title":"Cornea."},{"key":"10.1016\/j.ajo.2025.11.024_bib0688","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.2147\/OPTH.S264520","article-title":"The Effect of Lifitegrast on Refractive Accuracy and Symptoms in Dry Eye Patients Undergoing Cataract Surgery","volume":"14","author":"Hovanesian","year":"2020","journal-title":"Clin Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajo.2025.11.024_bib0689","doi-asserted-by":"crossref","DOI":"10.4103\/pajo.pajo_34_24","article-title":"Treatment of dry eyes with lifitegrast 5% before cataract surgery: A prospective trial","volume":"6","author":"Yang","year":"2024","journal-title":"The Pan-American Journal of Ophthalmology"},{"key":"10.1016\/j.ajo.2025.11.024_bib0690","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.2147\/OPTH.S296510","article-title":"Real-World Experience with Lifitegrast Ophthalmic Solution (Xiidra((R))) in the US and Canada: Retrospective Study of Patient Characteristics, Treatment Patterns, and Clinical Effectiveness in 600 Patients with Dry Eye Disease","volume":"15","author":"Hovanesian","year":"2021","journal-title":"Clin Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajo.2025.11.024_bib0691","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1097\/ICO.0000000000000803","article-title":"Safety of Lifitegrast Ophthalmic Solution 5.0% in Patients With Dry Eye Disease: A 1-Year, Multicenter, Randomized, Placebo-Controlled Study","volume":"35","author":"Donnenfeld","year":"2016","journal-title":"Cornea"},{"key":"10.1016\/j.ajo.2025.11.024_bib0692","doi-asserted-by":"crossref","first-page":"931","DOI":"10.2147\/OPTH.S237832","article-title":"Physician Satisfaction with Anti-Inflammatory Topical Medications for the Treatment of Dry Eye Disease","volume":"14","author":"White","year":"2020","journal-title":"Clin Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajo.2025.11.024_bib0693","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1159\/000080937","article-title":"Immunomodulatory therapy in ophthalmology - is there a place for topical application?","volume":"218","author":"Bertelmann","year":"2004","journal-title":"Ophthalmologica Journal international d'ophtalmologie International journal of ophthalmology Zeitschrift fur Augenheilkunde."},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0694","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1177\/1120672121992680","article-title":"Evaluation of the effect of topical tacrolimus 0.03% versus cyclosporine 0.05% in the treatment of dry eye secondary to Sjogren syndrome","volume":"32","author":"Moawad","year":"2022","journal-title":"Eur J Ophthalmol"},{"issue":"11","key":"10.1016\/j.ajo.2025.11.024_bib0695","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1080\/02713683.2017.1339805","article-title":"Tacrolimus Ointment for Refractory Posterior Blepharitis","volume":"42","author":"Sakassegawa-Naves","year":"2017","journal-title":"Curr Eye Res."},{"key":"10.1016\/j.ajo.2025.11.024_bib0696","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.actbio.2022.01.044","article-title":"Alleviation of dry eye syndrome with one dose of antioxidant, anti-inflammatory, and mucoadhesive lysine-carbonized nanogels","volume":"141","author":"Lin","year":"2022","journal-title":"Acta Biomater"},{"issue":"6","key":"10.1016\/j.ajo.2025.11.024_bib0697","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1167\/iovs.63.6.12","article-title":"PPAR-alpha Agonist Fenofibrate Ameliorates Sjogren Syndrome-Like Dacryoadenitis by Modulating Th1\/Th17 and Treg Cell Responses in NOD Mice","volume":"63","author":"Guo","year":"2022","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0698","doi-asserted-by":"crossref","first-page":"64","DOI":"10.5114\/ceji.2016.58817","article-title":"Fenofibrate treatment of rats with experimental autoimmune myocarditis by alleviating Treg\/Th17 disorder","volume":"41","author":"Cheng","year":"2016","journal-title":"Cent Eur J Immunol"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0699","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1053\/j.gastro.2007.03.113","article-title":"Fenofibrate represses interleukin-17 and interferon-gamma expression and improves colitis in interleukin-10-deficient mice","volume":"133","author":"Lee","year":"2007","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.ajo.2025.11.024_bib0700","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1167\/iovs.61.3.54","article-title":"PPAR-alpha Agonist Fenofibrate Suppressed the Formation of Ocular Surface Squamous Metaplasia Induced by Topical Benzalkonium Chloride","volume":"61","author":"He","year":"2020","journal-title":"Invest Ophthalmol Vis Sci."},{"issue":"8","key":"10.1016\/j.ajo.2025.11.024_bib0701","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.3390\/ijms18081697","article-title":"Herbal Supplement in a Buffer for Dry Eye Syndrome Treatment","volume":"18","author":"Chen","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ajo.2025.11.024_bib0702","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.exer.2013.05.020","article-title":"Lacritin and the tear proteome as natural replacement therapy for dry eye","volume":"117","author":"Karnati","year":"2013","journal-title":"Exp Eye Res."},{"key":"10.1016\/j.ajo.2025.11.024_bib0703","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1007\/978-3-030-34521-1_31","article-title":"The Lacritin-Syndecan-1-Heparanase Axis in Dry Eye Disease","volume":"1221","author":"Dias-Teixeira","year":"2020","journal-title":"Adv Exp Med Biol"},{"issue":"8","key":"10.1016\/j.ajo.2025.11.024_bib0704","doi-asserted-by":"crossref","first-page":"5401","DOI":"10.1167\/iovs.14-13924","article-title":"Topical administration of lacritin is a novel therapy for aqueous-deficient dry eye disease","volume":"55","author":"Vijmasi","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"7","key":"10.1016\/j.ajo.2025.11.024_bib0705","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1097\/ICO.0000000000003091","article-title":"Lacripep Study G, Lacripep Study G. Lacripep for the Treatment of Primary Sjogren-Associated Ocular Surface Disease: Results of the First-In-Human Study","volume":"42","author":"Tauber","year":"2023","journal-title":"Cornea"},{"key":"10.1016\/j.ajo.2025.11.024_bib0706","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120752","article-title":"Naringenin: A potential flavonoid phytochemical for cancer therapy","volume":"305","author":"Motallebi","year":"2022","journal-title":"Life Sci."},{"key":"10.1016\/j.ajo.2025.11.024_bib0707","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2021.106020","article-title":"Preparation and characterization of a naringenin solubilizing glycyrrhizin nanomicelle ophthalmic solution for experimental dry eye disease","volume":"167","author":"Li","year":"2021","journal-title":"Eur J Pharm Sci."},{"issue":"10","key":"10.1016\/j.ajo.2025.11.024_bib0708","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/s40261-023-01303-5","article-title":"Acthar((R)) Gel Treatment for Patients with Autoimmune and Inflammatory Diseases: An Historical Perspective and Characterization of Clinical Evidence","volume":"43","author":"Kaplan","year":"2023","journal-title":"Clin Drug Investig"},{"issue":"3","key":"10.1016\/j.ajo.2025.11.024_bib0709","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1007\/s40123-022-00501-2","article-title":"Results from a Prospective, OpenLabel, Phase 4 Pilot Study of Repository Corticotropin Injection for Moderate and Severe Dry Eye isease","volume":"11","author":"Toyos","year":"2022","journal-title":"Ophthalmol Ther"},{"issue":"3","key":"10.1016\/j.ajo.2025.11.024_bib0710","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1042\/BJ20111752","article-title":"Cell signalling by reactive lipid species: new concepts and molecular mechanisms","volume":"442","author":"Higdon","year":"2012","journal-title":"Biochem J."},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0711","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.exer.2007.09.010","article-title":"Carotenoid derived aldehydes-induced oxidative stress causes apoptotic cell death in human retinal pigment epithelial cells","volume":"86","author":"Kalariya","year":"2008","journal-title":"Exp Eye Res"},{"issue":"4","key":"10.1016\/j.ajo.2025.11.024_bib0712","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1089\/jop.2020.0087","article-title":"A Randomized Double-Masked Phase 2a Trial to Evaluate Activity and Safety of Topical Ocular Reproxalap, a Novel RASP Inhibitor, in Dry Eye Disease","volume":"37","author":"Clark","year":"2021","journal-title":"J Ocul Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0713","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.biochi.2012.07.010","article-title":"Bioactive aldehyde-modified phosphatidylethanolamines","volume":"95","author":"Guo","year":"2013","journal-title":"Biochimie"},{"issue":"3","key":"10.1016\/j.ajo.2025.11.024_bib0714","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.plipres.2011.03.003","article-title":"Lipidomics of human Meibomian gland secretions: Chemistry, biophysics, and physiological role of Meibomian lipids","volume":"50","author":"Butovich","year":"2011","journal-title":"Prog Lipid Res"},{"key":"10.1016\/j.ajo.2025.11.024_bib0715","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ajo.2021.01.011","article-title":"Early Onset and Broad Activity of Reproxalap in a Randomized, Double-Masked, Vehicle-Controlled Phase 2b Trial in Dry Eye Disease","volume":"226","author":"Clark","year":"2021","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2025.11.024_bib0716","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1089\/jop.2021.0131","article-title":"Topical Porphyrin Antioxidant Protects Against Ocular Surface Pathology in a Novel Rabbit Model for Particulate Matter-Induced Dry Eye Disease","volume":"38","author":"Ghosh","year":"2022","journal-title":"J Ocul Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.ajo.2025.11.024_bib0717","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.jtos.2019.02.006","article-title":"Manganese(III) tetrakis(1-methyl-4-pyridyl) porphyrin, a superoxide dismutase mimetic, reduces disease severity in in vitro and in vivo models for dry-eye disease","volume":"17","author":"Ziniauskaite","year":"2019","journal-title":"Ocul Surf."},{"issue":"4","key":"10.1016\/j.ajo.2025.11.024_bib0718","doi-asserted-by":"crossref","first-page":"e412","DOI":"10.1111\/aos.13526","article-title":"Dry eye disease and oxidative stress","volume":"96","author":"Seen","year":"2018","journal-title":"Acta Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0719","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s40123-018-0158-2","article-title":"The Role of SKQ1 (Visomitin) in Inflammation and Wound Healing of the Ocular Surface","volume":"8","author":"Wei","year":"2019","journal-title":"Ophthalmol Ther."},{"issue":"12","key":"10.1016\/j.ajo.2025.11.024_bib0720","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1007\/s12325-015-0273-6","article-title":"Results of a Multicenter, Randomized, Double-Masked, Placebo-Controlled Clinical Study of the Efficacy and Safety of Visomitin Eye Drops in Patients with Dry Eye Syndrome","volume":"32","author":"Brzheskiy","year":"2015","journal-title":"Adv Ther."},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0721","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/s12325-015-0274-5","article-title":"SkQ1 Ophthalmic Solution for Dry Eye Treatment: Results of a Phase 2 Safety and Efficacy Clinical Study in the Environment and During Challenge in the Controlled Adverse Environment Model","volume":"33","author":"Petrov","year":"2016","journal-title":"Adv Ther"},{"issue":"5","key":"10.1016\/j.ajo.2025.11.024_bib0722","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0025-7125(16)32585-8","article-title":"The tetracyclines","volume":"54","author":"Ory","year":"1970","journal-title":"Med Clin North Am."},{"issue":"4","key":"10.1016\/j.ajo.2025.11.024_bib0723","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0014-4835(03)00005-8","article-title":"Minocycline effect on meibomian gland lipids in meibomianitis patients","volume":"76","author":"Shine","year":"2003","journal-title":"Exp Eye Res"},{"issue":"6","key":"10.1016\/j.ajo.2025.11.024_bib0724","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1097\/00003226-200308000-00011","article-title":"Effects of minocycline on the ocular flora of patients with acne rosacea or seborrheic blepharitis","volume":"22","author":"Ta","year":"2003","journal-title":"Cornea."},{"issue":"11","key":"10.1016\/j.ajo.2025.11.024_bib0725","first-page":"2970","article-title":"The role of tetracycline in chronic blepharitis. Inhibition of lipase production in staphylococci","volume":"32","author":"Dougherty","year":"1991","journal-title":"Invest Ophthalmol Vis Sci."},{"issue":"3","key":"10.1016\/j.ajo.2025.11.024_bib0726","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.exer.2006.02.004","article-title":"Corticosteroid and doxycycline suppress MMP-9 and inflammatory cytokine expression, MAPK activation in the corneal epithelium in experimental dry eye","volume":"83","author":"De Paiva","year":"2006","journal-title":"Article. Exp Eye Res."},{"issue":"9","key":"10.1016\/j.ajo.2025.11.024_bib0727","first-page":"2544","article-title":"Doxycycline inhibition of interleukin-1 in the corneal epithelium","volume":"41","author":"Solomon","year":"2000","journal-title":"Invest Ophthalmol Vis Sci."},{"issue":"5-6","key":"10.1016\/j.ajo.2025.11.024_bib0728","first-page":"844","article-title":"Tetracyclines Revisited: Tetracyclines in the Field of Dermatology","volume":"240","author":"Kim","year":"2024","journal-title":"Dermatology"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0729","first-page":"e1","article-title":"Systemic antibiotic treatment for meibomian gland dysfunction-A systematic review and meta-analysis","volume":"102","author":"Ben Ephraim Noyman","year":"2024","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.ajo.2025.11.024_bib0730","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.jtos.2022.08.010","article-title":"Antibiotic treatment for dry eye disease related to meibomian gland dysfunction and blepharitis - A review","volume":"26","author":"Vernhardsdottir","year":"2022","journal-title":"Ocul Surf"},{"issue":"6","key":"10.1016\/j.ajo.2025.11.024_bib0731","article-title":"Oral antibiotics for chronic blepharitis","volume":"6","author":"Onghanseng","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.ajo.2025.11.024_bib0732","doi-asserted-by":"crossref","first-page":"258","DOI":"10.3341\/kjo.2005.19.4.258","article-title":"The effect of low-dose doxycycline therapy in chronic meibomian gland dysfunction","volume":"19","author":"Yoo","year":"2005","journal-title":"Korean J Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajo.2025.11.024_bib0733","first-page":"118","article-title":"A status report on the use of subantimicrobial-dose doxycycline: a review of the biologic and antimicrobial effects of the tetracyclines","volume":"74","author":"Del Rosso","year":"2004","journal-title":"Cutis."},{"issue":"4","key":"10.1016\/j.ajo.2025.11.024_bib0734","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1001\/archderm.139.4.459","article-title":"Effects of subantimicrobial-dose doxycycline in the treatment of moderate acne","volume":"139","author":"Skidmore","year":"2003","journal-title":"Arch Dermatol"},{"issue":"7","key":"10.1016\/j.ajo.2025.11.024_bib0735","article-title":"Tetracycline's effects on teeth preclude uses in children and pregnant or lactating women","volume":"76","author":"Peterson","year":"1984","journal-title":"Postgrad Med."},{"key":"10.1016\/j.ajo.2025.11.024_bib0736","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2022.116377","article-title":"Tetracyclines and bone: Unclear actions with potentially lasting effects","volume":"159","author":"Warner","year":"2022","journal-title":"Bone"},{"issue":"7","key":"10.1016\/j.ajo.2025.11.024_bib0737","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1001\/jama.291.7.827","article-title":"Antibiotic use in relation to the risk of breast cancer","volume":"291","author":"Velicer","year":"2004","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.ajo.2025.11.024_bib0738","first-page":"307","article-title":"Association between antibiotic use prior to breast cancer diagnosis and breast tumour characteristics (United States)","volume":"17","author":"Velicer","year":"2006","journal-title":"Cancer Causes Control."},{"issue":"7","key":"10.1016\/j.ajo.2025.11.024_bib0739","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1093\/aje\/kwi087","article-title":"Use of antibiotics and risk of breast cancer","volume":"161","author":"Garcia Rodriguez","year":"2005","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ajo.2025.11.024_bib0740","series-title":"Macrolide Antibiotics","first-page":"xi","article-title":"Preface","author":"\u014cmura","year":"2003"},{"issue":"3","key":"10.1016\/j.ajo.2025.11.024_bib0741","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/ICO.0000000000000351","article-title":"Can tetracycline antibiotics duplicate the ability of azithromycin to stimulate human meibomian gland epithelial cell differentiation?","volume":"34","author":"Liu","year":"2015","journal-title":"Cornea"},{"issue":"4","key":"10.1016\/j.ajo.2025.11.024_bib0742","doi-asserted-by":"crossref","first-page":"464","DOI":"10.4103\/ijo.IJO_1244_17","article-title":"Oral azithromycin and oral doxycycline for the treatment of Meibomian gland dysfunction: A 9-month comparative case series","volume":"67","author":"De Benedetti","year":"2019","journal-title":"Indian J Ophthalmol."},{"key":"10.1016\/j.ajo.2025.11.024_bib0743","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.2147\/OPTH.S480719","article-title":"Oral Azithromycin versus Oral Doxycycline in the Treatment of Meibomian Gland Dysfunction: A Systematic Review and Meta-Analysis","volume":"18","author":"Bukhari","year":"2024","journal-title":"Clin Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajo.2025.11.024_bib0744","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1067\/mpa.2000.110339","article-title":"Oral erythromycin treatment for childhood blepharokeratitis","volume":"4","author":"Meisler","year":"2000","journal-title":"J AAPOS"},{"issue":"4","key":"10.1016\/j.ajo.2025.11.024_bib0745","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/ICU.0000000000000167","article-title":"Blepharokeratoconjunctivitis in children","volume":"26","author":"Hammersmith","year":"2015","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.ajo.2025.11.024_bib0747","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ab.2015.04.002","article-title":"Single unit filter aided method for fast proteomic analysis of tear fluid","volume":"480","author":"Aass","year":"2015","journal-title":"Anal Biochem"},{"issue":"1-2","key":"10.1016\/j.ajo.2025.11.024_bib0748","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/prca.201400084","article-title":"Unraveling the molecular repertoire of tears as a source of biomarkers: beyond ocular diseases","volume":"9","author":"Pieragostino","year":"2015","journal-title":"Proteomics Clin Appl."},{"issue":"4","key":"10.1016\/j.ajo.2025.11.024_bib0749","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1586\/1744666X.4.4.457","article-title":"Cytokines and chemokines in immune-based ocular surface inflammation","volume":"4","author":"Enriquez-de-Salamanca","year":"2008","journal-title":"Expert Rev Clin Immunol."},{"key":"10.1016\/j.ajo.2025.11.024_bib0750","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/B978-0-12-800096-0.00004-4","article-title":"Tear fluid protein biomarkers","volume":"62","author":"You","year":"2013","journal-title":"Adv Clin Chem"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0751","first-page":"38","article-title":"Update on the association between dry eye disease and meibomian gland dysfunction","volume":"25","author":"Chan","year":"2019","journal-title":"Hong Kong Med J."},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0752","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.transci.2015.05.015","article-title":"Serum eye drop preparation in Australia: Current manufacturing practice","volume":"53","author":"Marks","year":"2015","journal-title":"Transfus Apher Sci"},{"issue":"4","key":"10.1016\/j.ajo.2025.11.024_bib0753","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.blre.2009.04.001","article-title":"Platelet alpha-granules: basic biology and clinical correlates","volume":"23","author":"Blair","year":"2009","journal-title":"Blood Rev"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0754","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.transci.2015.05.016","article-title":"Animal models to assess the therapeutic efficacy of human serum and serum-converted platelet lysates for dry eye syndrome: Seeing is believing","volume":"53","author":"Tseng","year":"2015","journal-title":"Transfus Apher Sci."},{"issue":"2","key":"10.1016\/j.ajo.2025.11.024_bib0755","article-title":"Autologous serum eye drops for dry eye","volume":"2","author":"Pan","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"10.1016\/j.ajo.2025.11.024_bib0756","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1159\/000505630","article-title":"Autologous Serum Eye Drops versus Artificial Tear Drops for Dry Eye Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials","volume":"63","author":"Wang","year":"2020","journal-title":"Ophthalmic research"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0757","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ophtha.2019.08.018","article-title":"Autologous Serum-Based Eye Drops for Treatment of Ocular Surface Disease: A Report by the American Academy of Ophthalmology","volume":"127","author":"Shtein","year":"2020","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0758","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1136\/annrheumdis-2019-216114","article-title":"EULAR recommendations for the management of Sjogren's syndrome with topical and systemic therapies","volume":"79","author":"Ramos-Casals","year":"2020","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.ajo.2025.11.024_bib0759","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.4103\/IJO.IJO_2756_22","article-title":"Autologous serum eye drops in dry eye disease: Preferred practice pattern guidelines","volume":"71","author":"Vazirani","year":"2023","journal-title":"Indian J Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajo.2025.11.024_bib0760","doi-asserted-by":"crossref","DOI":"10.5935\/0004-2749.2022-0192","article-title":"20% Autologous serum vs. 0.05% cyclosporine and preservative-free artificial tears in the treatment of Sjogren related dry eye","volume":"87","author":"Berhuni","year":"2022","journal-title":"Arq Bras Oftalmol"},{"issue":"4","key":"10.1016\/j.ajo.2025.11.024_bib0761","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.transci.2017.07.023","article-title":"Blood derived eye drops for the treatment of cornea and ocular surface diseases","volume":"56","author":"Giannaccare","year":"2017","journal-title":"Transfus Apher Sci."},{"issue":"8","key":"10.1016\/j.ajo.2025.11.024_bib0762","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1111\/aos.14788","article-title":"Allogeneic and autologous serum eye drops: a pilot double-blind randomized crossover trial","volume":"99","author":"van der Meer","year":"2021","journal-title":"Acta Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajo.2025.11.024_bib0763","doi-asserted-by":"crossref","first-page":"e396","DOI":"10.1111\/aos.14953","article-title":"Autologous versus allogeneic versus umbilical cord sera for the treatment of severe dry eye disease: a double-blind randomized clinical trial","volume":"100","author":"Rodriguez Calvo-de-Mora","year":"2022","journal-title":"Acta Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0764","doi-asserted-by":"crossref","DOI":"10.1016\/j.clae.2023.102091","article-title":"Platelet-rich plasma for treating dry eye disease - A systematic review and meta-analysis","volume":"47","author":"Kwaku Akowuah","year":"2024","journal-title":"Cont Lens Anterior Eye"},{"issue":"2","key":"10.1016\/j.ajo.2025.11.024_bib0765","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s40123-017-0100-z","article-title":"Treatment of Dry Eye Disease with Autologous Platelet-Rich Plasma: A Prospective, Interventional, Non-Randomized Study","volume":"6","author":"Alio","year":"2017","journal-title":"Ophthalmol Ther."},{"key":"10.1016\/j.ajo.2025.11.024_bib0766","article-title":"Randomised, prospective clinical trial of platelet-rich plasma injection in the management of severe dry eye","author":"Avila","year":"2018","journal-title":"The British journal of ophthalmology"},{"issue":"2","key":"10.1016\/j.ajo.2025.11.024_bib0767","doi-asserted-by":"crossref","first-page":"e170","DOI":"10.1111\/aos.13907","article-title":"Efficacy and safety of treatment of hyposecretory dry eye with platelet-rich plasma","volume":"97","author":"Garcia-Conca","year":"2019","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.ajo.2025.11.024_bib0768","doi-asserted-by":"crossref","first-page":"3195","DOI":"10.2147\/OPTH.S265701","article-title":"Human Platelets and Derived Products in Treating Ocular Surface Diseases - A Systematic Review","volume":"14","author":"You","year":"2020","journal-title":"Clin Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0769","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-46671-2","article-title":"Efficacy and safety of platelet-rich plasma and autologous-serum eye drops for dry eye in primary Sjogren's syndrome: a randomized trial","volume":"13","author":"Kang","year":"2023","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.ajo.2025.11.024_bib0770","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1002\/cre2.26","article-title":"Basic characteristics of plasma rich in growth factors (PRGF): blood cell components and biological effects","volume":"2","author":"Nishiyama","year":"2016","journal-title":"Clin Exp Dent Res."},{"issue":"2","key":"10.1016\/j.ajo.2025.11.024_bib0771","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1159\/000487951","article-title":"Plasma Rich in Growth Factors for the Treatment of Dry Eye after LASIK Surgery","volume":"60","author":"Sanchez-Avila","year":"2018","journal-title":"Ophthalmic research"},{"key":"10.1016\/j.ajo.2025.11.024_bib0772","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jtos.2022.04.007","article-title":"A multicenter report of the use of plasma rich in growth factors (PRGF) for the treatment of patients with ocular surface diseases in North America","volume":"25","author":"Soifer","year":"2022","journal-title":"Ocul Surf"},{"issue":"5","key":"10.1016\/j.ajo.2025.11.024_bib0773","article-title":"Impact of Plasma Rich in Growth Factors (PRGF) Eye Drops on Ocular Redness and Symptomatology in Patients with Dry Eye Disease","volume":"59","author":"Lozano-Sanroma","year":"2023","journal-title":"Medicina (Kaunas, Lithuania)"},{"issue":"5","key":"10.1016\/j.ajo.2025.11.024_bib0774","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12051841","article-title":"Recovery of Corneal Innervation after Treatment in Dry Eye Disease: A Confocal Microscopy Study","volume":"12","author":"Barros","year":"2023","journal-title":"J Clin Med."},{"issue":"9","key":"10.1016\/j.ajo.2025.11.024_bib0775","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12093126","article-title":"The Comparison between the Composition of 100% Autologous Serum and 100% Platelet-Rich Plasma Eye Drops and Their Impact on the Treatment Effectiveness of Dry Eye Disease in Primary Sjogren Syndrome","volume":"12","author":"Wrobel-Dudzinska","year":"2023","journal-title":"J Clin Med"},{"issue":"9","key":"10.1016\/j.ajo.2025.11.024_bib0776","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1097\/ICO.0000000000002943","article-title":"Short-term Efficacy and Safety of Biological Tear Substitutes and Topical Secretagogues for Dry Eye Disease: A Systematic Review and Network Meta-analysis","volume":"41","author":"Jongkhajornpong","year":"2022","journal-title":"Cornea"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0777","doi-asserted-by":"crossref","DOI":"10.1136\/bmjophth-2024-001857","article-title":"Efficacy of 100% autologous platelet-rich plasma and 100% autologous serum in dry eye disease: a randomised controlled trial","volume":"9","author":"Jongkhajornpong","year":"2024","journal-title":"BMJ Open Ophthalmol."},{"issue":"9","key":"10.1016\/j.ajo.2025.11.024_bib0778","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.18240\/ijo.2024.09.10","article-title":"Effect of autologous serum after amniotic membrane transplantation for persistent corneal ulcers","volume":"17","author":"Hristova","year":"2024","journal-title":"International journal of ophthalmology"},{"issue":"3","key":"10.1016\/j.ajo.2025.11.024_bib0779","doi-asserted-by":"crossref","first-page":"82","DOI":"10.4068\/cmj.2014.50.3.82","article-title":"Use of umbilical cord serum in ophthalmology","volume":"50","author":"Yoon","year":"2014","journal-title":"Chonnam medical journal"},{"issue":"5","key":"10.1016\/j.ajo.2025.11.024_bib0780","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1089\/jop.2023.0155","article-title":"Blood-Derived Eye Drops for the Treatment of Corneal Neuropathic Pain","volume":"40","author":"Anam","year":"2024","journal-title":"J Ocul Pharmacol Ther"},{"issue":"21","key":"10.1016\/j.ajo.2025.11.024_bib0781","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12216750","article-title":"Allogeneic Umbilical Cord Plasma Eyedrops for the Treatment of Recalcitrant Dry Eye Disease Patients","volume":"12","author":"Wong","year":"2023","journal-title":"J Clin Med."},{"issue":"8","key":"10.1016\/j.ajo.2025.11.024_bib0782","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1097\/ICO.0000000000001257","article-title":"Efficacy of 2-Month Treatment With Cord Blood Serum Eye Drops in Ocular Surface Disease: An In Vivo Confocal Microscopy Study","volume":"36","author":"Giannaccare","year":"2017","journal-title":"Cornea."},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0783","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ajo.2007.03.016","article-title":"Comparison of autologous serum and umbilical cord serum eye drops for dry eye syndrome","volume":"144","author":"Yoon","year":"2007","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0784","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.clae.2010.08.004","article-title":"Simple finger prick fresh blood technique for use on the ocular surface","volume":"34","author":"Sharma","year":"2011","journal-title":"Cont Lens Anterior Eye."},{"issue":"10","key":"10.1016\/j.ajo.2025.11.024_bib0785","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-026770","article-title":"The feasibility of finger prick autologous blood (FAB) as a novel treatment for severe dry eye disease (DED): protocol for a randomised controlled trial","volume":"8","author":"Balal","year":"2018","journal-title":"BMJ Open."},{"issue":"5","key":"10.1016\/j.ajo.2025.11.024_bib0786","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1097\/ICO.0000000000002230","article-title":"Finger-Prick Autologous Blood in the Treatment of Persistent Corneal Epithelial Defects","volume":"39","author":"Balal","year":"2020","journal-title":"Cornea"},{"key":"10.1016\/j.ajo.2025.11.024_bib0787","doi-asserted-by":"crossref","first-page":"3973","DOI":"10.2147\/OPTH.S384586","article-title":"Finger-Prick Autologous Blood (FAB) Eye Drops for Dry Eye Disease: Single Masked Multi-Centre Randomised Controlled Trial","volume":"16","author":"Hassan","year":"2022","journal-title":"Clin Ophthalmol"},{"issue":"12","key":"10.1016\/j.ajo.2025.11.024_bib0788","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1038\/eye.2017.118","article-title":"Fingerprick autologous blood: a novel treatment for dry eye syndrome","volume":"31","author":"Than","year":"2017","journal-title":"Eye (Lond)"},{"issue":"9","key":"10.1016\/j.ajo.2025.11.024_bib0789","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1097\/ICO.0000000000002624","article-title":"Fingerprick Autologous Blood in the Treatment of Severe Dry Eyes and Ocular Surface Disease","volume":"40","author":"Erikitola","year":"2021","journal-title":"Cornea"},{"issue":"10","key":"10.1016\/j.ajo.2025.11.024_bib0790","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/j.joca.2020.05.009","article-title":"Lubricin in experimental and naturally occurring osteoarthritis: a systematic review","volume":"28","author":"Watkins","year":"2020","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.ajo.2025.11.024_bib0791","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.exer.2014.06.015","article-title":"Characterization of full-length recombinant human Proteoglycan 4 as an ocular surface boundary lubricant","volume":"127","author":"Samsom","year":"2014","journal-title":"Exp Eye Res"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0792","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jtos.2016.08.004","article-title":"A Two-Week, Randomized, Double-masked Study to Evaluate Safety and Efficacy of Lubricin (150 ug\/mL) Eye Drops Versus Sodium Hyaluronate (HA) 0.18% Eye Drops (Vismed(R)) in Patients with Moderate Dry Eye Disease","volume":"15","author":"Lambiase","year":"2017","journal-title":"Ocul Surf"},{"key":"10.1016\/j.ajo.2025.11.024_bib0793","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2023.109643","article-title":"A structural and functional comparison between two recombinant human lubricin proteins: Recombinant human proteoglycan-4 (rhPRG4) vs ECF843","volume":"235","author":"Menon","year":"2023","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.ajo.2025.11.024_bib0794","doi-asserted-by":"crossref","first-page":"677","DOI":"10.2147\/OPTH.S162203","article-title":"Treatment outcomes in the DRy Eye Amniotic Membrane (DREAM) study","volume":"12","author":"McDonald","year":"2018","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.ajo.2025.11.024_bib0795","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.2147\/OPTH.S423040","article-title":"Association of Treatment Duration and Clinical Outcomes in Dry Eye Treatment with Sutureless Cryopreserved Amniotic Membrane","volume":"17","author":"McDonald","year":"2023","journal-title":"Clin Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0796","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s12962-020-00252-6","article-title":"Cost utility analysis of cryopreserved amniotic membrane versus topical cyclosporine for the treatment of moderate to severe dry eye syndrome","volume":"18","author":"Voigt","year":"2020","journal-title":"Cost Eff Resour Alloc"},{"issue":"11","key":"10.1016\/j.ajo.2025.11.024_bib0797","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1097\/ICO.0000000000003491","article-title":"Clinical Outcomes and Indications of In-Office Sutureless Dried Gamma Ray-Sterilized Human Amniotic Membrane Transplantation With Bandage Contact Lenses in Various Ocular Surface Disorders","volume":"43","author":"Jo","year":"2024","journal-title":"Cornea"},{"issue":"6","key":"10.1016\/j.ajo.2025.11.024_bib0798","article-title":"Sutureless Dehydrated Amniotic Membrane (Omnigen) Application Using a Specialised Bandage Contact Lens (OmniLenz) for the Treatment of Dry Eye Disease: A 6-Month Randomised Control Trial","volume":"60","author":"Trave-Huarte","year":"2024","journal-title":"Medicina (Kaunas, Lithuania)"},{"key":"10.1016\/j.ajo.2025.11.024_bib0799","article-title":"Spotlight on Amniotic Membrane Extract Eye Drops: A Review of the Literature","author":"Kilian","year":"2024","journal-title":"Eye Contact Lens"},{"issue":"Pt A","key":"10.1016\/j.ajo.2025.11.024_bib0801","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/978-1-4615-0717-8_75","article-title":"Nerve growth factor (NGF): an important molecule for trophism and healing of the ocular surface","volume":"506","author":"Bonini","year":"2002","journal-title":"Adv Exp Med Biol"},{"issue":"5","key":"10.1016\/j.ajo.2025.11.024_bib0800","first-page":"1063","article-title":"Nerve growth factor promotes corneal healing: structural, biochemical, and molecular analyses of rat and human corneas","volume":"41","author":"Lambiase","year":"2000","journal-title":"Invest Ophthalmol Vis Sci."},{"issue":"4","key":"10.1016\/j.ajo.2025.11.024_bib0802","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1097\/ICU.0b013e3283543b61","article-title":"Nerve growth factor therapy for corneal disease","volume":"23","author":"Lambiase","year":"2012","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.ajo.2025.11.024_bib0803","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.preteyeres.2018.04.003","article-title":"Neurotrophic keratopathy","volume":"66","author":"Dua","year":"2018","journal-title":"Prog Retin Eye Res."},{"issue":"5","key":"10.1016\/j.ajo.2025.11.024_bib0804","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s40265-020-01289-w","article-title":"Cenegermin: A Review in Neurotrophic Keratitis","volume":"80","author":"Deeks","year":"2020","journal-title":"Drugs."},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0805","first-page":"127","article-title":"Effect of recombinant human nerve growth factor eye drops in patients with dry eye: a phase IIa, open label, multiple-dose study","volume":"104","author":"Sacchetti","year":"2020","journal-title":"The British journal of ophthalmology"},{"issue":"9","key":"10.1016\/j.ajo.2025.11.024_bib0806","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/j.ophtha.2018.02.022","article-title":"Phase II Randomized, Double Masked, Vehicle-Controlled Trial of Recombinant Human Nerve Growth Factor for Neurotrophic Keratitis","volume":"125","author":"Bonini","year":"2018","journal-title":"Ophthalmology."},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0807","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ophtha.2019.08.020","article-title":"Topical Recombinant Human Nerve Growth Factor (Cenegermin) for Neurotrophic Keratopathy: A Multicenter Randomized Vehicle-Controlled Pivotal Trial","volume":"127","author":"Pflugfelder","year":"2020","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0808","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24010554","article-title":"0.1% RGN-259 (Thymosin ss4) Ophthalmic Solution Promotes Healing and Improves Comfort in Neurotrophic Keratopathy Patients in a Randomized, Placebo-Controlled, Double-Masked Phase III Clinical Trial","volume":"24","author":"Sosne","year":"2022","journal-title":"Int J Mol Sci."},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0809","article-title":"RGN-259 (thymosin beta4) improves clinically important dry eye efficacies in comparison with prescription drugs in a dry eye model","volume":"8","author":"Kim","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.ajo.2025.11.024_bib0810","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2020.108115","article-title":"Biological functions of tear film","volume":"197","author":"Pflugfelder","year":"2020","journal-title":"Exp Eye Res"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0811","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.engreg.2023.11.002","article-title":"Applications of silk-based biomaterials in biomedicine and biotechnology","volume":"5","author":"Babu","year":"2024","journal-title":"Engineered Regeneration"},{"issue":"Pt 1","key":"10.1016\/j.ajo.2025.11.024_bib0812","article-title":"Effect of silk fibroin protein hydrolysis on biochemistry, gelation kinetics, and NF-kB bioactivity in vitro","volume":"272","author":"Lawrence","year":"2024","journal-title":"Int J Biol Macromol"},{"issue":"5","key":"10.1016\/j.ajo.2025.11.024_bib0813","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.3892\/ijmm.2012.1120","article-title":"Silk fibroin hydrolysate inhibits osteoclastogenesis and induces apoptosis of osteoclasts derived from RAW 264.7 cells","volume":"30","author":"Chon","year":"2012","journal-title":"Int J Mol Med."},{"issue":"9","key":"10.1016\/j.ajo.2025.11.024_bib0814","article-title":"Silk-derived protein-4 (SDP-4) inhibits nuclear factor Kappa B (NF-\u03baB) inflammatory signaling that underlies dry eye disease (DED)","volume":"60","author":"Infanger","year":"2019","journal-title":"Investigative Ophthalmology & Visual Science"},{"key":"10.1016\/j.ajo.2025.11.024_bib0815","doi-asserted-by":"crossref","DOI":"10.1016\/j.jff.2022.104942","article-title":"Silk fibroin hydrolysate improves memory impairment via multi-target function","volume":"89","author":"Yao","year":"2022","journal-title":"Journal of Functional Foods"},{"key":"10.1016\/j.ajo.2025.11.024_bib0816","article-title":"Effects of silk fibroin in murine dry eye","volume":"7","author":"Kim","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.ajo.2025.11.024_bib0817","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.ajo.2024.08.034","article-title":"Silk-Derived Protein-4 Versus Vehicle Control in Treating Patients With Moderate to Severe Dry Eye Disease: A Randomized Clinical Trial","volume":"269","author":"Lawrence","year":"2025","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2025.11.024_bib0818","first-page":"963","article-title":"Identification of insulin in the tear film and insulin receptor and IGF-1 receptor on the human ocular surface","volume":"43","author":"Rocha","year":"2002","journal-title":"Invest Ophthalmol Vis Sci."},{"issue":"2","key":"10.1016\/j.ajo.2025.11.024_bib0819","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1385\/ENDO:18:2:191","article-title":"Impact of gender on insulin signaling pathway in lacrimal and salivary glands of rats","volume":"18","author":"Rocha","year":"2002","journal-title":"Endocrine"},{"issue":"8","key":"10.1016\/j.ajo.2025.11.024_bib0820","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/j.bbagen.2007.05.002","article-title":"Extra-pancreatic insulin production in RAt lachrymal gland after streptozotocin-induced islet beta-cells destruction","volume":"1770","author":"Cunha","year":"2007","journal-title":"Biochim Biophys Acta"},{"issue":"14","key":"10.1016\/j.ajo.2025.11.024_bib0821","doi-asserted-by":"crossref","first-page":"6105","DOI":"10.1167\/iovs.17-22425","article-title":"Tear Levels of Insulin-Like Growth Factor Binding Protein 3 Correlate With Subbasal Nerve Plexus Changes in Patients With Type 2 Diabetes Mellitus","volume":"58","author":"Stuard","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"10.1016\/j.ajo.2025.11.024_bib0822","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jtos.2012.01.004","article-title":"Elevated IGFBP3 levels in diabetic tears: a negative regulator of IGF-1 signaling in the corneal epithelium","volume":"10","author":"Wu","year":"2012","journal-title":"Ocul Surf."},{"issue":"3","key":"10.1016\/j.ajo.2025.11.024_bib0823","first-page":"208","article-title":"Topical insulin for healing of diabetic epithelial defects?: A retrospective review of corneal debridement during vitreoretinal surgery in Malaysian patients","volume":"68","author":"Bastion","year":"2013","journal-title":"Med J Malaysia"},{"issue":"Suppl 1","key":"10.1016\/j.ajo.2025.11.024_bib0824","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1097\/ICL.0000000000000623","article-title":"Short-Term Results of Trial of Topical Insulin for Treatment of Dry Eyes in Diabetics","volume":"46","author":"Aniah Azmi","year":"2020","journal-title":"Eye Contact Lens"},{"issue":"5","key":"10.1016\/j.ajo.2025.11.024_bib0825","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1167\/iovs.14-16337","article-title":"The impact of conjunctivochalasis on dry eye symptoms and signs","volume":"56","author":"Chhadva","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"10.1016\/j.ajo.2025.11.024_bib0826","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.survophthal.2017.10.010","article-title":"Conjunctivochalasis: a systematic review","volume":"63","author":"Marmalidou","year":"2018","journal-title":"Surv Ophthalmol"},{"issue":"11","key":"10.1016\/j.ajo.2025.11.024_bib0827","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1097\/01.opx.0000232814.39651.fa","article-title":"The features of dry eye disease in a Japanese elderly population","volume":"83","author":"Uchino","year":"2006","journal-title":"Optom Vis Sci."},{"issue":"8","key":"10.1016\/j.ajo.2025.11.024_bib0828","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/j.ophtha.2013.01.007","article-title":"Conjunctivochalasis interferes with tear flow from fornix to tear meniscus","volume":"120","author":"Huang","year":"2013","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.ajo.2025.11.024_bib0829","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1167\/iovs.14-15908","article-title":"Impact of conjunctival folds on central tear meniscus height","volume":"56","author":"Pult","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0830","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/00002341-198601040-00005","article-title":"Conjunctivochalasis. A cause of tearing and its management","volume":"2","author":"Liu","year":"1986","journal-title":"Ophthalmic Plast Reconstr Surg"},{"issue":"4","key":"10.1016\/j.ajo.2025.11.024_bib0831","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1097\/IOP.0b013e3182831dd3","article-title":"Medial conjunctival resection for tearing associated with conjunctivochalasis","volume":"29","author":"Petris","year":"2013","journal-title":"Ophthalmic Plast Reconstr Surg"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0832","article-title":"The Location of Conjunctivochalasis and Its Clinical Correlation with the Severity of Dry Eye Symptoms","volume":"5","author":"Dalianis","year":"2018","journal-title":"Medicines (Basel)"},{"key":"10.1016\/j.ajo.2025.11.024_bib0833","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.jtos.2022.02.002","article-title":"Effects of meibomian gland dysfunction and aqueous deficiency on friction-related disease","volume":"26","author":"Ahn","year":"2022","journal-title":"Ocul Surf"},{"key":"10.1016\/j.ajo.2025.11.024_bib0834","doi-asserted-by":"crossref","DOI":"10.1038\/srep37570","article-title":"Evaluation of the Effects of Conjunctivochalasis Excision on Tear Stability and Contrast Sensitivity","volume":"6","author":"Qiu","year":"2016","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.ajo.2025.11.024_bib0835","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.jtos.2019.04.008","article-title":"Medical and surgical management of conjunctivochalasis","volume":"17","author":"Marmalidou","year":"2019","journal-title":"Ocul Surf."},{"issue":"10","key":"10.1016\/j.ajo.2025.11.024_bib0836","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1097\/ICO.0000000000003464","article-title":"Comparison of 2 Different Treatments for Conjunctivochalasis: Plasma-Based Conjunctivoplasty Versus Argon Laser Photocoagulation","volume":"43","author":"Ucar","year":"2024","journal-title":"Cornea"},{"issue":"2","key":"10.1016\/j.ajo.2025.11.024_bib0837","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/ICO.0000000000003276","article-title":"Alternative Approach for the Treatment of Conjunctivochalasis: Plasma-Based Conjunctivoplasty","volume":"43","author":"Ucar","year":"2024","journal-title":"Cornea"},{"issue":"3","key":"10.1016\/j.ajo.2025.11.024_bib0838","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s40123-023-00877-9","article-title":"The Influence of Lid-Parallel Conjunctival Folds and Conjunctivochalasis on Dry Eye Symptoms with and Without Contact Lens Wear: A Review of the Literature","volume":"13","author":"Ballesteros-Sanchez","year":"2024","journal-title":"Ophthalmol Ther"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0839","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1038\/s41598-021-82088-5","article-title":"The correction of conjunctivochalasis using high-frequency radiowave electrosurgery improves dry eye disease","volume":"11","author":"Ji","year":"2021","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0840","article-title":"A Quick Surgical Treatment of Conjunctivochalasis Using Radiofrequencies","volume":"6","author":"Trivli","year":"2018","journal-title":"Healthcare (Basel)"},{"issue":"7","key":"10.1016\/j.ajo.2025.11.024_bib0841","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0132656","article-title":"Isotonic Glycerol and Sodium Hyaluronate Containing Artificial Tear Decreases Conjunctivochalasis after One and Three Months: A Self-Controlled, Unmasked Study","volume":"10","author":"Kiss","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ajo.2025.11.024_bib0842","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1007\/978-1-4615-5359-5_120","article-title":"Using LIPCOF (lid-parallel conjunctival fold) for assessing the degree of dry eye, it is essential to observe the exact position of that specific fold","volume":"438","author":"Schirra","year":"1998","journal-title":"Adv Exp Med Biol"},{"issue":"2","key":"10.1016\/j.ajo.2025.11.024_bib0843","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1097\/ICO.0000000000002575","article-title":"Systematic Review: Effects of Pterygium and Pingueculum on the Ocular Surface and Efficacy of Surgical Excision","volume":"40","author":"Linaburg","year":"2021","journal-title":"Cornea"},{"key":"10.1016\/j.ajo.2025.11.024_bib0844","article-title":"The Improvement of Dry Eye Symptoms after Pinguecula Excision and Conjunctival Autograft with Fibrin Glue","volume":"2019","author":"Jeong","year":"2019","journal-title":"J Ophthalmol"},{"key":"10.1016\/j.ajo.2025.11.024_bib0845","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2024.109900","article-title":"Risk factors for pterygium: Latest research progress on major pathogenesis","volume":"243","author":"Ding","year":"2024","journal-title":"Exp Eye Res"},{"issue":"11","key":"10.1016\/j.ajo.2025.11.024_bib0846","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2013-003787","article-title":"Geographical prevalence and risk factors for pterygium: a systematic review and meta-analysis","volume":"3","author":"Liu","year":"2013","journal-title":"BMJ Open"},{"issue":"4","key":"10.1016\/j.ajo.2025.11.024_bib0847","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1159\/000493544","article-title":"Dry-Eye Disease in Recurrent Pterygium","volume":"61","author":"Tan","year":"2019","journal-title":"Ophthalmic research"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0848","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/OPX.0000000000002084","article-title":"The unique properties of tear film breakup process in patients with nasal unilateral pterygium","volume":"101","author":"Chang","year":"2024","journal-title":"Optom Vis Sci"},{"issue":"3","key":"10.1016\/j.ajo.2025.11.024_bib0849","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/OPX.0000000000001996","article-title":"The Influence of Pterygium on Meibomian Glands and Dry Eye Parameters","volume":"100","author":"Devebacak","year":"2023","journal-title":"Optom Vis Sci"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0850","article-title":"Effect of pterygium surgery on tear osmolarity","volume":"2013","author":"Turkyilmaz","year":"2013","journal-title":"J Ophthalmol"},{"issue":"10","key":"10.1016\/j.ajo.2025.11.024_bib0851","doi-asserted-by":"crossref","first-page":"5899","DOI":"10.4103\/jfmpc.jfmpc_790_22","article-title":"Ophthalmic manifestations of nutritional deficiencies: A mini review","volume":"11","author":"Serhan","year":"2022","journal-title":"J Family Med Prim Care"},{"key":"10.1016\/j.ajo.2025.11.024_bib0852","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1388787","article-title":"Recommendations for nutritional supplements for dry eye disease: current advances","volume":"15","author":"Cong","year":"2024","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.ajo.2025.11.024_bib0853","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/978-3-030-21735-8_3","article-title":"Immunoresolvent Resolvin D1 Maintains the Health of the Ocular Surface","volume":"1161","author":"Dartt","year":"2019","journal-title":"Adv Exp Med Biol"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0854","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1476-9255-11-6","article-title":"Anti-inflammatory effects of resolvin-D1 on human corneal epithelial cells: in vitro study","volume":"11","author":"Erdinest","year":"2014","journal-title":"J Inflamm (Lond)"},{"issue":"4","key":"10.1016\/j.ajo.2025.11.024_bib0855","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.2353\/ajpath.2010.100322","article-title":"Novel lipid mediators and resolution mechanisms in acute inflammation: to resolve or not?","volume":"177","author":"Serhan","year":"2010","journal-title":"Am J Pathol"},{"issue":"5","key":"10.1016\/j.ajo.2025.11.024_bib0856","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1089\/jop.2010.0019","article-title":"Resolvin E1 improves tear production and decreases inflammation in a dry eye mouse model","volume":"26","author":"Li","year":"2010","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1016\/j.ajo.2025.11.024_bib0857","doi-asserted-by":"crossref","DOI":"10.1194\/jlr.TR120000954","article-title":"Docosanoid signaling modulates corneal nerve regeneration: effect on tear secretion, wound healing, and neuropathic pain","volume":"62","author":"Pham","year":"2021","journal-title":"J Lipid Res"},{"issue":"2","key":"10.1016\/j.ajo.2025.11.024_bib0858","first-page":"136","article-title":"Omega-3 fatty acids, pro-inflammatory signaling and neuroprotection","volume":"10","author":"Bazan","year":"2007","journal-title":"Curr Opin Clin Nutr Metab Care"},{"issue":"2","key":"10.1016\/j.ajo.2025.11.024_bib0859","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/aos.13844","article-title":"Role of corneal nerves in ocular surface homeostasis and disease","volume":"97","author":"Labetoulle","year":"2019","journal-title":"Acta Ophthalmol."},{"issue":"9","key":"10.1016\/j.ajo.2025.11.024_bib0860","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1038\/s41433-022-02259-0","article-title":"Association between systemic omega-3 polyunsaturated fatty acid levels, and corneal nerve structure and function","volume":"37","author":"Britten-Jones","year":"2023","journal-title":"Eye (Lond)"},{"issue":"12","key":"10.1016\/j.ajo.2025.11.024_bib0861","article-title":"Omega-3 and omega-6 polyunsaturated fatty acids for dry eye disease","volume":"12","author":"Downie","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"issue":"18","key":"10.1016\/j.ajo.2025.11.024_bib0862","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1056\/NEJMoa1709691","article-title":"n-3 Fatty Acid Supplementation for the Treatment of Dry Eye Disease","volume":"378","author":"Asbell","year":"2018","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.ajo.2025.11.024_bib0863","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.jtos.2019.08.003","article-title":"Why DREAM should make you think twice about recommending Omega-3 supplements","volume":"17","author":"Asbell","year":"2019","journal-title":"Ocul Surf"},{"issue":"4","key":"10.1016\/j.ajo.2025.11.024_bib0864","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24044236","article-title":"Polymorphisms in Lymphotoxin-Alpha as the \"Missing Link\" in Prognosticating Favourable Response to Omega-3 Supplementation for Dry Eye Disease: A Narrative Review","volume":"24","author":"Paik","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.ajo.2025.11.024_bib0865","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.4103\/IJO.IJO_2789_22","article-title":"Omega-3 fatty acids supplements for dry eye - Are they effective or ineffective?","volume":"71","author":"Bhargava","year":"2023","journal-title":"Indian J Ophthalmol"},{"issue":"22","key":"10.1016\/j.ajo.2025.11.024_bib0866","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12227026","article-title":"Efficacy of Omega-3 Intake in Managing Dry Eye Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials","volume":"12","author":"Wang","year":"2023","journal-title":"J Clin Med."},{"issue":"4","key":"10.1016\/j.ajo.2025.11.024_bib0867","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1093\/ajcn\/82.4.887","article-title":"Relation between dietary n-3 and n-6 fatty acids and clinically diagnosed dry eye syndrome in women","volume":"82","author":"Miljanovic","year":"2005","journal-title":"Am J Clin Nutr"},{"issue":"6","key":"10.1016\/j.ajo.2025.11.024_bib0868","doi-asserted-by":"crossref","DOI":"10.3390\/foods10061231","article-title":"Searching for the Antioxidant, Anti-Inflammatory, and Neuroprotective Potential of Natural Food and Nutritional Supplements for Ocular Health in the Mediterranean Population","volume":"10","author":"Valero-Vello","year":"2021","journal-title":"Foods"},{"issue":"5","key":"10.1016\/j.ajo.2025.11.024_bib0869","doi-asserted-by":"crossref","DOI":"10.3390\/nu12051289","article-title":"Effectiveness of Mediterranean Diet Implementation in Dry Eye Parameters: A Study of PREDIMED-PLUS Trial","volume":"12","author":"Molina-Leyva","year":"2020","journal-title":"Nutrients"},{"issue":"4","key":"10.1016\/j.ajo.2025.11.024_bib0870","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/opo.12365","article-title":"Omega-3 supplementation is neuroprotective to corneal nerves in dry eye disease: a pilot study","volume":"37","author":"Chinnery","year":"2017","journal-title":"Ophthalmic Physiol Opt"},{"issue":"4","key":"10.1016\/j.ajo.2025.11.024_bib0871","first-page":"649","article-title":"Oral flaxseed oil (Linum usitatissimum) in the treatment for dry-eye Sjogren's syndrome patients","volume":"70","author":"Pinheiro","year":"2007","journal-title":"Arq Bras Oftalmol"},{"issue":"Suppl 1","key":"10.1016\/j.ajo.2025.11.024_bib0872","doi-asserted-by":"crossref","DOI":"10.2459\/01.JCM.0000289275.72556.13","article-title":"The role of dietary n-6 fatty acids in the prevention of cardiovascular disease","volume":"8","author":"Willett","year":"2007","journal-title":"J Cardiovasc Med (Hagerstown)."},{"issue":"4","key":"10.1016\/j.ajo.2025.11.024_bib0873","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1093\/ajcn\/79.4.606","article-title":"Dietary intake of trans fatty acids and systemic inflammation in women","volume":"79","author":"Mozaffarian","year":"2004","journal-title":"Am J Clin Nutr"},{"issue":"21","key":"10.1016\/j.ajo.2025.11.024_bib0874","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232113156","article-title":"Topical Omega-3 Fatty Acids Eyedrops in the Treatment of Dry Eye and Ocular Surface Disease: A Systematic Review","volume":"23","author":"Paik","year":"2022","journal-title":"Int J Mol Sci."},{"issue":"6","key":"10.1016\/j.ajo.2025.11.024_bib0875","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1167\/iovs.63.6.1","article-title":"Corneal Epithelium-Derived Netrin-1 Alleviates Dry Eye Disease via Regulating Dendritic Cell Activation","volume":"63","author":"Yu","year":"2022","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajo.2025.11.024_bib0876","series-title":"Present Knowledge in Nutrition","first-page":"73","article-title":"Vitamin A and provitamin A carotenoids","author":"Blaner","year":"2020"},{"issue":"17","key":"10.1016\/j.ajo.2025.11.024_bib0877","doi-asserted-by":"crossref","first-page":"3703","DOI":"10.1080\/10408398.2016.1160362","article-title":"The vicious cycle of vitamin a deficiency: A review","volume":"57","author":"Wiseman","year":"2017","journal-title":"Critical Reviews in Food Science and Nutrition"},{"issue":"7","key":"10.1016\/j.ajo.2025.11.024_bib0878","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1111\/jpc.13243","article-title":"Vitamin A deficiency and xerophthalmia in children of a developed country","volume":"52","author":"Chiu","year":"2016","journal-title":"J Paediatr Child Health"},{"key":"10.1016\/j.ajo.2025.11.024_bib0879","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2015-209413","article-title":"Xerophthalmia and vitamin A deficiency in an autistic child with a restricted diet","volume":"2015","author":"Chiu","year":"2015","journal-title":"BMJ Case Rep"},{"issue":"5","key":"10.1016\/j.ajo.2025.11.024_bib0880","doi-asserted-by":"crossref","first-page":"287","DOI":"10.5694\/mja11.10292","article-title":"Tunnel vision and night blindness in a 52-year-old man","volume":"195","author":"Sanli","year":"2011","journal-title":"Med J Aust."},{"key":"10.1016\/j.ajo.2025.11.024_bib0881","doi-asserted-by":"crossref","first-page":"599","DOI":"10.2147\/OPTH.S198349","article-title":"Effects of short-term oral vitamin A supplementation on the ocular tear film in patients with dry eye","volume":"13","author":"Alanazi","year":"2019","journal-title":"Clin Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajo.2025.11.024_bib0882","first-page":"127","article-title":"Efficacy of 0.05% cyclosporine A combined with vitamin A palmitate in the treatment of meibomian gland dysfunction-related dry eye","volume":"60","author":"Hao","year":"2024","journal-title":"Zhonghua Yan Ke Za Zhi"},{"issue":"3","key":"10.1016\/j.ajo.2025.11.024_bib0883","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s00417-014-2853-6","article-title":"Evaluation of oxidative stress levels in the conjunctival epithelium of patients with or without dry eye, and dry eye patients treated with preservative-free hyaluronic acid 0.15 % and vitamin B12 eye drops","volume":"253","author":"Macri","year":"2015","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2025.11.024_bib0884","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.4103\/IJO.IJO_3174_22","article-title":"Vitamin D and eye: Current evidence and practice guidelines","volume":"71","author":"Gorimanipalli","year":"2023","journal-title":"Indian J Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajo.2025.11.024_bib0885","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1080\/08164622.2022.2033601","article-title":"Effect of oral vitamin D supplementation on dry eye disease patients with vitamin D deficiency","volume":"106","author":"Najjaran","year":"2023","journal-title":"Clin Exp Optom"},{"issue":"9225","key":"10.1016\/j.ajo.2025.11.024_bib0886","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0140-6736(00)02490-9","article-title":"The importance of selenium to human health","volume":"356","author":"Rayman","year":"2000","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.ajo.2025.11.024_bib0887","doi-asserted-by":"crossref","first-page":"e9911","DOI":"10.1371\/journal.pone.0009911","article-title":"Selenoprotein P controls oxidative stress in cornea","volume":"5","author":"Higuchi","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.ajo.2025.11.024_bib0888","doi-asserted-by":"crossref","first-page":"731","DOI":"10.2147\/OPTH.S175321","article-title":"Acupuncture and dry eye: current perspectives. A double-blinded randomized controlled trial and review of the literature","volume":"13","author":"Dhaliwal","year":"2019","journal-title":"Clin Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajo.2025.11.024_bib0889","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1007\/s11684-022-0923-4","article-title":"Acupuncture for the management of dry eye disease","volume":"16","author":"Prinz","year":"2022","journal-title":"Front Med"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0890","doi-asserted-by":"crossref","DOI":"10.1016\/j.imr.2020.100456","article-title":"Acupuncture for dry eye syndrome after refractive surgery: A randomized controlled pilot trial","volume":"10","author":"Lee","year":"2021","journal-title":"Integr Med Res"},{"issue":"22","key":"10.1016\/j.ajo.2025.11.024_bib0891","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000010875","article-title":"Effect of laser acupuncture on dry eye: A study protocol for a 2-center randomized controlled trial","volume":"97","author":"Hu","year":"2018","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"10.1016\/j.ajo.2025.11.024_bib0892","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0306-9877(95)90117-5","article-title":"Acupuncture\u2013from empiricism to science: functional background to acupuncture effects in pain and disease","volume":"45","author":"Andersson","year":"1995","journal-title":"Med Hypotheses"},{"issue":"3-4","key":"10.1016\/j.ajo.2025.11.024_bib0893","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3727\/036012902816025988","article-title":"Is acupuncture an useful tool for pain-treatment in ophthalmology?","volume":"27","author":"Nepp","year":"2002","journal-title":"Acupunct Electrother Res"},{"key":"10.1016\/j.ajo.2025.11.024_bib0894","doi-asserted-by":"crossref","DOI":"10.1093\/ecam\/nem051","article-title":"Acupuncture affects regional blood flow in various organs","author":"Uchida","year":"2008","journal-title":"Evidence-based Complementary and Alternative Medicine"},{"issue":"4","key":"10.1016\/j.ajo.2025.11.024_bib0895","first-page":"258","article-title":"Effects of acupuncture and moxibustion on tear-film of the patients with xerophthalmia","volume":"27","author":"Zhang","year":"2007","journal-title":"J Tradit Chin Med"},{"issue":"3 Pt 1","key":"10.1016\/j.ajo.2025.11.024_bib0896","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1600-0420.2004.00254.x","article-title":"Acupuncture treatment in patients with keratoconjunctivitis sicca: a pilot study","volume":"82","author":"Gronlund","year":"2004","journal-title":"Acta Ophthalmol Scand"},{"key":"10.1016\/j.ajo.2025.11.024_bib0897","article-title":"Acupuncture therapy is more effective than artificial tears for dry eye syndrome: Evidence based on a meta-analysis","author":"Yang","year":"2015","journal-title":"Evidence-based Complementary and Alternative Medicine"},{"key":"10.1016\/j.ajo.2025.11.024_bib0898","first-page":"438","article-title":"Dry eye treatment with acupuncture - A prospective, randomized, double-masked study","author":"Nepp","year":"1998","journal-title":"Advances in Experimental Medicine and Biology"},{"key":"10.1016\/j.ajo.2025.11.024_bib0899","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/492150","article-title":"Fourier-domain optical coherence tomography for monitoring the lower tear meniscus in dry eye after acupuncture treatment","volume":"2015","author":"Lin","year":"2015","journal-title":"Evid Based Complement Alternat Med"},{"issue":"5","key":"10.1016\/j.ajo.2025.11.024_bib0900","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0036638","article-title":"Acupuncture for the treatment of dry eye: a multicenter randomised controlled trial with active comparison intervention (artificial teardrops)","volume":"7","author":"Kim","year":"2012","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.ajo.2025.11.024_bib0901","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1142\/S0192415X10008123","article-title":"Clinical curative effect of acupuncture therapy on xerophthalmia","volume":"38","author":"Gong","year":"2010","journal-title":"Am J Chin Med"},{"issue":"2","key":"10.1016\/j.ajo.2025.11.024_bib0902","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1755-3768.2009.01855.x","article-title":"Acupuncture for treating dry eye: a systematic review","volume":"89","author":"Lee","year":"2011","journal-title":"Acta Ophthalmol"},{"issue":"8","key":"10.1016\/j.ajo.2025.11.024_bib0903","doi-asserted-by":"crossref","first-page":"e328","DOI":"10.1111\/j.1755-3768.2010.02027.x","article-title":"Acupuncture for treating dry eye: a randomized placebo-controlled trial","volume":"88","author":"Shin","year":"2010","journal-title":"Acta Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0904","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000036374","article-title":"Effectiveness of acupuncture combined with artificial tears in managing dry eye syndrome: A systematic review and meta-analysis","volume":"103","author":"Wang","year":"2024","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0905","doi-asserted-by":"crossref","DOI":"10.1136\/bmjophth-2018-000150","article-title":"Acupuncture and herbal formulation compared with artificial tears alone: evaluation of dry eye symptoms and associated tests in randomised clinical trial","volume":"3","author":"Tong","year":"2018","journal-title":"BMJ Open Ophthalmol"},{"key":"10.1016\/j.ajo.2025.11.024_bib0906","first-page":"813","article-title":"A randomized, double-blind, placebocontrolled study of oral antioxidant supplement therapy in patients with dry eye syndrome","volume":"10","author":"Huang","year":"2016","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.ajo.2025.11.024_bib0907","article-title":"Efficacy of Ethanol Extract of Fructus lycii and Its Constituents Lutein\/Zeaxanthin in Protecting Retinal Pigment Epithelium Cells against Oxidative Stress: In Vivo and In Vitro Models of Age-Related Macular Degeneration","volume":"2013","author":"Xu","year":"2013","journal-title":"J Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0908","first-page":"809","article-title":"Effects of Lycium barbarum (goji berry) on dry eye disease in rats","volume":"17","author":"Chien","year":"2018","journal-title":"Mol Med Rep"},{"issue":"2","key":"10.1016\/j.ajo.2025.11.024_bib0909","doi-asserted-by":"crossref","first-page":"181","DOI":"10.5114\/ceji.2019.87070","article-title":"Therapeutic potential of curcumin in eye diseases","volume":"44","author":"Radomska-Lesniewska","year":"2019","journal-title":"Cent Eur J Immunol"},{"issue":"FEB","key":"10.1016\/j.ajo.2025.11.024_bib0910","first-page":"66","article-title":"Curcumin, A Potential Therapeutic Candidate for Anterior Segment Eye Diseases: A Review","volume":"8","author":"Liu","year":"2017","journal-title":"Front Pharmacol"},{"issue":"3","key":"10.1016\/j.ajo.2025.11.024_bib0911","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.exer.2009.12.004","article-title":"Curcumin protects against hyperosmoticity-induced IL-1beta elevation in human corneal epithelial cell via MAPK pathways","volume":"90","author":"Chen","year":"2010","journal-title":"Exp Eye Res"},{"issue":"18","key":"10.1016\/j.ajo.2025.11.024_bib0912","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph16183229","article-title":"Achyranthis radix Extract Improves Urban Particulate Matter-Induced Dry Eye Disease","volume":"16","author":"Lee","year":"2019","journal-title":"Int J Environ Res Public Health"},{"issue":"6","key":"10.1016\/j.ajo.2025.11.024_bib0913","first-page":"401","article-title":"Effects of ferulic acid on antioxidant activity in Angelicae Sinensis Radix, Chuanxiong Rhizoma, and their combination","volume":"13","author":"Wang","year":"2015","journal-title":"Chin J Nat Med"},{"issue":"12","key":"10.1016\/j.ajo.2025.11.024_bib0914","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1038\/eye.2017.117","article-title":"Topical administration of Esculetin as a potential therapy for experimental dry eye syndrome","volume":"31","author":"Jiang","year":"2017","journal-title":"Eye (Lond)."},{"key":"10.1016\/j.ajo.2025.11.024_bib0915","doi-asserted-by":"crossref","DOI":"10.1097\/ICO.0b013e31821ddd3a","article-title":"Influence of modest changes in whole-body hydration on tear fluid osmolarity: Important considerations for dry eye disease detection","author":"Walsh","year":"2011","journal-title":"Cornea"},{"issue":"10","key":"10.1016\/j.ajo.2025.11.024_bib0916","doi-asserted-by":"crossref","first-page":"6622","DOI":"10.1167\/iovs.12-10175","article-title":"Is whole-body hydration an important consideration in dry eye?","volume":"53","author":"Walsh","year":"2012","journal-title":"Invest Ophthalmol Vis Sci."},{"issue":"8","key":"10.1016\/j.ajo.2025.11.024_bib0917","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1249\/MSS.0b013e31820e7cb6","article-title":"Tear fluid osmolarity as a potential marker of hydration status","volume":"43","author":"Fortes","year":"2011","journal-title":"Med Sci Sports Exerc."},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0918","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/aos.15227","article-title":"The relationship between habitual water intake and dry eye disease","volume":"101","author":"Nguyen","year":"2023","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.ajo.2025.11.024_bib0919","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222011264","article-title":"Diverse mechanisms of antimicrobial activities of lactoferrins, lactoferricins, and other lactoferrin-derived peptides","author":"Gruden","year":"2021","journal-title":"International Journal of Molecular Sciences"},{"issue":"5","key":"10.1016\/j.ajo.2025.11.024_bib0920","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1136\/bjo.68.5.321","article-title":"Diagnostic implications of tear protein profiles","volume":"68","author":"Mackie","year":"1984","journal-title":"The British journal of ophthalmology"},{"issue":"1-2","key":"10.1016\/j.ajo.2025.11.024_bib0921","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/BF00142704","article-title":"Analysis of human tear protein profiles using high performance liquid chromatography (HPLC)","volume":"67","author":"Boukes","year":"1987","journal-title":"Doc Ophthalmol"},{"key":"10.1016\/j.ajo.2025.11.024_bib0922","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtos.2018.11.001","article-title":"A novel and innovative paper based analytical device for assessing tear lactoferrin of dry eye patients","author":"Sonobe","year":"2019","journal-title":"Ocular Surface"},{"issue":"22","key":"10.1016\/j.ajo.2025.11.024_bib0923","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222212384","article-title":"Lactoferrin Ameliorates Dry Eye Disease Potentially through Enhancement of Short-Chain Fatty Acid Production by Gut Microbiota in Mice","volume":"22","author":"Connell","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ajo.2025.11.024_bib0924","doi-asserted-by":"crossref","DOI":"10.1001\/archophthalmol.2011.364","article-title":"Dry eye disease: An immune mediated ocular surface disorder","author":"Stevenson","year":"2012","journal-title":"Archives of Ophthalmology"},{"key":"10.1016\/j.ajo.2025.11.024_bib0925","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21186668","article-title":"Therapeutic effects of lactoferrin in ocular diseases: From dry eye disease to infections","author":"Vagge","year":"2020","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/j.ajo.2025.11.024_bib0926","doi-asserted-by":"crossref","DOI":"10.1016\/j.ophtha.2007.06.027","article-title":"Lactoferrin in Sj\u00f6gren's Syndrome","author":"Dogru","year":"2007","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2025.11.024_bib0927","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/8367846","article-title":"Honey as a Potential Natural Antioxidant Medicine: An Insight into Its Molecular Mechanisms of Action","volume":"2018","author":"Ahmed","year":"2018","journal-title":"Oxid Med Cell Longev"},{"issue":"5","key":"10.1016\/j.ajo.2025.11.024_bib0928","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1080\/08164622.2022.2106779","article-title":"Efficacy and safety of manuka honey for dry eye","volume":"106","author":"Hu","year":"2023","journal-title":"Clin Exp Optom"},{"issue":"5","key":"10.1016\/j.ajo.2025.11.024_bib0929","doi-asserted-by":"crossref","DOI":"10.3390\/ph16050762","article-title":"Honey Related Treatment Strategies in Dry Eye Disease","volume":"16","author":"Prinz","year":"2023","journal-title":"Pharmaceuticals (Basel)"},{"issue":"6","key":"10.1016\/j.ajo.2025.11.024_bib0930","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1111\/cxo.12524","article-title":"Randomised controlled trial of topical antibacterial Manuka (Leptospermum species) honey for evaporative dry eye due to meibomian gland dysfunction","volume":"100","author":"Albietz","year":"2017","journal-title":"Clin Exp Optom"},{"issue":"6","key":"10.1016\/j.ajo.2025.11.024_bib0931","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1136\/bjophthalmol-2020-317506","article-title":"Randomised assessor-masked trial evaluating topical manuka honey (Optimel) in treatment of meibomian gland dysfunction","volume":"106","author":"Li","year":"2022","journal-title":"The British journal of ophthalmology"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0932","doi-asserted-by":"crossref","DOI":"10.1136\/bmjophth-2016-000066","article-title":"Randomised masked trial of the clinical safety and tolerability of MGO Manuka Honey eye cream for the management of blepharitis","volume":"1","author":"Craig","year":"2017","journal-title":"BMJ Open Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajo.2025.11.024_bib0933","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.clae.2017.10.001","article-title":"Treatment of contact lens related dry eye with antibacterial honey","volume":"40","author":"Wong","year":"2017","journal-title":"Cont Lens Anterior Eye"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0934","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0169069","article-title":"Clinical Evaluation of a Royal Jelly Supplementation for the Restoration of Dry Eye: A Prospective Randomized Double Blind Placebo Controlled Study and an Experimental Mouse Model","volume":"12","author":"Inoue","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ajo.2025.11.024_bib0935","article-title":"A novel multi-ingredient supplement significantly improves ocular symptom severity and tear production in patients with dry eye disease: results from a randomized, placebo-controlled clinical trial","volume":"4","author":"Gioia","year":"2024","journal-title":"Original Research. Front Ophthalmol (Lausanne)"},{"issue":"3","key":"10.1016\/j.ajo.2025.11.024_bib0936","doi-asserted-by":"crossref","DOI":"10.3390\/jcm13030748","article-title":"Preventing and Managing Iatrogenic Dry Eye Disease during the Entire Surgical Pathway: A Study Focusing on Patients Undergoing Cataract Surgery","volume":"13","author":"Giannaccare","year":"2024","journal-title":"J Clin Med"},{"issue":"2","key":"10.1016\/j.ajo.2025.11.024_bib0937","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jcjo.2019.07.005","article-title":"Dry eye after refractive surgery: a meta-analysis","volume":"55","author":"Sambhi","year":"2020","journal-title":"Can J Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajo.2025.11.024_bib0938","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.jtos.2017.05.004","article-title":"TFOS DEWS II iatrogenic report","volume":"15","author":"Gomes","year":"2017","journal-title":"Ocul Surf"},{"issue":"6","key":"10.1016\/j.ajo.2025.11.024_bib0939","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.ajo.2014.02.036","article-title":"Evaluation of dry eye and meibomian gland dysfunction after cataract surgery","volume":"157","author":"Han","year":"2014","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2025.11.024_bib0940","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.ajo.2021.04.031","article-title":"Effects of Lipiflow Treatment Prior to Cataract Surgery: A Prospective, Randomized, Controlled Study","volume":"230","author":"Park","year":"2021","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2025.11.024_bib0941","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.2147\/OPTH.S406530","article-title":"Dry Eye Disease as a Cause of Refractive Errors After Cataract Surgery - A Systematic Review","volume":"17","author":"Biela","year":"2023","journal-title":"Clin Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0942","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-77572-7","article-title":"Short-term variability in ocular biometry and the impact of preoperative dry eye","volume":"14","author":"Ahn","year":"2024","journal-title":"Sci Rep"},{"issue":"5","key":"10.1016\/j.ajo.2025.11.024_bib0943","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.jcrs.2019.03.023","article-title":"An algorithm for the preoperative diagnosis and treatment of ocular surface disorders","volume":"45","author":"Starr","year":"2019","journal-title":"J Cataract Refract Surg"},{"issue":"5","key":"10.1016\/j.ajo.2025.11.024_bib0944","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1007\/s40123-023-00740-x","article-title":"Preoperative Treatment of Meibomian Gland Dysfunction with a Vectored Thermal Pulsation System Prior to Extended Depth of Focus IOL Implantation","volume":"12","author":"Matossian","year":"2023","journal-title":"Ophthalmol Ther"},{"issue":"1-2","key":"10.1016\/j.ajo.2025.11.024_bib0945","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1080\/08820538.2021.1881567","article-title":"Preoperative Management of MGD with Vectored Thermal Pulsation before Cataract Surgery: A Prospective, Controlled Clinical Trial","volume":"36","author":"Zhao","year":"2021","journal-title":"Semin Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2025.11.024_bib0946","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/j.jcrs.0000000000001124","article-title":"Efficacy of vector thermal pulsation treatment in reducing postcataract surgery dry eye disease in patients affected by meibomian gland dysfunction","volume":"49","author":"Mencucci","year":"2023","journal-title":"J Cataract Refract Surg"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0947","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s12886-020-01357-5","article-title":"Evaluation of the efficacy of optimal pulsed technology treatment in patients with cataract and Meibomian gland dysfunction in the perioperative period","volume":"20","author":"Ge","year":"2020","journal-title":"BMC Ophthalmol"},{"key":"10.1016\/j.ajo.2025.11.024_bib0948","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/2737968","article-title":"Preoperative Management of MGD Alleviates the Aggravation of MGD and Dry Eye Induced by Cataract Surgery: A Prospective, Randomized Clinical Trial","volume":"2019","author":"Song","year":"2019","journal-title":"Biomed Res Int"},{"issue":"6","key":"10.1016\/j.ajo.2025.11.024_bib0949","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1177\/1120672119867642","article-title":"The effect of tea tree oil on dry eye treatment after phacoemulsification cataract surgery: A randomized clinical trial","volume":"30","author":"Mohammadpour","year":"2020","journal-title":"Eur J Ophthalmol."},{"issue":"3","key":"10.1016\/j.ajo.2025.11.024_bib0950","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.ajo.2005.10.006","article-title":"The incidence and risk factors for developing dry eye after myopic LASIK","volume":"141","author":"De Paiva","year":"2006","journal-title":"Am J Ophthalmol."},{"key":"10.1016\/j.ajo.2025.11.024_bib0951","doi-asserted-by":"crossref","DOI":"10.1038\/s41433-025-03783-5","article-title":"Dry eye disease treatment following refractive surgery among young patients: a population-based study","author":"Nitzan","year":"2025","journal-title":"Eye (Lond)"},{"issue":"3","key":"10.1016\/j.ajo.2025.11.024_bib0952","first-page":"155","article-title":"Intense Pulse Light for Treating Post LASIK Refractory Dry Eye","volume":"39","author":"Pazo","year":"2021","journal-title":"Photobiomodul Photomed Laser Surg"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0953","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3928\/1081597X-20161006-05","article-title":"Effectiveness of an Eyelid Thermal Pulsation Procedure to Treat Recalcitrant Dry Eye Symptoms After Laser Vision Correction","volume":"33","author":"Schallhorn","year":"2017","journal-title":"J Refract Surg"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0954","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1186\/s12886-021-02091-2","article-title":"Effects of warm compress on tear film, blink pattern and Meibomian gland function in dry eyes after corneal refractive surgery","volume":"21","author":"Zhou","year":"2021","journal-title":"BMC Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0955","doi-asserted-by":"crossref","DOI":"10.1016\/j.apjo.2023.100029","article-title":"Perioperative intense pulsed light to prevent and improve symptoms of post-laser corneal refractive surgery dry eye. A randomized clinical trial","volume":"13","author":"Martinez-Hergueta","year":"2024","journal-title":"Asia Pac J Ophthalmol (Phila)"},{"issue":"4","key":"10.1016\/j.ajo.2025.11.024_bib0956","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.4103\/IJO.IJO_3361_22","article-title":"Assessing clinical and molecular outcomes of prophylactic thermal pulsation therapy on ocular surface health following refractive surgery","volume":"71","author":"Shetty","year":"2023","journal-title":"Indian J Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajo.2025.11.024_bib0957","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jcrs.2017.10.050","article-title":"Prevalence of meibomian gland dysfunction at the time of cataract surgery","volume":"44","author":"Cochener","year":"2018","journal-title":"J Cataract Refract Surg"},{"issue":"4","key":"10.1016\/j.ajo.2025.11.024_bib0958","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.4103\/IJO.IJO_2808_22","article-title":"Aqueous-deficient dry eye disease: Preferred practice pattern guidelines on clinical approach, diagnosis, and management","volume":"71","author":"Donthineni","year":"2023","journal-title":"Indian J Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajo.2025.11.024_bib0959","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/ICO.0000000000002384","article-title":"Long-term Outcomes of Punctal Cauterization in the Management of Ocular Surface Diseases","volume":"40","author":"Wang","year":"2021","journal-title":"Cornea"},{"issue":"12","key":"10.1016\/j.ajo.2025.11.024_bib0960","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/S0161-6420(78)35555-X","article-title":"Punctal occlusion in keratoconjunctivitis sicca","volume":"85","author":"Dohlman","year":"1978","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.ajo.2025.11.024_bib0961","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.4103\/IJO.IJO_2572_22","article-title":"Aqueous deficiency dry eye in post conjunctivitis cicatrization - Effect of deep thermal punctal cautery","volume":"71","author":"Agarwal","year":"2023","journal-title":"Indian J Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajo.2025.11.024_bib0962","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1080\/02713683.2020.1833349","article-title":"Changes in Corneal ubbasal Nerves after Punctal Occlusion in Dry Eye Disease","volume":"46","author":"Latifi","year":"2021","journal-title":"Curr Eye Res"},{"issue":"2","key":"10.1016\/j.ajo.2025.11.024_bib0963","doi-asserted-by":"crossref","first-page":"143","DOI":"10.18502\/jovr.v18i2.13179","article-title":"Surgical Punctal Occlusion; Combined Lacrimal Canaliculi Cauterization and Punctal Suturing for Severe Dry Eye","volume":"18","author":"Kuroda","year":"2023","journal-title":"J Ophthalmic Vis Res"},{"key":"10.1016\/j.ajo.2025.11.024_bib0964","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.jtos.2024.08.006","article-title":"Punctal cautery in dry eye disease: A systematic review","volume":"34","author":"Ranjan","year":"2024","journal-title":"Ocul Surf"},{"issue":"10","key":"10.1016\/j.ajo.2025.11.024_bib0965","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1089\/jop.2023.0063","article-title":"Surgical Procedures in the Treatment of Dry Eye Disease","volume":"39","author":"Moller-Hansen","year":"2023","journal-title":"J Ocul Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.ajo.2025.11.024_bib0966","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.4103\/IJO.IJO_2826_22","article-title":"Management of corneal perforations in dry eye disease: Preferred practice pattern guidelines","volume":"71","author":"Kate","year":"2023","journal-title":"Indian J Ophthalmol"},{"issue":"8","key":"10.1016\/j.ajo.2025.11.024_bib0967","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1097\/00003226-200111000-00002","article-title":"Tarsorrhaphy: clinical experience from a cornea practice","volume":"20","author":"Cosar","year":"2001","journal-title":"Cornea"},{"issue":"11","key":"10.1016\/j.ajo.2025.11.024_bib0968","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/S0968-0004(02)02177-1","article-title":"Botulinum and tetanus neurotoxins: structure, function and therapeutic utility","volume":"27","author":"Turton","year":"2002","journal-title":"Trends Biochem Sci"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0969","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.survophthal.2006.10.003","article-title":"Botulinum toxin in ophthalmology","volume":"52","author":"Dutton","year":"2007","journal-title":"Surv Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajo.2025.11.024_bib0970","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1136\/jnnp.51.6.767","article-title":"Blepharospasm: a review of 264 patients","volume":"51","author":"Grandas","year":"1988","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"Pt 5","key":"10.1016\/j.ajo.2025.11.024_bib0971","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/eye.1987.93","article-title":"Botulinum toxin A induced protective ptosis","volume":"1","author":"Adams","year":"1987","journal-title":"Eye (Lond)"},{"issue":"9","key":"10.1016\/j.ajo.2025.11.024_bib0972","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1038\/sj.eye.6702866","article-title":"Anterior chemodenervation of levator palpebrae superioris with botulinum toxin type-A (Botox) to induce temporary ptosis for corneal protection","volume":"22","author":"Naik","year":"2008","journal-title":"Eye (Lond)"},{"issue":"2","key":"10.1016\/j.ajo.2025.11.024_bib0973","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3109\/01676830903324268","article-title":"Transcutaneous dysport injection for treatment of upper eyelid retraction associated with thyroid eye disease","volume":"29","author":"Salour","year":"2010","journal-title":"Orbit"},{"key":"10.1016\/j.ajo.2025.11.024_bib0974","first-page":"105","article-title":"Smet H. Botulinum A-toxin treatment of spasmodic entropion of the lower eyelid","volume":"224","author":"Neetens","year":"1987","journal-title":"Bull Soc Belge Ophtalmol"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0975","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3109\/01676830.2010.544443","article-title":"Botulinum toxin for lower lid entropion correction","volume":"30","author":"Deka","year":"2011","journal-title":"Orbit"},{"issue":"4","key":"10.1016\/j.ajo.2025.11.024_bib0976","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1001\/archophthalmol.2011.2713","article-title":"Botulinum toxin injection for the management of refractory filamentary keratitis","volume":"130","author":"Gumus","year":"2012","journal-title":"Arch Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0977","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s40123-017-0079-5","article-title":"Comparison Between Botulinum Toxin A Injection and Lacrimal Punctal Plugs for the Control of Post-LASIK Dry Eye Manifestations: A Prospective Study","volume":"6","author":"Fouda","year":"2017","journal-title":"Ophthalmol Ther"},{"issue":"4","key":"10.1016\/j.ajo.2025.11.024_bib0978","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0002-9394(99)00408-0","article-title":"Effect of eyelid botulinum toxin injection on lacrimal drainage","volume":"129","author":"Sahlin","year":"2000","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2025.11.024_bib0979","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1159\/000131089","article-title":"Eyelid botulinum toxin injections for the dry eye","volume":"41","author":"Sahlin","year":"2008","journal-title":"Dev Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajo.2025.11.024_bib0980","doi-asserted-by":"crossref","first-page":"e132","DOI":"10.1111\/aos.13140","article-title":"Paralysis of the orbicularis muscle of the eye using botulinum toxin type A in the treatment for dry eye","volume":"95","author":"Serna-Ojeda","year":"2017","journal-title":"Acta Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajo.2025.11.024_bib0981","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s00417-018-4194-3","article-title":"Effects of botulinum toxin type A on the treatment of dry eye disease and tear cytokines","volume":"257","author":"Choi","year":"2019","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajo.2025.11.024_bib0982","doi-asserted-by":"crossref","DOI":"10.3390\/toxins11020066","article-title":"A Review of Periocular Botulinum Neurotoxin on the Tear Film Homeostasis and the Ocular Surface Change","volume":"11","author":"Ho","year":"2019","journal-title":"Toxins (Basel)"},{"issue":"4","key":"10.1016\/j.ajo.2025.11.024_bib0983","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/ana.410130406","article-title":"Blepharospasm and orofacial-cervical dystonia: clinical and pharmacological findings in 100 patients","volume":"13","author":"Jankovic","year":"1983","journal-title":"Ann Neurol"},{"issue":"Pt 4","key":"10.1016\/j.ajo.2025.11.024_bib0984","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/eye.1988.79","article-title":"The significance of ophthalmological symptoms in idiopathic blepharospasm","volume":"2","author":"Elston","year":"1988","journal-title":"Eye (Lond)"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0985","first-page":"67","article-title":"A comparative study of tear secretion in blepharospasm and hemifacial spasm patients treated with botulinum toxin","volume":"13","author":"Price","year":"1993","journal-title":"J Clin Neuroophthalmol"},{"issue":"3","key":"10.1016\/j.ajo.2025.11.024_bib0986","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajo.2013.11.014","article-title":"The influence of benign essential blepharospasm on dry eye disease and ocular inflammation","volume":"157","author":"Lu","year":"2014","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajo.2025.11.024_bib0987","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.1111\/aos.12002","article-title":"Tear production and drainage after botulinum toxin A injection in patients with essential blepharospasm","volume":"91","author":"Park","year":"2013","journal-title":"Acta Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0988","doi-asserted-by":"crossref","first-page":"8367","DOI":"10.1038\/s41598-018-26750-5","article-title":"Increase lipid tear thickness after botulinum neurotoxin A injection in patients with blepharospasm and hemifacial spasm","volume":"8","author":"Ho","year":"2018","journal-title":"Sci Rep"},{"issue":"8","key":"10.1016\/j.ajo.2025.11.024_bib0989","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1007\/s10792-022-02253-1","article-title":"Tear meniscus, corneal topographic and aberrometric changes after botulinum toxin-a injection in patients with blepharospasm and hemifacial spasm","volume":"42","author":"Bayraktar Bilen","year":"2022","journal-title":"Int Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajo.2025.11.024_bib0990","doi-asserted-by":"crossref","first-page":"830","DOI":"10.5301\/ejo.5000482","article-title":"Ocular surface alterations in blepharospasm patients treated with botulinum toxin A injection","volume":"24","author":"Kocabeyoglu","year":"2014","journal-title":"Eur J Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0991","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1136\/bjo.87.1.54","article-title":"Botulinum toxin A treatment in patients suffering from blepharospasm and dry eye","volume":"87","author":"Horwath-Winter","year":"2003","journal-title":"The British journal of ophthalmology"},{"issue":"8","key":"10.1016\/j.ajo.2025.11.024_bib0992","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1002\/mds.23658","article-title":"Efficacy and safety of incobotulinumtoxinA (NT 201, Xeomin) in the treatment of blepharospasm-a randomized trial","volume":"26","author":"Jankovic","year":"2011","journal-title":"Mov Disord"},{"issue":"5","key":"10.1016\/j.ajo.2025.11.024_bib0993","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/aos.15036","article-title":"Impact of upper blepharoplasty, with or without orbicularis oculi muscle removal, on tear film dynamics and dry eye symptoms: A randomized controlled trial","volume":"100","author":"Hollander","year":"2022","journal-title":"Acta Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajo.2025.11.024_bib0994","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S0002-9394(14)73926-1","article-title":"Dermatochalasis and dry eye","volume":"115","author":"Vold","year":"1993","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajo.2025.11.024_bib0995","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1034\/j.1600-0420.2003.00064.x","article-title":"A conservative blepharoplasty may be a means of alleviating dry eye symptoms","volume":"81","author":"Floegel","year":"2003","journal-title":"Acta Ophthalmol Scand"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib0996","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/01676830.2016.1243134","article-title":"Effects of Muller's muscle-conjunctival resection for ptosis on ocular surface scores and dry eye symptoms","volume":"36","author":"Rymer","year":"2017","journal-title":"Orbit."},{"key":"10.1016\/j.ajo.2025.11.024_bib0997","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ajo.2019.11.021","article-title":"The Effect of a Ptosis Procedure Compared to an Upper Blepharoplasty on Dry Eye Syndrome","volume":"212","author":"Zloto","year":"2020","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajo.2025.11.024_bib0998","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1590\/S0004-27492012000600010","article-title":"Upper eyelid entropion and dry eye in cicatricial trachoma without trichiasis","volume":"75","author":"Lucena","year":"2012","journal-title":"Arq Bras Oftalmol"},{"key":"10.1016\/j.ajo.2025.11.024_bib0999","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/801971","article-title":"Bell's palsy: symptoms preceding and accompanying the facial paresis","volume":"2014","author":"De Seta","year":"2014","journal-title":"ScientificWorldJournal"},{"issue":"15","key":"10.1016\/j.ajo.2025.11.024_bib1000","doi-asserted-by":"crossref","DOI":"10.4045\/tidsskr.24.0191","article-title":"Entropion","volume":"144","author":"Khan","year":"2024","journal-title":"Tidsskr Nor Laegeforen"},{"issue":"2","key":"10.1016\/j.ajo.2025.11.024_bib1001","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1080\/08820530590931377","article-title":"Adnexal surgery for severe ocular surface disease","volume":"20","author":"Geerling","year":"2005","journal-title":"Semin Ophthalmol."},{"issue":"5","key":"10.1016\/j.ajo.2025.11.024_bib1005","doi-asserted-by":"crossref","first-page":"328","DOI":"10.5935\/0004-2749.20150087","article-title":"Eyelid aging: pathophysiology and clinical management","volume":"78","author":"Damasceno","year":"2015","journal-title":"Arq Bras Oftalmol"},{"issue":"7","key":"10.1016\/j.ajo.2025.11.024_bib1006","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1038\/sj.eye.6702768","article-title":"Clinical evaluation of changes in cornea and tear film after surgery for trachomatous upper lid entropion","volume":"22","author":"Monga","year":"2008","journal-title":"Eye (Lond)"},{"issue":"4","key":"10.1016\/j.ajo.2025.11.024_bib1007","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1097\/SCS.0000000000005466","article-title":"Comparison of four Combined Procedures for Correction of Involutional Lower Eyelid Entropion","volume":"30","author":"Poon","year":"2019","journal-title":"J Craniofac Surg"},{"issue":"4","key":"10.1016\/j.ajo.2025.11.024_bib1008","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1080\/01676830.2023.2204498","article-title":"Mucous membrane grafting for cicatricial entropion repair: review of surgical techniques and outcomes","volume":"43","author":"Singh","year":"2024","journal-title":"Orbit"},{"issue":"6","key":"10.1016\/j.ajo.2025.11.024_bib1009","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1097\/SCS.0000000000004584","article-title":"Management of Severe Cicatricial Entropion With Labial Mucous Membrane Graft in Cicatricial Ocular Surface Disorders","volume":"29","author":"Osaki","year":"2018","journal-title":"J Craniofac Surg."},{"issue":"5","key":"10.1016\/j.ajo.2025.11.024_bib1010","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1055\/s-2008-1035055","article-title":"Rehabilitation of the eye in patients with facial paralyses: indications and results of gold weight implantation","volume":"210","author":"Linder","year":"1997","journal-title":"Klin Monbl Augenheilkd."},{"issue":"6","key":"10.1016\/j.ajo.2025.11.024_bib1011","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1177\/019459989010300622","article-title":"Early gold weight eyelid implantation for facial paralysis","volume":"103","author":"Kartush","year":"1990","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"2","key":"10.1016\/j.ajo.2025.11.024_bib1012","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1136\/bjophthalmol-2016-310089","article-title":"Late outcomes of gold weights and platinum chains for upper eyelid loading","volume":"102","author":"Siah","year":"2018","journal-title":"The British journal of ophthalmology"},{"issue":"6","key":"10.1016\/j.ajo.2025.11.024_bib1013","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1097\/PRS.0b013e3181a65a56","article-title":"Thin-profile platinum eyelid weighting: a superior option in the paralyzed eye","volume":"123","author":"Silver","year":"2009","journal-title":"Plast Reconstr Surg"},{"issue":"2","key":"10.1016\/j.ajo.2025.11.024_bib1014","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/SAP.0b013e318248b87c","article-title":"Alternative surgical treatment of paralytic lagophthalmos using autogenic cartilage grafts and canthopexy","volume":"71","author":"Friedhofer","year":"2013","journal-title":"Ann Plast Surg"},{"issue":"3","key":"10.1016\/j.ajo.2025.11.024_bib1015","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/00002341-199209000-00005","article-title":"Eyelid reconstruction with hard palate mucosa grafts","volume":"8","author":"Cohen","year":"1992","journal-title":"Ophthalmic Plast Reconstr Surg"},{"issue":"5","key":"10.1016\/j.ajo.2025.11.024_bib1016","doi-asserted-by":"crossref","first-page":"e409","DOI":"10.1097\/SCS.0000000000001875","article-title":"Long-Term Outcome of Combined Lateral Tarsal Strip With Temporal Permanent Tarsorrhaphy for Correction of Paralytic Ectropion Caused By Facial Nerve Palsy","volume":"26","author":"Kwon","year":"2015","journal-title":"J Craniofac Surg"},{"issue":"8 Suppl","key":"10.1016\/j.ajo.2025.11.024_bib1017","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1097\/01.ico.0000178740.14212.1a","article-title":"Clinical impact of conjunctivochalasis on the ocular surface","volume":"24","author":"Yokoi","year":"2005","journal-title":"Cornea"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib1018","doi-asserted-by":"crossref","first-page":"90","DOI":"10.9738\/CC59.1","article-title":"Electrocoagulative surgical procedure for treatment of conjunctivochalasis","volume":"97","author":"Zhang","year":"2012","journal-title":"Int Surg"},{"key":"10.1016\/j.ajo.2025.11.024_bib1019","doi-asserted-by":"crossref","DOI":"10.1038\/srep12239","article-title":"Change in Tear Film Lipid Layer Thickness, Corneal Thickness, Volume and Topography after Superficial Cauterization for Conjunctivochalasis","volume":"5","author":"Chan","year":"2015","journal-title":"Sci Rep"},{"issue":"5","key":"10.1016\/j.ajo.2025.11.024_bib1020","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1097\/ICO.0b013e3181dc81d2","article-title":"Thermocautery for inferior conjunctivochalasis","volume":"31","author":"Nakasato","year":"2012","journal-title":"Cornea"},{"issue":"3","key":"10.1016\/j.ajo.2025.11.024_bib1021","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0002-9394(99)00384-0","article-title":"A new surgical technique for management of conjunctivochalasis","volume":"129","author":"Otaka","year":"2000","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"10.1016\/j.ajo.2025.11.024_bib1022","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1097\/ICO.0b013e318255eaaa","article-title":"New approach for conjunctivochalasis using an argon green laser","volume":"32","author":"Yang","year":"2013","journal-title":"Cornea"},{"issue":"8","key":"10.1016\/j.ajo.2025.11.024_bib1023","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1097\/ICO.0b013e3182400100","article-title":"Paste-pinch-cut conjunctivoplasty: subconjunctival fibrin sealant injection in the repair of conjunctivochalasis","volume":"31","author":"Doss","year":"2012","journal-title":"Cornea"},{"issue":"3","key":"10.1016\/j.ajo.2025.11.024_bib1024","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.jcjo.2016.11.003","article-title":"Surgical techniques for the treatment of conjunctivochalasis: paste-pinch-cut conjunctivoplasty versus thermal cautery conjunctivoplasty","volume":"52","author":"Santiago","year":"2017","journal-title":"Can J Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib1025","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3390\/healthcare6010014","article-title":"A Quick Surgical Treatment of Conjunctivochalasis Using Radiofrequencies","volume":"6","author":"Trivli","year":"2018","journal-title":"Healthcare (Basel)"},{"issue":"11","key":"10.1016\/j.ajo.2025.11.024_bib1026","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1016\/j.ophtha.2010.02.023","article-title":"Simple surgical approach with high frequency radio-wave electrosurgery for conjunctivochalasis","volume":"117","author":"Youm","year":"2010","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.ajo.2025.11.024_bib1027","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1055\/s-2007-962928","article-title":"Superficial conjunctiva cauterization to reduce moderate conjunctivochalasis","volume":"224","author":"Haefliger","year":"2007","journal-title":"Klin Monbl Augenheilkd"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib1028","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S1542-0124(12)70103-9","article-title":"The pathogenesis of pterygium: current concepts and their therapeutic implications","volume":"6","author":"Chui","year":"2008","journal-title":"Ocul Surf"},{"issue":"3","key":"10.1016\/j.ajo.2025.11.024_bib1029","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1159\/000050860","article-title":"Pterygium and dry eye","volume":"215","author":"Ishioka","year":"2001","journal-title":"Ophthalmologica Journal international d'ophtalmologie International journal of ophthalmology Zeitschrift fur Augenheilkunde"},{"issue":"12","key":"10.1016\/j.ajo.2025.11.024_bib1031","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1097\/ICO.0b013e318259c934","article-title":"Tear osmolarity and ocular changes in pterygium","volume":"31","author":"Julio","year":"2012","journal-title":"Cornea"},{"issue":"5","key":"10.1016\/j.ajo.2025.11.024_bib1032","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1007\/s00417-023-06191-1","article-title":"The effect of different pterygium surgery techniques on the ocular surface parameters in different durations: a systematic review and meta-analysis","volume":"262","author":"Chang","year":"2024","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajo.2025.11.024_bib1033","first-page":"641","article-title":"Comparison of postoperative recovery of primary pterygium excision combined with either limbal stem cell transplantation or amniotic membrane transplantation: a randomized controlled trial-based meta-analysis","volume":"15","author":"Yin","year":"2023","journal-title":"Am J Transl Res"},{"issue":"12","key":"10.1016\/j.ajo.2025.11.024_bib1034","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1097\/ICO.0b013e31823cbecb","article-title":"Comparison of pterygium recurrence rates after limbal conjunctival autograft transplantation and other techniques: meta-analysis","volume":"31","author":"Zheng","year":"2012","journal-title":"Cornea"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib1035","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2022.103416","article-title":"Pharmacological treatment strategies of pterygium: Drugs, biologics, and novel natural products","volume":"28","author":"Baheran","year":"2023","journal-title":"Drug Discov Today"},{"issue":"6","key":"10.1016\/j.ajo.2025.11.024_bib1036","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1038\/s41433-020-0786-3","article-title":"Pterygium: new insights","volume":"34","author":"Chu","year":"2020","journal-title":"Eye (Lond)"},{"issue":"2","key":"10.1016\/j.ajo.2025.11.024_bib1037","doi-asserted-by":"crossref","DOI":"10.3390\/jcm13020521","article-title":"Salivary Gland Transplantation as a Promising Approach for Tear Film Restoration in Severe Dry Eye Disease","volume":"13","author":"Chen","year":"2024","journal-title":"J Clin Med"},{"key":"10.1016\/j.ajo.2025.11.024_bib1038","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jtos.2022.07.013","article-title":"Salivary gland transplantation for dry eye disease: Indications, techniques, and outcomes","volume":"26","author":"Singh","year":"2022","journal-title":"Ocul Surf"},{"issue":"8","key":"10.1016\/j.ajo.2025.11.024_bib1039","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.jcms.2013.01.015","article-title":"Allogenic submandibular gland transplantation following hematopoietic stem cell transplantation","volume":"41","author":"Jacobsen","year":"2013","journal-title":"J Craniomaxillofac Surg"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib1041","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1080\/08820538.2021.1926518","article-title":"A novel diagnostic technique of measuring labial minor salivary gland secretions using sodium fluorescein dye: Implications for patients with dry eyes","volume":"37","author":"Singh","year":"2022","journal-title":"Semin Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib1042","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ijom.2018.07.006","article-title":"Factors influencing the long-term results of autologous microvascular submandibular gland transplantation for severe dry eye disease","volume":"48","author":"Zhang","year":"2019","journal-title":"Int J Oral Maxillofac Surg"},{"issue":"11","key":"10.1016\/j.ajo.2025.11.024_bib1043","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1016\/j.joms.2018.05.008","article-title":"Microvascular Submandibular Gland Transplantation for Severe Keratoconjunctivitis Sicca: A Single-Institution Experience of 61 Grafts","volume":"76","author":"Wang","year":"2018","journal-title":"J Oral Maxillofac Surg"},{"issue":"6","key":"10.1016\/j.ajo.2025.11.024_bib1044","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.ajo.2010.05.010","article-title":"Long-term follow-up after submandibular gland transplantation in severe dry eyes secondary to cicatrizing conjunctivitis","volume":"150","author":"Borrelli","year":"2010","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajo.2025.11.024_bib1045","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.oooo.2021.09.005","article-title":"Clinical and histopathologic characteristics of submandibular gland in Stevens-Johnson syndrome: A comparative study","volume":"133","author":"Wang","year":"2022","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"10.1016\/j.ajo.2025.11.024_bib1046","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1159\/000131093","article-title":"Minor salivary gland transplantation","volume":"41","author":"Geerling","year":"2008","journal-title":"Dev Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajo.2025.11.024_bib1047","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1136\/bjo.2010.199901","article-title":"Minor salivary glands and labial mucous membrane graft in the treatment of severe symblepharon and dry eye in patients with Stevens-Johnson syndrome","volume":"96","author":"Sant' Anna","year":"2012","journal-title":"The British journal of ophthalmology"},{"issue":"Suppl 1","key":"10.1016\/j.ajo.2025.11.024_bib1049","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1097\/ICO.0000000000001358","article-title":"Minor Salivary Gland Transplantation for Severe Dry Eyes","volume":"36","author":"Wakamatsu","year":"2017","journal-title":"Cornea"},{"key":"10.1016\/j.ajo.2025.11.024_bib1050","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jtos.2021.07.005","article-title":"A new option for treatment of severe cicatricial entropion in patients with Stevens-Johnson syndrome","volume":"22","author":"Sant'Anna","year":"2021","journal-title":"Ocul Surf"},{"issue":"11","key":"10.1016\/j.ajo.2025.11.024_bib1051","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1136\/bjophthalmol-2020-316611","article-title":"Minor salivary gland transplantation for severe dry eye disease due to cicatrising conjunctivitis: multicentre long-term outcomes of a modified technique","volume":"105","author":"Vazirani","year":"2021","journal-title":"The British journal of ophthalmology"},{"key":"10.1016\/j.ajo.2025.11.024_bib1053","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jtos.2024.08.010","article-title":"The clinical outcomes of minor salivary gland transplantation for severe dry eye disease secondary to chronic StevensJohnson syndrome","volume":"34","author":"Sharma","year":"2024","journal-title":"Ocul Surf"},{"key":"10.1016\/j.ajo.2025.11.024_bib1054","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.ajo.2022.05.019","article-title":"Submandibular Gland Transplantation vs Minor Salivary Glands Transplantation for Treatment of Dry Eye: A Retrospective Cohort Study","volume":"241","author":"Su","year":"2022","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.024_bib1055","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/ICO.0000000000003126","article-title":"Sural Nerve Vertical Cross-Face Graft for Lacrimal Gland Neurotization to Improve Tear Secretion in eurodeprivative Dry Eye","volume":"42","author":"Giannaccare","year":"2023","journal-title":"Cornea"},{"key":"10.1016\/j.ajo.2025.11.024_bib1056","article-title":"Long-term outcomes of sural nerve vertical cross-face graft for lacrimal gland neurotization in neurodeprivative dry eye","author":"Strianese","year":"2024","journal-title":"Graefes Arch Clin Exp Ophthalmol."}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939425006233?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939425006233?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T16:26:43Z","timestamp":1783441603000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939425006233"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":1044,"alternative-id":["S0002939425006233"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2025.11.024","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"TFOS DEWS III \u7ba1\u7406\u4e0e\u6cbb\u7597\u62a5\u544a","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2025.11.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}